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Abstract 
Diabetes mellitus is recognized as one of the leading causes of 
morbidity and mortality in the world . About 5 to 6% of the world population 
suffers from this disease and the number of people diagnosed with diabetes is 
rapidly increasing. Diabetes has been demonstrated to be associated with 
oxidative stress and hyperglycemia, one of the most important indictors of 
oxidative stress. Normally the endogenous mechanisms of enzymes and 
antioxidants are able to destroy the reactive species and create a balance 
between antioxidant and free radicals. In diabetes, the oxidative stress is  
increased due to the deficiency in  the antioxidant defense. The intake of 
antioxidants such as vitamin E and C may reduce the oxidative stress 
associated with diabetes and hence help to restore the antioxidant defense 
system. 
The aim of thi.s study is to investigate the effect of different doses of 
either vitamin E or C on the metabolic and biochemical parameters of normal 
and streptozotocin (STZ)-induced diabetic rats. Biochemical analysis, 
immunohistochemistry, and radioimmunoassay techniques were used to study 
the effect of these vitamins on the metabolic and biochemical parameters of 
normal and diabetic rats. The result of this study revealed that the oral 
administration of vitamin E and C significantly reduced the body weight gain 
i n  a dose-correlated manner. Moreover, vitamin E and C significantly 
(p<O.OOO l )  reduced the blood glucose level in normal (p<O.OOO8) and in 
diabetic (p<O.OOO7) rats. The oral administration of these vitamins 
significantly enhanced glucose tolerance in normal and diabetic rats. Both 
vitamin E and C significantly affect the biochemical parameters of both 
normal and diabetic rats. Both vitamin E and C have an effect on liver 
function, for example the low dose of vitamin E significantly (p<O.0 1 2) 
i ncreased the plasma gamma-glutamyl level i n  normal rats while the moderate 
dose of vitamin C significantly (p<O.OOO8) reduced plasma gamma-glutamyl 
level in  diabetic rats. 
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Moreover, the kidney function of normal and diabetic rats was affected 
after the oral administration of vitamin E and C. High dose of vitamin C 
significantly (p<O.O l )  increased the blood urea nitrogen level of diabetic rats, 
while low do e of vitamin E significantly i ncreased (p<O.03) blood urea 
nitrogen of normal rats. The plasma level of electrolytes such as calcium and 
sodium also changed significantly (p<O.OOOO I )  after oral administration of 
either vitamin E or C. 
In an immunohistochemical study of pancreas on the number and 
distribution of insulin and glucagon cel is, a significant i ncrease in the number 
of insulin positive cells was observed i n  rats treated with vitamin E and C after 
the onset of diabetes when compared to control . However, the number was 
sti l l  significantly less than that obtained for control normal rats. 
However, both vitamin E and C fail to i ncrease the insulin level of 
normal and diabetic rats. The level of plasma glucagon i ncreased after the 
onset of diabetes mellitus and both of vitamin E and C significantly reduced i ts 
level in  diabetic rats when compared to control. 
In conclusion antioxidants such as vitamin E and C may ameliorate the 
metabolic and biochemical parameters of diabetic rats. 
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1 .  Diabetes Mellitus 
1 . 1  History of diabetes mellitus 
Diabete mellitus is a disease which has a very old history. The clinical 
features of diabetes mellitus that we see today were observed 3000 years ago by 
the ancient Egyptians. Araetus of Coppodocia described the term diabetes in  
(8 1 - l 33 AD) ( 1 ) . Diabetes is  derived from the Greek word "diabaniein" which 
means to pass through and this mean the large quantity of water taken orally due 
to 'polydipsia' has passed through the body in the same way 'polyuria' (2) .  
After that, Thomas Will is in  1 675 added the word mellitus which mean "honey 
sweet" after rediscovering the sweetness of urine and blood of the patients. Later 
on, Claude Bernard discovered the role of the liver in glycogen and that diabetes 
resu lted from the excess of glucose production while the role of pancreas in  
diabetes was discovered by Mering and Minkowski in  1 889 ( 1 ) .  Insu lin was 
eventually discovered by Banting and Best in 1 922 (3) .  
1 .2 Epidemiology 
Diabetes mellitus, recently, i s  taking i ts place as one at the main threats 
to human health in the 2 1  Sl century .  In the past two decades the number of 
people with diabetes has increased worldwide. This increase in the incidence 
and prevalence of diabetes mellitus is due to behavioral and lifestyle changes in 
the past two decades (4). 
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Diabete mellitu affects approximately 6% of the world popu lation . 
India has the greatest number of diabetic patients, fol lowed by China which has 
1 7  million diabetic patients and then USA which has 1 5  million in the year 2000 
(2) .  In the year 2000, the total number of people with diabetes mellitus is 1 5 1  
mi llion and the number is projected to increase by 46% to reach 2 2 1  mi l lion by 
the year 20 1 0  and 300 mi l lion in 2025 (4). By the year 2025, diabetes wi l l  
increase by more than 1 93% in  both the Middle East and India and this means 
that more than 50 mi l lion people wil l  have diabetes in each of these regions (2).  
1 .3 Definition 
Diabetes mellitus (DM) is a heterogeneous group of disorders 
characterized by high blood glucose level (5) .  DM is associated with abnormal 
changes in protein, carbohydrate and fat metabolism (6) and induce disturbances 
in lipid profi les especially, an increased susceptibi lity to lipid peroxidation (7) .  
These are the result of insufficient insul in action (6) . 
1 .4 Classification 
Diabetes mellitus is classified into two main types (8) .  Recently, the terms 
insulin dependent diabetes mellitus and non insulin dependent diabetes mellitus 
were dropped and American Diabetes Association (ADA) and WHO proposed 
new c lassification for diabetes based on i ts etiology. Diabetes mellitus is now 
classified into four categories type 1 ,  type 2, diabetes due to other specific 
mechanisms or condition, and gestational diabetes (9). 
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1 .4. 1 Type 1 d iabetes mell i tus 
Type I diabetes was fonnally referred to as insulin dependent diabetes or 
j uveni le on et diabetes ( 1 0) .  It is an older disorder, it was found in  the ancient 
Egyptian and Greek writing. Type 1 diabetes affects about 0.5% of the population 
in developed countries. Type 1 diabetes mellitus is an autoimmune disease 
resu lting from a specific destruction of B-cell of the islets of Langerhans of the 
pancreas ( 1 1 ) . Recently, the B-ceU destruction has been suggested to be due to 
islet cell autoantibodies to insulin, glutamic acid decarboxylase and tyrosine 
phosphatase ( 1 2) .  
Type I DM is the most common endocrine disorder among chi ldren and 
young adu lts and it may be caused by infections (enteroviruses), genetic 
disorder, and! or inappropriate diet ( 1 3) .  
Type 1 diabetes has two different phases. The fust phase is the insulitis 
phase. In  this phase the is let has leukocytes which infi l trate the islets. The second 
phase is cal led the diabetes phase. I n  this phase, the B-cell of the islets has been 
destroyed, and it is unable to produce sufficient insulin, which control glucose 
levels, resulting in hyperglycemia ( 1 1 ) . 
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1 .4.2 Type 2 diabete mell i tus 
Type 2 diabetes is the most common fonn of diabetes. It affects more than 
90% of the diagnosed cases ( 1 4) .  It is a heterogeneous syndrome characterized by 
abnonnalities in  the metabolism of fat and carbohydrate. Type 2 DM is caused by 
a multi-factorial mechanism including both genetic and environment factors that 
affect B-cel l function and tissue insulin sensitivity. Several adipocytokines such as 
leptin,  TNF-alpha, resistin and adiponectin play a role in insuli n  resistance and 
possible B-cell dysfunction ( 1 5) .  The onset of type 2 diabetes begins in middle 
age ( 1 6) .  It has different subtypes and each one is characterized by different 
degrees of i nsulin resistance and B-cell dysfunction (5) .  
1 .4.3 Gestational diabetes mell itus 
Gestational diabetes (GDM) is a carbohydrate intolerance resulting in  
hyperglycemia during pregnancy. GDM develops in  0. 1 5  to 1 5% of all pregnant 
women. It is characterized by preeclampsia in pregnant women and macrosomia 
and birth trauma in  the fetus.  According to the latest WHO recommendation, 
GDM is diagnosed by performing the universal standard 75 g OGrr and 
evaluating blood glucose level after 2 h ( 1 7) .  
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1 .S Complications of diabetes mellitus 
Diabetes mellitus is  a chronic disease associated with severe late 
complications. It affects the metabolism of carbohydrates, protein, fat and 
electrolytes which cau e changes in the structure of the vascular system (2). 
Recently, studies sugge t that protein kinase C activation may play an important 
role in the development of diabetes complication, and the use of i ts inhibitors 
can reduce these complications. It is reported that an inhibitor of protein kinase 
C was able to reduce renal and retinal dysfunction in diabetic animals ( 1 8) .  The 
end product of the non enzymatic glycation induces cytokines in vascular cel ls  
which play role in the development of diabetic complication ( 1 9) .  
Furthennore, oxidative stress is  derived from glucose autooxidation, 
advanced glycation and mitochondrial dysfunction may damage endothelial cell 
function (20) . Hyperglycemia induces the production of superoxide by 
mitochondria, leading to the fonnation of a strong oxidant proxy nitrite, which 
damage DNA. The damage of the DNA activates the nuclear enzyme poly 
(ADP-ribose) polymerase, which depletes the intracellu lar concentration of 
NAD (+), thus slowing glycolysis, A TP fonnation, and ADP ribosylation of 
GAPDH. All of these processes contribute to the development of late 
degenerative complications (2 1 ) . 
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Both type of diabetes mellitus are characterized by chronic 
hyperglycemia which leads to the development of specific microvascular and 
macrovascular di sorders (22). The most common chronic complications of 
diabetes include retinopathy, nephropathy, neuropathy and atherosclerosis 
(23) .  Diabetic nephropathy causes thickening of the glomerular capi l lary and 
tubular basement membranes. DM also causes expansion of the mesangial 
matrix (24). 
Diabetic retinopathy is a leading cause of blindness .  Other severe 
complications of diabetes include cardiovascu lar i llness, which is the major 
cause of morbidity and mortality, and encompasses macrovascu lar disease 
with heart attacks, strokes, and gangrene and hardening of the skin and 
cataract formation (25) .  
1 .6 Management and treatment of diabetes mellitus 
Currently, the treatment of type 2 diabetes mellitus involves diet 
modification, weight reduction ,  exercise; insulin and oral medications (26) . Diet 
and exercise therapy may be beneficial in the treatment and prevention of type 2 
DM. Physical exercise i ncreases the uti lization of blood glucose level and 
decreases its level. It shou ld not be considered as a lone therapy, it should be 
combined with dietary therapy and medications (27) .  The diet treatment is the 
basic therapy of type 2 diabetes. It plays an important role i n  preventing diabetes 
from developing, and it is effective in the management of DM. Diet treatment 
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hou ld include a balanced combination of proteins, carbohydrates, lipid and 
vegetables (28) .  
Patients with type I diabetes depend on insulin so the usual treatment is  
by subcutaneous injection of insulin (29). There are many kinds of insulin 
preparations, such as rapid acting insulin like insulin lisper (homolog) and 
insulin aspart (novo log), and these insulin products are rapidly absorbed. 
Insulin lisper is di fferent from human i nsulin by the exchange of the amino acid 
lysine and proline at position 28 and 29 while substitution of aspartic acid for 
proline at position 28 created i nsulin asp art. This type of insulin is injected at 
meal time or used in insu lin pump. Short acting insulin is a regular insulin with 
onset of action between 30 to 60 min .  Moreover, regular insulin acts almost 
immediately after intravenous injection. Intermediate insu lin, such as neutral 
protamine hagedorn, is absorbed slowly because of the addition of protamine to 
regular insulin.  Lente insulin which is regu lar insulin bound to zinc and has 
longer effective duration than NPH. Long acting insulin such as ultra lente 
insulin (insulin  zinc extended) is absorbed slowly in i ts zinc crystalline form 
(30). 
Currently, several alternative methods for insulin delivery, instead of 
injection, have been developed to eliminate pain and disruption of lifestyle, which 
are associated with insulin injection. Intrapulmonary insulin (inhaled insulin) is an 
alternative to regular insulin injection . It i s  good in  control ling glucose levels and 
it had no adverse bronchopulmonary effects (3 1 ) . 
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Type 2 OM therapy relies main ly in  agents purposed to reduce 
hyperglycemia (32).  Five classes of agents currently exist. Su lfonylureas which 
lower plasma glucose by acting on the beta cell to stimulate insulin secretion 
(33) .  Su lfonylureas bind to ATP-sensitive potassium channels and inhibit i ts 
efflux and this lead to efflux of calcium through the voltage-dependent calcium 
channels. The high intracytosolic calcium concentration resu lted in the release 
of insulin (34). Meglitinides agents are non sulfonylureas which target different 
sites on beta cells, leading to a s imi lar cascade of events increasing i nsulin 
release (35). 
B iguanides such as metformin decrease hepatic glucose production by 
reducing gluconeogenesis. I t  i s  not a hypoglycemic agent because i t  does not 
i ncrease i nsulin secretion (36). Thiazolidine enhances glucose uptake and 
uti lization in peripheral tissues, mainly skeletal muscle tissue (34). 
Alpha-glycosidase inhibitors such as carobs and miglitol act by delaying 
carbohydrate absorption i n  the small i ntestine (36). 
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2. Oxidative stress 
Oxidative stres refer to the state in which cells are exposed to 
excessive levels of molecu lar reactive species (38) . It is also defined as a 
di turbance in the balance between the production of the reactive species and 
antioxidant defence (39). 
These reactive species are generated as a result of metabolic reaction in 
the form of free radicals or non free radicals and they could be oxygen or 
nitrogen derived. They are cal led peroxidants (40) . 
The free radical molecule which is formed from oxygen is cal led reactive 
oxygen species (ROS) such as superoxide and hydroxyl and it i s  also referred to 
oxygen derived non radicals like hydrogen peroxide. On the other hand, the free 
radical molecule which is formed from nitrogen is called reactive nitrogen 
species ( RNS) like nitric oxide and nitrogen dioxide (4 1 ) . 
Most biological molecu les contain paired electrons i n  their outer orbit 
but in the case of the free radicals the molecule contains an unpair electron i n  
the outer orbit and this results i n  very reactive molecu les which can gain or lose 
electron. ROS and RNS function as immunological host defence. They are 
generated by macrophages and neutrophi lis to ki l l  microbes and destroy other 
foreign matter. Nitric oxide plays an important role in neurotransmission and 
regulation of blood pressure. Moreover, several cytokines, growth factors, 
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hormone and neurotransmitters induce rapid production of reactive specie to 
act a signaIling molecule in many tran duction pathways (42). 
Some ROS play an important cellu lar messenger role in  the regulation of 
apoptosis, tran cription factor activation, kina e activation and gene expression 
at low concentration (43) .  llighly reactive molecu les which are cal led free 
radicals react with any molecule which they come in contact with causing a kind 
of chemical havoc. They can cause damage to important biological molecu les, 
like protein, carbohydrates, lipids and DNA (44).  
3. Diabetes mellitus and Oxidative stress 
Diabetes mellitus can be caused by oxidative stress. The sources of the 
reactive species in diabetes include free radical reactions related to g lycation of 
proteins, consumption of NADPH through the polyol pathway, glucose 
autoxidation, hyperglycemia-induced pseudo hypoxia and activation of protein 
kinase C (45) .  
In  the normal condition, endogenous mechanisms, enzymes and 
antioxidant molecu les are able to destroy reactive molecular species and reduce 
the harmful effect of oxidants (46) but in diabetes the hyperglycemia and 
possible free fatty acid induce the reactive molecular species and oxidative 
stress which play role in causing insulin resistance and B cell dysfunction. 
Reactive oxygen and nitrogen species may also play a role in the pathogenesis 
1 4  
of the late diabetes complication becau e they have the abi lity to oxidize and 
damage DNA, protein and lipid (38) .  
4. Antioxidants 
An antioxidant is defined as any substance that when present at low 
concentration compared to those of an oxidisable substrate, significantly delays 
or prevents oxidation (47) .  Antioxidant can be produced endogenously or 
provided from exogenous sources such as vitamins C and E (40). Fruits and 
vegetables are good sources of antioxidants (48) . 
Actually endogenous antioxidants i nclude enzymes like superoxidase 
dismutase. superoxidase dismutase is metalloenzymes, which catalyzes the 
dismustation of superoxide radicals into H202 and oxygen. Catalase catalyzes 
the decomposition of hydrogen peroxide into molecular oxygen and water. They 
are located in peroxisomes and i n  the cytosol (49).  The antioxidant glutathione 
peroxidase is an enzyme with much greater affinity for hydrogen peroxide than 
catalase, and it is located in both mitochondria and the cytosol where it serves as 
a cellu lar protectant against free radical induced damage to membrane lipids, 
protein and nucleic acid (50) . 
Melatonin is  another example of endogenous antioxidant. I t  can 
neutralize oxygen and nitrogen reactive species, acts as indirect antioxidant by 
stimulating the synthesis of glutathione and it can preserve the functional 
integrity of superoxide dismutase and catalase (5 1 ) . 
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Al 0, the endogenous antioxidant sy tern includes some minerals such as 
elenium, copper and zinc. These trace elements are linked together in cytosolic 
defense against free radicals. Copper and zinc ions stimulate protective cellu lar 
stre s signaling pathway. Selenium exists in  the cel l as selenocysteine and 
elenomethionine which catalyzes the reduction of peroxynitrite at the expense 
of glutathione (52) .  Some compounds which also act as antioxidant include 
flavonoids, bilirubin and uric acid (40) . 
5. Vitamin E (a-tocopherol ) 
In 1 920, Evans and co-workers described a dietary substance, which is  
important i n  rat 's  reproduction and they called it vitamin E.  It is naturally found in  
oi ls from vegetable and plants. Synthetic vitamin E can be made from the reaction of 
trimethylhydroquinone with isophytol (53) .  
Vitamin E is defined as  a lipid soluble, chain breaking radical scavenger 
(54). It is a highly viscous oi l, i nsoluble in water and rapidly oxidized by 
atmospheric oxygen (Fig 1 ) . These properties of a-tocopherol l imit its therapeutic 
application. Because of i ts high instabi lity to oxidation, the acetate and acid 
succinate esters of the vitamin are commonly used for clinical uses (43) .  It is also 
characterized by low molecular weight and lipid solubi lity, which help it to 
scavenge reactive species in lipid laden compartments like cell membrane (55) .  
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Vitamin E ha the abi l ity to scavenge a wide pectrum of free radical 
including singlet oxy gen, supero ide and hydro y l  radical (56) .  Al o. i t  is 
bel ieved that v i tamin E can act as membrane tabi l i zer b form ing complexes 
"" i1h the product of membrane l ipid hydrolysi uch as I ysophosphol ipids and 
fr fatty acid ( 5 7 ). 
F igure I :  Chem ical structure of a-tocopherol .  (58 ) .  
Vitamin E dose not function as an antioxidant only, i t  has a great benefit 
against several di sorders such as atherosclerosis, ischemic heart disease and 
tumors (59), because it acts as a transcriptional regulator for gene expression via 
a transcription factor TAP (60). I t  also down regulates protein kinase- C  activity, 
thus decreasing smooth muscle cel l pro l iferation ( 5 7 )  
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Vitamin E occurs naturally in four i orner Ca, B, y and 8) of both 
tocopherols and tocotrienols (6 1 ) . The difference between tocopherols and 
tocotrienols re ides in the phytyl-chain saturation. Tocopherols are saturated, 
while tocotrienol are unsaturated but they both scavenge lipid peroxyl radicals 
before reacting with other lipids, thereby ending the propagation of lipid 
peroxidation in membranes. 
Alpha-tocotrienol is more efficient than a-tocopherol in scavenging 
peroxyl radicals in vitro while a-tocopherol and y-tocopberol are more effective 
in  scavenging nitrogen-oxide species (57).  Alpha-tocopherol is the most 
important form in nature and has the highest biological activity (62) . I ts name is 
derived from the Greek (toco) term meaning "to bear offspring" because of it is 
role in  reproduction of rats (63) .  
6- Vitamin C (Ascorbic acid) 
Vitamin C is a water soluble antioxidant that was firstly isolated and 
characterized by Szent-Gyorgyi in 1 928 (64). It is an abundant component of 
plants (Fig 2) .  In plants, it reaches a concentration of over 20 mM in chloroplast 
and occurs i n  the cell compartments including cell wall .  It plays a role i n  
photosynthesis a s  an  enzyme cofactor and in  the control of cell growth (65) .  
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Ascorbate is synthe ized by most vertebrates excluding humans, 
monkeys, guinea pigs, the Indian fruit  bat and in some fish it is synthesized in 
the li ver (55) .  
o 
H - Q OH 
Figure 2: Chemical structure of Ascorbic acid 
Vitamin C (66). 
Vitamin C is important for many enzymatic reactions and also acts as a 
free radical scavenger. Specific non overlapping transport protein mediate the 
transport of the oxidised form of vitamin C, dehydroascorbic acid, and the 
reduced form, L-ascorbic acid across biological membranes. Dehydroascorbic 
acid uptake across the membrane occurs via the facilitated diffusion through 
glucose transporters Glut I ,  3 and 4, whi le L-ascorbic acid enters cel l  via N a 
dependent system (SVCT 1 and SVCT 2) (67) . 
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The cellu lar uptake of vitamin C is promoted by in ulin and inhibited by 
hyperglycemia (68). A corbic acid has se eral antioxidant properties (69). It is an 
essential cofactor involved in many biochemical functions, and it acts as an 
electron donor or reducing agent, it is said to have ascorbate oxidant activity (62) .  
I t  has greater roles in  the aqueous intersti tial and intracellular fluid 
compartments (55) .  Ascorbate effectively scavenge singlet oxygen, 
superoxide, hydroxyl and water soluble peroxyl radical, and hypochlorous acid 
(63 ). 
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Objectives of this study 
The main objective of this study is to determine which antioxidants 
have anti -diabetic effects, examine the effect of antioxidant on metabolic and 
biochemical parameters of both nonnal and diabetic rats, and determine the 
mechanism of action of these antioxidants. 
Specific aims of this study: 
1 .  To study the hypoglycemic effect of vitamin E and C in  normal and diabetic 
rats. 
2. To investigate the effect of vitamin E and C on metabolic parameters such as 
body weight, plasma glucose level, and oral glucose tolerance test in normal 
and diabetic rats. 
3 .  To examine the effect of vitamin E and C on biochemical parameters such as 
liver enzymes, kidney paranleters, and plasma electrolytes level in normal 
and diabetic rats. 
4. To investigate the effect of vitamin E and C on plasma i nsu lin and glucagon 
level in normal and diabetic rats. 
5 .  To examine the effect of vitamin E and C on the morphology of pancreatic 
islets of Langerhans in normal and diabetic rats. 




1 .  Experimental animals 
Male Wistar rats aged seven to eight weeks and weighting 200-300 g 
were used in  this study. All rats were obtained from the Facu lty of Medicine and 
Health Sciences, United Arab Emirates University. Al l  rats were housed in a 
temperature (25 °C) and humidi ty controlled rooms and 1 2  hours light and dark 
periods. The animals were fed on a standard rat chow and tap water ad libitum. 
2. Induction of experimental diabetes 
Diabetes was induced in the rats by a single intraperitoneal injection of 
streptozotocin (STZ) (Sigma, St Louis, MO) at a dose of 60 mg/kg body weight 
(70). The STZ was freshly dissolved in citrate buffer (0.5 M, pH4.5). The rats 
were considered diabetic i f  the fasting blood glucose level values were more 
than 250 mgldl .  
3. Experimental design 
Rats were randomly divided into three groups according to three 
different doses of both vitamin E and vitamin C ( low dose 0.2 mg, moderate 
dose 0.4 mg, and high dose 0.8 mg per animal of vitamin E) and ( low dose 1 0  
mg/kg, moderate dose 50 mg/kg and high dose 1 00  mg/kg of vitamin C). Rats 
were orally treated with either vitamin E and vitamin C by using i ntubation loop. 
Each of these groups was divided into five subgroups of six animals each: 
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1 - Group 1 erved a normal untreated group, where the rats have not been 
treated either with STZ or with vitamin E or C. 
2- Group 2 served as diabetic control. STZ-induced diabetic rats that was not 
treated with either vitamin E or C. 
3- Group 3 served as diabetic treated group.  This  group was treated with three 
different doses ( low, moderate and high) of either vitamin E or vitamin C for ten 
days prior to the STZ-induction of diabetes. 
4- Group 4 also served as a diabetic treated group. This group was induced with 
STZ to develop diabetes and it was treated with the three different doses low, 
moderate and high of either vitamin E or vitamin C ten days after the induction 
of diabetes. 
5- Group 5 served as normal non diabetic treated group.  This group was treated 
with the three different doses of either vitamin E or vitamin C only.  
4. Weight measurement 
The weights of normal and diabetic rats were recorded on a weekly basis 
using a 900 1 Scale (Satorius, UK) .  The mean ± standard deviation of the weight 
for each of the experimental groups was calculated for each week of the 
experimental period. 
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5. Plasma glucose measurement 
The blood glucose level was measured weekly using (One Touch II 
Glucometer, Life Scan, Johnson and Johnson, USA) for each individual 
animal of all the groups. The blood samples for glucose measurement were 
drawn from the tai l  vein, and rats were considered diabetic if their blood 
glucose levels exceeded 250 mgldl (7 1 ) . The mean ± standard deviation of the 
blood glucose for each of the experimental groups was calculated for each 
week of the experimental period. 
6. Oral glucose tolerance test (OGTT) 
At the end of the four weeks from the commencement of the treatment, 
rats were subjected to an oral glucose tolerance test, after an overnight fast of 
1 8  h .  On the day of the OGTT the animals were given an oral dose of glucose 
1 0  ml/k:g body weight, 30% w/v. The blood glucose measurements were made 
at 0, 30, 60, 1 20, and 1 80 min after glucose challenge. 
7. Tissue collection and tissue processing 
At the end of the experiment, normal and treated rats were anaesthetized 
with diether. A long abdominal incision was made and the pancreas was quickly 
removed, trimmed of connective tissue and fixed overnight in Zamboni ' s  
fixative (72). The tissue samples were later dehydrated in  graded concentration 
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of ethanol .  The specimens were changed every 2 hours in 70% and 95% and 3 
changes in absolute ethanol for 2 hour . After dehydration the specimens were 
cleared in xylene and subsequently embedded in paraffin wax at 55°C. Section 
of 6 � m  thickness were cut on a microtom (Shandon AS325, USA), and placed 
in water bath at 49°C. Thereafter, they were transferred onto microscopic slides, 
which were dried in an oven at 60°C for 30 min to enhance attachment of 
sections. 
8. Immunohistochemistry 
6 � m  thickness paraffin sections were deparaffinised with xylene two 
times (5 min each) and then transferred into absolute ethanol two times (5 min 
each). After that the sections were incubated in  0.3% of hydrogen peroxide 
solution in methanol for 30 min to block the activity of endogenous peroxidase. 
The tissues were then hydrated in descending concentration of ethanol and 
washed 3 times i n  PBS (phosphate buffered saline) for 5 min each. After 
washing in PBS the tissues were marked around with a Dako pen to prevent 
solutions draining away from the tissue section. The staining procedure was 
started by i ncubating the sections with blocking reagent for 30 min .  After that, 
the blocking reagent was drained off and appropriate dilution of the primary 
antibodies were applied and incubated at 4°C for 24 hr. On the fol lowing day the 
sections were incubated at the room temperature for 1 hr. The slides were then 
washed 3 times in PBS for (5 min each) and incubated with predi luted 
biotinylated anti-guniea pig or anti-mouse or anti-rabbit IgG (Sigma, St Louis, 
MO, USA) for 1 hr, then washed in  PBS 3 times (5 min each) and subsequently 
i ncubated in streptavidin peroxidase conjugate (Sigma) for I h .  After a fmal 
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wa h in  PBS 2 times (5 nUn each), the peroxida e activity was revealed by 
incubating the sections in  3 ,3-diaminobenzidine tetrahydrochloride DAB 
(Sigma) in  PBS for (5 nUn) .  The slides were then washed for 5 min under 
running tap water, and counterstained with haematoxylin for 1 5  s and washed 
briefly in tap water. Then they were differentiated in acid ethanol and washed 
for 5 min under running tap water, then dehydrated in ascending grades of 
ethanol, and subsequently c leared in  xylene for longer time to dissolve the Dako 
pen mark . The tissues were subsequently mounted in DPX. S lides were 
examined under microscope and i nununopositive areas of the tissue section were 
photographed. 
9. Immunofluorescenece 
Isolated pancreatic tissues were retrieved, fixed and embedded i n  
paraffin a s  described in  section 7 .  Sections of  about 611 m thickness were 
deparaffinised in xylene, hydrated in descending concentration of ethanol (3 min 
each) and washed 3 times i n  PBS for (5 nUn each) .  After washing in  PBS,  the 
tissue was marked around with a Dako pen to prevent solutions draining away 
from the tissue section . The staining procedure was started by incubating the 
sections with blocking reagent for 30 min .  After that, the blocking reagent was 
drained off and appropriate di lution of primary antibodies were applied and 
incubated at 4°C for 24 h. On the fol lowing days the sections were incubated at 
the room temperature for 1 hr. The slides were then washed 3 times in PBS (5 
min each) and incubated with secondary antibodies conjugated with either FITC 
or TRITC (Jackson Laboratory, USA) for 1 h and washed in PBS (3 times 5 nUn 
wash in PBS 2 times (5 min each), the peroxidase activity was revealed by 
incubating the section in  3 ,3-diaminobenzidine tetrahydrochloride DAB 
(Sigma) in  PBS for (5 min) .  The slides were then wa hed for 5 min under 
running tap water, and counter tained with haematoxylin for 1 5  s and washed 
briefly in tap water. Then they were differentiated in acid ethanol and washed 
for 5 min under running tap water, then dehydrated in ascending grades of 
ethanol, and subsequently cleared in xylene for longer time to dissolve the Dako 
pen mark . The tissues were subsequently mounted in DPX. S lides were 
examined under microscope and irnmunopositive areas of the tissue section were 
photographed . 
9. Immunofluorescenece 
Isolated pancreatic tissues were retrieved, fixed and embedded i n  
paraffm as described i n  section 7 .  Sections of  about 6� m thickness were 
deparaffmised in xylene, hydrated in descending concentration of ethanol (3 min 
each) and washed 3 times i n  PBS for (5 min each) . After washing i n  PBS,  the 
tissue was marked around with a Dako pen to prevent solutions draining away 
from the tissue section. The staining procedure was started by i ncubating the 
sections with blocking reagent for 30 min . After that, the blocking reagent was 
drained off and appropriate di lution of primary antibodies were applied and 
i ncubated at 4°C for 24 h. On the fol lowing days the sections were incubated at 
the room temperature for I hr. The s lides were then washed 3 times in PBS (5 
min each) and incubated with secondary antibodies conjugated with either FITC 
or TRITC (Jackson Laboratory, USA) for 1 h and washed in PBS (3 times 5 min 
each). Sections were then mounted in  CITI-Fluore mounting media, and viewed 
and photographed under Nikkon Fluorescence microscope. 
10. Radioimmunoassay 
1 0. 1  I nsulin assay 
Insulin was determined by using a modified method of Herbert (73) .  Al l  
test amples and control were assayed in duplicates. Insulin measurement was 
performed using LINCO Research, I nc (Missouri , USA) radioimmunoassay kits. 
The procedure was conducted as described in the kit manual. Briefly, a volume 
of 200 II I of either calibrator controls or test samples were pi petted to previously 
labeled tubes. After this, 1 00  II I of hydrated I-insulin was added to al l  tubes. 
1 00  II I of rat i nsulin antibody was added to al l  tubes except the total count and 
NSB tubes and then vortexed. After vortexing, the tubes were covered with 
parafi lm and i ncubated at 4°C for 24 h .  On the fol lowing day a volume of 1 mI 
of cold (4°C) precipitating reagent was added to al l  tubes except the total count 
tubes. Then the tubes were vortexed and i ncubated at 4°C for 20 min .  After 
incubation, al l  tubes except the total count tube were centrifuged for 20 min at 
2,000 xg at 4°C. The tubes were decanted gently and radioactivity was counted 
for 1 min using a gamma counter (Beckman) .  Resu lts were analyzed by using  
Beckman I mmunofit EINRIA analysis software, version 2 .00 and values were 
expressed as ng/mI. 
1 0.2 Glucagon assay 
Glucagon was determined by double antibody technique of Nishio (74). 
All te t sample and control were assayed in duplicates. Glass tubes were used 
for this as ay becau e it ha been shown that glucagon adheres onto plastic 
surfaces. Glucagon mea urement was perfom1ed using DPC® (Los Angeles, 
USA) radioimmunoassay kits. The procedure was conducted as described in the 
kit manual .  Briefly, a volume of 200 � l  of calibrator, control, or sample was 
pipetted into previously labeled tubes.  After this, 1 00 � I of glucagon antiserum 
was added to aU tubes except the NSB (non -speciflc binding) and total count 
tubes and vortexed. After vortexing the tubes were covered with parafl lm and 
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i ncubated at 4°C for 24 h. After the flrst i ncubation, 1 00  � l  of I-glucagon 
was added to all tubes and vortexed. The samples were incubated at 4 °C for 24 
h. On the fol lowing day a volume of 1 ml of cold (4°C) precipitating reagent was 
added to aU tubes except the total count and centrifuged at 4°C for 1 5  min at 
1 500 xg. The tubes were decanted gently and radioactivity was counted for 1 
min using a gamma counter (Beckman) .  Results were analyzed by using 
Beckman Immunoflt EINRIA analysis software, version 2 .00 and values were 
expressed as pglml .  
1 1 . Biochemical analysis 
Blood urea ni trogen (BUN), Creatinine (CRE), alkaline phosphatase 
(ALP), alanine aminotran fera e (ALT) , aspartate aminotransferase (AST), 
lactic dehydrogenase (LDH), gamma-glutamyl transferase (GOT), calcium (Ca), 
pho phorus (PHOS) sodium (Na), potassium (K) and magnesium (Mg) were 
performed in AI-Qattara Veterinary Laboratory by using Beckman cou lter 
(Synchron Lx20 PRO clinical system). 
1 2. Statistical analyses 
Data are expressed as mean ±SD .  Student's t-test was used to analyze the 
significance of differences between mean values and different groups were 
analyzed by analysis of variance using Duncan ' s  mu ltiple range tests. A p value 
of less than 0.05 was considered statistically sign ificant. 
-------------------------- � < ------------------------------------------------------------------------
1 .  Effect of Vita m i n E on m eta bol ic  pa ra m eters of n o r m a l  
a n d  d i a betic rat 
1 . 1  Body weight  
Figure 3 hows the effect o f  d ifferent d o  e o f  vitamin E o n  bod weight 
f nom1al and diabet ic rat . The oral admini  trat ion of low dose (0 .2 mg) of 
\ i tamin E to rats treated 1 0  da s after the onset of diabetes resulted in weight gain 
compared to untreated diabet ic rat , during the experimental period . However, 
thi weight gain wa t i l l  s ignificantly  smal ler compared to nom1 al untreated and 
nom1al treated rats. Iso, the \veight gain b normal treated rats with low dose of 
\'i tamin E \\ as smal ler compared to untreated nonnal rats. On the other hand, the 
admini  tration of 100v do e of itamin E to rats treated 10 days before the onset of 
d iabete resulted in high weight loss. 
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F igure 3 :  H istograms sho'" ing the effect of v itam in  E (0 .2  mg) on body weight gained or 
lost of normal and d iabetic rats. DM= diabetes me l l i tus 
Rat recei \  ing mod rate do e (0 .4  mg) of v i tamin E 1 0  da) after the 
on Cl of diabete \\ ere ubj cted to more \veight I s compared to untreated 
diabet ic rat . 1 re \ er, the \'v eight los observ d in rat treated 1 0  days bet! re 
the on et of diab te rat \'v a the highest when compar d to nomlal and diabetic 
control  . Ho\vever, oral admini tration of ( OAmg) of i tamin fai l  d to 
increa e weight of treated nonnal rats i n  the same was, as I e  e l  of untreated rats 
Fig -l) .  
The high dose ( 0.8mg) of itamin E gi en to  diabetic rats also resul ted 
in weight loss in both diabetes rats treated before and after the onset of diabetes. 
omlal rat . which received h igh dose of v i tamin E fai led to gain weight in the 
ame manner a untreated normal rats F ig  5 .  I t  i c lear, however, that rats which 
received v i tamin E before the onset of diabetes showed the h ighest weight loss 
compared to other groups Fig 3 -5 
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F igure 4 Hi togram ho\\ ing the effect of v ital11 in  E (OA I11g) on bod) \\ e ight gained 
or 10 t ill normal and d iabetic rat DM diabetes me l l itu . 
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F igure 5 :  H istogram sho\\ i ng the effect of itam in  (0 .8  mg) on body we ight 
gained or lost in normal and diabet ic rat . DM- diabete l11e l l i tu . 
1 .2 Blood g l ueo e leve l  
1 h e  admini trat ion o f  0 .2  m g  o f  \ itamin E t rats that \,,,'ere al read 
diabet ic igni ficantl) (p < 0 .05 ) reduced the blo d gl uco e lev I "" hen compared 
to untreated diabetic rat . [n contra t. there \'va n ignificant difference in 
blood gluc e le\ el  of rat gi\"en 0 .2  mg befor the on et of diabete when 
compared to untreated diabetic rat ormal rat treated \'v ith vitamin had a 
mal l but not ignifi ant decr a e in blood gluco e Ie el compared to untreated 
nonnal rat ( Fig. ) 
The effect 0 2  rrg of vltamn E on blood glucose level 
of nomal and diabetic rats 
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F igure 6: H i  togram sho\'" i ng the effect of 0 2 mg of itam in  on blood glucose level of 
normal and d iabetic rat . I n  \\ eek.s 2 and 4 there wa a ign i ficant d i fference in  blood 
gluco e level in rats treated after the onset of DM compared to control *p<O.05 (d iab cont 
\ er us treated after D M )  ( Data are mean r D, n=6) DM diabete mel l itu . 
The blood gl uco e level \\ a l ight l)  redu ed in diabetic rats treated \\ ith 
a higher d e of \ i tamin (0.4 mg)  before and after the onset of diab te 
compared to untr ated diabetic . Ilo\\,ever, the reducti n in  blood gluco e level 
\\ a not tat i tical l y  ignificant Fig 7. The blo d glucose level of normal rats 
treat d \\ i th vitamin E \\ a comparable with that of untreated normal rats. 
Figure 8 how that the ad mini tration of 0 .8  mg of vitamin E in rats 
treated after the on et of diabetes ignificant l y  reduced the blood glucose Ie e l  
\\ hen compared to  untreated diabetic  rats. The reduction in  the level of blood 
gluco e le\'el was con i tent throughout the experimental period. imi larly, 
th re \\'a a significant reduction in  the blood glucose level of rats given 0 .8mg 
before the on et of diabetes when compared to untreated d iabetic rats. Vitamin 
E (0 .8  mg also decreased the b lood sugar level of normal rats markedl y  
compared t o  untreated normal rats. 
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igure 7: H I  togram ho\\ ing the effect of 0.4 mg of v itam in  on b lood gl ucose level of 
normal and d iabetl rat . In \\ eel.. 3 and 4 there \\ a a ign i ticant d i fference in  blood 
glu o.e lev e l 111 rat treated before the onset of DM compared to ontrols * p<0.05 (d iab 
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F igure 8: H istograms sho\', i ng the effect of 0 .8 mg of v itam in  E on blood g luco e leve l of  
normal and diabetic rat . I n  week. 2,  3 and 4 there vvas a ign i ficant d i fference in  blood 
gluco e lev e l  111 rats treated after the on et of DM compared to control * p<'0.05 (diab cont 
v er u treated after D M )  and rat treated before the on et of DM compared to contro ls in 
\', eek 3 * *p<O 05 (d iab cont versus treated after DM). ( Data are mean ± D, n-6) DM 
diabetes mel l i tu . 
1 .3 O ra l  gl uco e tole ra n ce te t ( OGTT )  
fhe TT or rat that re ei\ ed \ itamin E ( 0 .2 mg) after the n t of 
diabete \\ a b tt r than that of untreat d diabetic rat Fig.  9 .  Howe\ er. rat that 
recei\ ed \ i tamin bel' re the on et of diabete had a poorer OGTT at 1 20 min 
after the giuco'e load compared to untreated diabet ic rat . Although, the TT 
\ a lue of n m1al rat treated \\ ith \ itamin E \\ a better than that of the untreated 
normal rat . the) \\ ere nonethele normal . 
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F igure 9 :  H i  togram ho\\ ing the effect of 0.2 mg of v itam in  E on OGTT of normal and 
d iabet i c  rat . ( Data are mean :!: D. n 6)  DM- d iabete mel l i tu 
[he TT of rat that recei \ ed \ itamin � (OA mg) before the on et of 
diabete \\ as better than that r untr ated diabetic rats Fig. I O . Moreover, rat 
that recei \ t�d \ itamin a fter the on et of diabete had a b tter OGTT in the fi r t 
o min compared to untreated diabetic rat . The handl ing of g lucose \\ a  poorl )  
done in rat f thi group after 60 min .  Hov. e\ er, it appeared that the OGTT of 
rat that received vitamin E (OAmg) b fore the onset of diabetes wa better than 
that of rat that recei \  ed \'itamin E after the on et of diabetes. The OGTT values 
of nomlal rat tr at d with v i tamin E was comparable  to that of untreated 
n n11::11 rat . 
The OGTT of rat that recei ed vitamin E before and after the onset of 
diabete \\ a better than that of  untreated diabetic rats F ig. 1 1 .  Howe er ,  i t  
appeared t hat the OGTT of rats t hat received vitamin E ( 0 .8mg) before the onset 
of diabetes v;as better than that of rats that received vitamin E after the onset of 
d iabetes. The OGTT value of nonnal rats treated with vitamin E was 
comparable  to that of untreated nomlal rats.  
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F igure I I :  H i  tograms ho\\ ing the effect of 0 .8  mg of itam lO on OGTT of normal and 
d iabetic rat . ( Data are mean ± D. n 6)  DM d iabetes me l l itu 
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2. Effect of Vita m i n  E on bioc h e m i c a l  pa ra m eters of 
norm a l  a n d  d ia betic rat 
2. 1 Liver enzymes 
2 . 1 . 1  Pia rn a A l k a l i n e  p h o  p h a tase level 
Figur 1 2  ho\\- the ffect f low do e ( 0 .2  mg) of vi tamin E on pia rna 
alkal ine pho phata e I \'el  of nomlal and diabet ic rat . The result how that low 
do e (0 .2 mg) of vitamin E signi ficantl increa ed the le el  of plasma alkal ine 
pho phata e ( p< 0.03 5 )  in n rmal rat . The low dose decreased the plasma level 
of alkal ine phosphata e in rat treated with i tamin E l O  days after the on et of 
diabet . However. the alkal ine phosphatase plasma level l ight ly  increased in rats 
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The effect of 0 2  rrg of v ltamn E on plasrra alkaline phosphatase level 
In norrral and diabetic rats 
* 
o --'---'---
�rm cont �rm +vrt E Dab cont T before D'II1 T after D'II1 
o �rm cont 
. �rm +vlt E 
o Dab cont 
o T bef ore D'II1 
• T after D'II1 
F igure 1 2 : H i stograms showing the effect of 0.2 mg of vitamin E on plasma alka l i ne 
phosphatase level of normal and d iabetic rats. 0.2 mg of itamin  E induced s ign i ficant 
increases in  plasma alkal ine phosphatase level in  normal non diabetic rats * p <0.05 (noml 
cont versus norm'" v itamin  E ). ( Data are mean ± S O, n=6) DM= diabetes mel l itus. 
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2 .  Effect of Vita m i n E on bioc h e m i c a l  pa ra m eters of 
n o r m a l  a n d  d ia betic ra ts 
2 . 1 Liver enzymes 
2 . 1 . 1  P ia  rn a A l ka l i n e  p h o  p h a t a  e level 
Figure 1 _  h "" the effect of low do e (0 .2  mg) of vitamin E on pia ma 
alkal ine pho phatase le\ el of normal and diabet ic rat . The result hows that low 
do e (0 .2  mg) of vi tamin E signi ficant l  increased the Ie el of plasma al kal ine 
pho phata e ( p< 0.03 5 )  in normal rats .  The low dose decreased the plasma level 
of alkal ine phosphata e in rats treated with itam in E 1 0  days after the onset of 
diabete . However. the a lkal in phosphatase p Ia  rna Ie el sl ightly increased in rats 
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The effect of 0 2 rrg of vrtamn E on plasma alkaline phosphatase level 
In normal and diabetic rats 
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F igure 1 2 : H istograms showing the effect of 0.2 mg of v itamin  E on plasma alkal ine 
phosphatase level of normal and d iabetic rats. 0.2 mg of v itam in  E induced sign ificant 
increases in plasma alka l ine phosphatase level  in normal non diabet ic rats * p <0.05 (norm 
cont versus norm� v itamin  E ). ( Data are mean ± S O, n=6 ) OM= d iabetes me l l itus. 
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The moderate do e (0.4 mg) of vitamin E had no ignificant effect on the 
pIa rna alkaline pho phata e level of normal treated rats. On the other hand, the 
moderate do e increased the pIa rna alkaline pho phatase level in the treated 
before DM group. Thi increa e is not statistical ly di fferent when compared to 
control .  No i gnificant change was ob erved in  plasma alkaline phosphatase level 
of rats treated after the onset of diabetes (Fig. 1 3) .  The oral administration of high 
dose (0.8 mg) of vitamin E had no effect on plasma alkaline phosphatase level of 
normal and treated diabetic rats (Fig. 1 4) .  
2. 1 . 2  Plasma alanine ami notransferase level 
Figure 1 5  shows the effect of low dose (0.2 mg) of vitamin E on plasma 
alan ine aminotransferase of normal and diabetic rats. The oral administration of 
low dose of vitamin E had no effect on normal rats when compared to controls. 
On the other hand, low dose (0.2 mg) of vitamin E significantly reduced the level 
of plasma alanine aminotransferase in rats treated before (p<0.0 1 4) and after 
(p<0.OO6) the onset of diabetes. 
Moderate dose (0.4 mg) of vitamin E reduced plasma alanine 
aminotransferase level i n  rats treated before and after the onset of diabetes but 
without any sign ificance. Moderate dose had no effect on normal treated rats 
when compared with normal control (Fig 1 6) .  
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The oral admini tration of high do e (0.8 rng) of vi tamin E increased 
pIa rna alanine aminotran [era e level without any significance compared to 
diabetic control (Fig. 1 7) .  No ignificant change was ob erved in the alanine 
aminotransfera e level of normal rats after oral administration of high dose of 
itamin E. 
2. 1 .3 Plasma aspartate aminotransferase 
Figure 1 8  shows that low dose (0.2 mg) of vitamin E had no effect on 
pIa rna aspartate aminotran fera e level of normal rats when compared with 
normal control. In diabetic rats, the low dose reduces pLasma aspartate 
aminotransferase level of rat treated 1 0  days after the onset of diabetes rats with 
significance (p<0.0 1 9) and without any sign ificance in rats treated 1 0  days before 
the onset of diabetes. 
After the oral administration of moderate dose (0.4 rng) of vitamin E a 
decrease in the plasma aspartate aminotransferase level of normal treated rats was 
observed but without any sign ificance (Fig. 1 9) .  The moderate dose can increase 
the plasma aspartate aminotransferase level of rats treated before and after the 
onset of diabetes. This increase had no statistical significance when compared 
with diabetic control. 
The high dose (0.8 mg) of vitamin E had no effect in the p lasma aspartate 
aminotransferase level of normal treated rats (Fig. 20) . The high dose increased 
the plasma aspartate aminotransferase level of rats treated before and after the 
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on et of diabete . Thi increa e ha no tati tical ignificance when compared to 
diabetic control .  
2. 1 .4 Plasma lactic dehydrogenase level 
The oral admini tration of low dose (0.2 mg) of vitamin E significantly 
(p<O.033) reduced the level of plasma lactic dehydrogenase in untreated normal 
rat . However, the low dose also increased plasma lactic dehydrogenase level but 
without any ignificance (Fig. 2 1 ) . 
No change in  plasma lactic dehydrogenase level was observed in normal 
rats after oral administration of moderate (0.4 mg) of vitamin E.  While the 
moderate dose i ncreased the lactic dehydrogenase plasma level in rats treated 1 0  
day after the onset of diabetes without any significance (Fig.  22), and it had no 
effect on the plasma lactic dehydrogenase level of rats treated before the onset of 
diabetes. 
The high dose (0.8 mg) of vitamin E had no effect on the level of plasma 
lactic dehydrogenase in normal rats and rats treated 1 0  days before the onset of 
diabetes rats. On the other hand, there was a sign ificant (p<0.03) increase in 
plasma lactic dehydrogenase level of rats treated 1 0  days after the onset of 
diabetes (Fig.  23) .  
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2. 1 .5 Plasma ga rnma-gl utamy l  t ransferase 
The result of the effect of different low dose (0.2 mg) of vitamin E on 
plasma ganuna-glutarnyl transferase level of normal and diabetic rats is shown in 
Fig.  24.  In normal rats with low dose of vitamin E, there was a significant 
increa e in  plasma gamma-glutarnyl transferase level (p<0.0 1 2) .  Diabetic rats 
exhibited high plasma ganuna-glutamyl transferase level .  The low dose of vitamin 
E uccessful ly reduced this level in  rats treated before and after the onset of 
diabetes but without any statistical significance. 
However, after the oral administration of the moderate dose (0.4 mg) of 
vitamin E, the plasma gamma-glutamyl transferase level of rats treated 1 0  days 
before and after the onset of diabetes was i ncreased compared to the plasma 
gamma-glutamyl transferase level of diabetic control rats (Fig.25) .  
Figure 26 shows the effect of high dose (0.8 mg) of vitamin E on plasma 
gamma-glutamyl transferase of normal and diabetic rats. The resu lt showed that 
high dose of vitamin E had no significant effect on the plasma gamma-glutamyl 
transferase level of normal and diabetic rats. 
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2. 1 .5 Plasma gamma-glutamy l  transferase 
The result of the effect of different low dose (0.2 mg) of vitamin E on 
plasma gamma-glutamyl transferase level of nonnal and diabetic rats is shown in 
Fig. 24.  In nonnal rats with low dose of vitamin E, there was a significant 
increa e in plasma gamma-glutamyl transfera e level (p<0.0 1 2) .  Diabetic rats 
exhibited high plasma gamma-glutamyl transferase level .  The low dose of vitamin 
E successful ly reduced this level in rats treated before and after the onset of 
diabetes but without any statistical significance. 
However, after the oral administration of the moderate dose (0.4 mg) of 
vitamin E, the plasma gamma-glutamyl transferase level of rats treated 1 0  days 
before and after the onset of diabetes was i ncreased compared to the plasma 
gamma-glutamyl transferase level of diabetic control rats (Fig.25).  
Figure 26 shows the effect of high dose (0.8 mg) of vitamin E on plasma 
gamma-glutamyl transferase of nonnal and diabetic rats. The resu lt showed that 
high dose of vitamin E had no significant effect on the plasma gamma-glutamyl 
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F igure 1 3 :  H istograms showing the effect of 0 .4 mg of v itam in  E on p lasma a lka l ine 
phosphatase leve l of normal  and diabet ic rat . ( Data are mean ± SD, n=6) DM= diabetes 
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F igure 1 4 : H istograms show ing the effect of 0.8 mg of vitamin  E on plasma a lka l i ne 
phosphatase Ie e l  of normal and d iabet ic  rats. ( Data are mean ± SD, n=6) DM= diabetes 
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F igure 1 5 : H i  togram showing the effect of 0.2 mg of v itam in  E on plasma alanine 
aminotran fera e level of normal and d iabetic rat . 0.2 of v itam in  E induced significant 
decrea e in  pia ma alanine aminotran ferase Ie e l  i n  rat treated before and after the onset 
of OM *p 0.05 ( treated before OM ersus d iab cont), * * p<O.O I ( treated after OM versus 
d iab cont). ( Data are mean ± O. n=6) OM= diabete mel l itu . 
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F igure 1 6: H istograms show ing the effect of 0.4 mg of vitam in  E on plasma alanine 
aminotransferase level of normal and diabetic rats. ( Data are mean ± SO, n=6 ) DM= 
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F igure 1 7: H i  tograms showing the effect of 0.8 mg of v itam in  E on plasma alanine 
aminotransferase Ie  el of normal and d iabet ic  rats. ( Data are mean ± D, n=6) DM= 
diabete mel l itus 
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F igure 1 8 : H istograms showing the effect of 0.2 mg of v itam in  E on p lasma aspartate 
aminotransferase level of nOl1l1al and diabet ic  rats. 0.2 mg induced a signi ficant decrease 
in the p lasma aspartate aminotransferase level in rats treated after the onset of DM * p< 
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F igure 1 9: H i  tograms howing the effect of 0.4 mg of v itam in E on plasma aspmtate 
aminotransferase level of normal and diabetic  rats. ( Data are mean ± D, n=6). DM= 
d iabetes mel l i tus 
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F igure 20: H istograms showing the effect of 0 .8  mg of v itamin  E on plasma aspartate 
aminotransferase Ie el of normal and diabetic rats. ( Data are mean ± SO, n=6). DM= 
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F igure 2 1 :  H i  togram how ing the effect of 0.2 mg of vitamin E on plasma lact ic 
deh) drogena e level of normal and diabetic rats. 0.2 mg of v itamin  E induced a sign ificant 
decrease in the pIa rna lactic dehydrogenase leve l in normal non diabetic rats *p < 0.05 
( orm com versus norm cont 1- itam in  E). ( Data are mean ± D. n=6). DM= diabetes 
me l l itus 
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F igure 22'  Histograms showi ng the effect of 0 .4 mg of vitam in  E on plasma lactic 
deh)drogenase level of normal and diabetic rats. ( Data are mean ± 0, n=6) DM= diabetes 
mel l i tus 
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F igure 23 :  H i  togram ho\, ing the effect of 0.8 mg of itam in E on plasma lactic 
deh) drogena e le\ e l  of normal and d iabetic rats. 0.8 mg of itamin  E induced a significant 
1l1crea e in  pia rna lactic de) drogena e level of rats treated after the onset OM * p<0.05 
(d iab cont \ ersus treated after on et of OM). ( Data are mean ± SO, n=6) OM= diabete 
mel l itu 
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F igure 24: H istograms howing the effect of 0.2 mg of v itam in  E on plasma gamma­
glutamJ I transferase level of normal and d iabet ic rats. 0.2 mg of v itamin  E induced a 
sign ificant Increase in the plasma gamma-glutamyl Ie el in normal non d iabet ic rats * p<0.05 
( norm cont versus norm 4- v itami n  E). ( Data are mean ± D, n=6 ) OM= diabetes mel l itus. 
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F igure 25 :  H i  tog ram how ing the effect of 0.4 mg of vitamin E on p lasma gamma­
glutam) I tran ferase level of normal and diabetic rat . ( Data are mean ± 0, n=6) DM= 
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F igure 26:  H istograms showing the effect of 0 .8 mg of v itam in E on plasma gamma­
glutamy l transferase leve l of normal and diabet ic  rats. ( Data are mean ± SO, n=6) DM= 
d iabetes mel l itus. 
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2.2 Effect of Vitamin E on Kidney parameters of normal and 
diabetic rats 
2.2. 1 Blood u rea nitrogen level 
The level of blood urea nitrogen of normal rats was found to be 
sign ificantly increased after the administration of low dose (0.2mg) of vitamin E 
(p<O.03).  The treatment of diabetic rats before and after the onset of diabetes with 
low dose of vitamin E reduced the level of blood urea nitrogen without any 
stati tical sign ificance (Fig. 27). 
Treatment with moderate dose (0.4 mg) of vitamin E resu lted in increase 
ill the level of blood urea nitrogen of normal and diabetic rats without any 
statistical significance (Fig.  28) .  The oral administration of high dose (0.8 mg) of 
vitamin E significantly (p<0.03) increased the b lood urea nitrogen level of rats 
treated before the onset of diabetes. Also, high dose of vitamin E i ncrease blood 
urea nitrogen level of normal treated rats without any statistical sign ificance (Fig.  
29) . 
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2.2.2 Plasma creatinine level 
Figure 30 shows that low does of vitamin E can significantly increase the 
plasma creatinine level in normal rats when compared with control rats. No 
ignificant changes were observed in rats treated before and after the onset of 
diabetes. 
No change was observed in the plasma creatinine level of normal and 
diabetic rats after oral administration of moderate dose of vitamin E (Fig. 3 1 ) . 
Also, after the oral administration of high dose of vitamin E no significant 
change was observed in the plasma creatinine level of normal rats. There was a 
decrease in the plasma creatinine level of rats treated before and after the onset of 
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The effect of 0 2  rrg of vrtamn E on plasrre urea nitrogen level 
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Figure n· H I  tograms ho\\ ing the effect of 0.2 mg of v itam in E on plasma urea 
n i trogen lev e l of nonnal and d iabetic rats. 0.2 mg/kg of itam in E induced a sign ificant 
mcrea e in  the plasma urea n itrogen level of nonnal non diabet ic rats *p<0.05 ( nonn 
cont 'v er u norm � v itam in E ) .  ( Data are mean ± SD, n=6) DM= diabetes mel l i tus. 
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F igure 28 :  H istograms showing the effect of OA mg of vi tamin E on plasma urea n itrogen Ie e l  
of normal and d iabetic rats. ( Data are mean ± D, n=6) DM= diabetes mel l itus. 
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F igure 29: H i  tograms ho\\ ing the effect of 0.8 mg of itamin  E on plasma urea n itrogen 
le\ el of normal and d iabet ic  rat . 0 .8 mg of v itami n  E induced a sign ificant increase in the 
pla ma urea n itrogen level of rats treated before the onset of OM rats * p<0.05 (d iab cont 
vel' us treated before O M ). ( Oata are mean ± SO. n=6) OM= d iabetes mel l itus. 
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F igure 30 :  H istograms showing the effect of 0.2 mg of v itam in  E on plasma creat in i ne 
le'vel  of normal and d iabetic rats. 0.2 mg of itam in  E induced a significant increase in the 
plasma creat in ine level of normal non d iabetic rats *p<0.05 (norm cont versus norm 
v itamin  E ). ( Oata are mean ± SO, n=6) OM= diabetes mel l i tus. 
56 
0 6  
0 5  
� 0 4  
cr, 
.s 
� 0 3  c m � o 0 2  
0 1  
The effect of 0 4  rrg of vltamn E on plasrre creatinine level 
In norrrel and diabetIC rats 
0 0  _-L-_-'--__ 
N:xm cont f\brm +vrt E Dab cont T before D'v1 T after D'v1 
o f\brmcont 
• f\brm +vl! E 
o Dab cont 
o T before D'v1 
• T after D'v1 
F igure 3 1 :  H i  togram sho\\ i ng the effect of 0.4 mg of itamin  E on plasma creat in ine 
le\ e l  of nomlal and diabetic rat . ( Data are mean ± D, n=6) DM= diabetes mel l itu . 
0 7 -
0.6 -1 
c- 0 5  � :!? Ol 
.s 0 4  
QJ !; 
!; 0 3 -m � o 0 2 , 
0 1  
The effect of 0 8  rrg of vltamn E on plasrre creatinine level 
In norrrel and diabetIC rats 
O O --'--�--
f\brm cont f\brm +vl! E Dab cont T bef ore D'v1 T after D'v1 
o f\brmcont 
• f\brm +vl! E 
o Dab cont 
o T before D'v1 
• T after D'v1 
F igure 32 :  H istograms sho\ i ng the effect of 0 .8  mg of vi tamin E on plasma creat in ine level 
of normal and diabetic rats. ( Data are mean ± SO, n=6)  DM= diabetes mel l itus 
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2.3 Effect of Vitamin E on electrolytes level of normal and 
diabetic rats 
2.3. 1 Plasma calcium level 
Low dose of vitamin E had no significant effect on plasma calcium level 
of normal rats. In contrast, low dose caused a sign ificant increase in the plasma 
calcium level of rats treated 1 0  days before the onset of diabetes. It also increased 
the plasma calcium level of rats treated after the onset of diabetes rats without any 
statistical significance (Fig. 33) .  
The moderate dose of vitamin E i nduced significant increases (p<0.OO2) i n  
plasma calcium level of the normal rats when compared to normal untreated rats 
(Fig.  34) . On the other h and, the moderate dose can reduce the plasma calciu m  
level o f  rats treated before and after the onset o f  diabetes but without any 
statistical significance. 
The oral administration of high dose of vitamin E 1 0  days before and after 
the onset of diabetes brought a small but not significant decrease in  plasma 
calcium level. Also, the high dose failed to affect the plasma calciu m  level in 
normal rats (Fig. 35) .  
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2.3.2 Plasma phosphorus level 
Figure 36 shows the effect of low dose of vitamin E on plasma 
pho phoru level of nonnal rats. The resu lt indicates that low dose of vitamin E 
failed to change the plasma phosphorus level in normal and diabetic rats. 
The moderate dose of vitamin E did not have any effect on the plasma 
phosphours level of normal and rats treated 1 0  days before the onset of diabetes. 
however, the moderate dose caused a significant decrease in the plasma 
phosphorus level of rats treated after the onset of diabetes compared to diabetic 
control (Fig. 37).  
The oral administration of high dose of vitamin E did not have any effect 
on the plasma phosphours level of normal rats and rats treated 1 0  days before the 
onset of diabetes. However, the high dose of vitamin E caused a significant 
increase in the plasma phosphorus level of rats treated after the onset of diabetes 
compared to diabetic control (Fig.  38) .  
2.3.3 Plasma sod i u m  level 
Low dose of vitamin E affected the plasma sodium level in nonnal rats. 
However, in diabetic rats, the low dose of vitamin E caused significant increases 
in the plasma sodium level in rats treated before (p<O.02) and after (p<O.OO5) the 
onset of diabetes (Fig .  39). The moderate dose of vitamin E also caused 
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significant (p< 0.(03) reduction in the plasma sodium level of rats treated 1 0  days 
after the onset of diabete . There wa an increase in the pIa rna sodium level of 
the normal rats without any stati tical ignificance (Fig. 40) . In rats treated before 
and after the on et of diabetes the level of sodium was slightly increased when 
compared to control (Fig.  4 ] ) . 
2.3.4 Plasma potassiu m  level 
Figure 42 shows the effect of low dose of vitamin E on plasma potassium 
Ie el of normal and diabetic rats. The result shows that low dose of vitamin E has 
no effect on the plasma potassi urn level of normal rats and rats treated after the 
onset of diabetes. However, the low dose of vitamin E increased plasma 
potas ium level of rats treated before the onset of diabetes. However, this increase 
did not reach statistical significance. 
The oral administration of moderate dose of vitamin  E i ncreased the 
plasma potassiu m  level of normal rats and rats treated before the onset of 
diabetes. While the plasma potassium level of rats treated after the onset of 
diabetes was reduced (Fig. 43) .  
The oral administration of high dose of vitamin E significantly increased 
the level of potassium in  rats treated normal rats (p<0.003) and in  rats treated 
before the onset of diabetes (p<0.032) .  It also increased the plasma potassium 
level of rats treated before the onset of the diabetes without any statistical 
significance (Fig.  44) .  
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2 .3.5 Pia rn a m a g n e  i u m  level 
Figure 45 hows the effect of low dose of vitamin E on plasma magnesium 
Je\ el of normal and diabetic rat . The re ult  ind icates that low dose of vitamin E 
had no effect on plasma magne ium level of normal and diabetic rats. Moreo er, 
the oral admini trat ion of moderate dose of itamin E also has no sign i ficant 
effect on the plasma magnesi um Ie el of normal and diabetics rats ( Fig. 46) .The 
oral administration of high dose of itamin E had no effect on the plasma 
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F igure 34:  H i  togram sho\\ ing the effect ofOA mg of v i tam in  E on pia rna calcium level of  
normal and d iabetic rat . OA mg of itam in  E induced a ign i ficant increase in the plasma 
calcium le\ e l  of normal non diabetic rat * p<0.05 ( n01111 cont versus norm+ vitam in E) .  
( Data are mean ± D. n=6)  DM= diabetes mel l itu . 
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F igure 3 5 '  H istograms showing the effect of 0 .8  mg of vitam in E on plasma calcium level 
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The effect of 0 2 rrg of vrtamn E on plasma phosphorus level 
In normal and diabetIC rats 
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F igure 36 :  H istogram ho\\ i ng the effect of 0.2 mg of i tamin  E on plasma phosphoru 
le\ e l  of normal and d iabetic rat . ( Data are mean ± SO, n=6) DM= diabetes mel l i tus .  
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The effect of 0 4 rrg/kg of vrtamn E on plasma phosphorus level 
In normal and diabetic rats 
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F igure 37 :  H istograms showing the effect of 0 .4 mg of itamin E on plasma phosphorus 
level of normal and d iabetic rats. 0.4 mg of v itam in  E i nduced a significant increase in the 
plasma pho phorus Ie  e l  in rats treated after the onset of OM * p<0.05 (d iab cont versus 
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The effect of 0 8  rrg of vrtamn E on plasrra phosphorus level 
In norrral and diabetic rats 
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F igure � 8 :  H i  togram showing the effect o f  0 . 8  m g  o f  itamin  E o n  plasma pho phoru 
lev e l  of nomlal and d iabetic rat . 0 .8  mg of v itam in  E induced a ign i ficant increase in the 
plasma pho phorus leye l in rat treated after the onset of DM *p<0.05 (d iab cont versus 
treated after DM) .  ( Data are mean ± 0, n=6) OM= diabete mel l itus. 
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The effect of 0 2  rrg of vrtamn E on plasrra sodium level 
In norrral and diabetic rats 
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Figure 39 :  H istograms showing the effect of 0 .2 mg of vi tamin E on plasma sod ium leve l 
of normal and diabet ic rats. 0 .2 mg of vitamin  E induced a s ign ificant increa e in the 
plasma sodium level in rats treated before and after the onset of OM * p<0.05 (d iab cont 
ersus treated before O M )  * * p<0.05 (d iab cont ersus treated after O M ). ( Data are mean ± 
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The effect of 0 4 rrg of v ltamn E on plasma sodium level 
In normal and diabetIC rats 
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F igure 40: H istograms showing the effect of 0.4 mg of v itami n  E on plasma sod ium level of 
normal and diabet ic rats. 0.4 mg of v itam in  E induced a significant decrease in the plasma 
sod ium leve l in rats treated after the onset of DM * p<0.05 (d iab cont versus treated after 
D n. ( Data are mean ± D, n=6) DM= diabetes. 
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F igure 4 1 :  H istograms showing the effect of 0 .8  mg of v itam in E on plasma sod ium level of 
normal and diabetic rats. ( Data are mean ± SD, n=6) DM= diabetes mel l itus. 
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The effect of 0 2 rrg of vrtamn E on plasrre potassium level 
In normal and diabetIC rats 
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F Igure 42:  H i  tograms sho\ ing the effect of 0.2 mg of itam in  E on plasma potassium level 





The effect of 0 4  rrg of vitanin E on plasrra potassium level 
In norrral and diabetic rats 
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Figure 4 3 :  H istograms showing the effect of 0.4 mg of vitamin  E on plasma potass ium level 
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The effect of 0 8  rrg of v ltamn E on plasrra potassium level 
In norrral and diabetic rats 
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F igur 44: H i  tograms howing the e ffect of 0 .8 mg of v itam in E on plasma potass ium level 
of nomlal and d iabetic rats. 0.8 mg of itam in  E induced a sign i ficant increase in the plasma 
potassium level in  normal non d iabetic rats and in  rats treated after the onset of OM * p<O.OS 
(norm cont versus norm +vitamin  E) * * p<O.OS (d iab cont ver us treated after OM) .  ( Data are 
mean :t: 0, n=6) DM= diabetes mel l i tus. 
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The effect of 0 2  rrg of vrtanin E on plasrra rragnesium level 
In norrral and diabetic rats 
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Figure 45 :  H istograms showing the effect of 0.2 mg of v i tamin E on plasma magnesium 
level of nonnal and d iabetic rats. (Data are mean ± SO, n=6) DM= diabetes mel l i tus. 
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Figure 46. H i  togram ho\\ ing the effect of 0.4 mg of v itam in  E on plasma magnesium 
le\ e l  of normal and d iabetic rat . ( Data are mean ± D n=6) DM= diabetes mel l itus. 
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F igure 47· H istograms show i ng the effect of 0.8 mg of vitamin E on plasma magnesium 
level of normal and d iabet ic rats. ( Data are mean :t: D, n=6) DM= diabetes mel l i tus. 
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3. Effect of vitamin E on the pattern of distribution of 
insulin im munoreactive cells in normal and diabetic rats. 
Figure 49 shows the effect of 10\ dose of itamin E on i nsul in 
immunoreacti\ e cel ls  in normal and diab tic rats .  The result shows that the 
insul in posit iye cel l s  vvere distributed in both central and peripheral portions of 
the islet in  normal rats. In diabetic rats the pattern of distribution of insul in 
posit ive cel ls  d iffered from that of nonnal rats. The oral admini stration of low 
dose of yitanl in E induced any significant changes i n  the pattern of distribution 
of the in u l in positive ce l l s  in  nonnal and diabet ic rats. Moreover, low dose of 
\ ' itanl in  E i nduced a significant (p<O.002 ) decrease in  the number of positi e 
insul i n  immunoreactive cel l s  of nomlal rats ( Fig.  4 8 ) . 
A l so, moderate dose of v itamin  E did caused significant morphological 
changes to pancreatic i slets of d iabetic  rats ( Fig.  50 ) .  Moderate dose of vi tamin 
E increased the number of insul i n  positive cel l s  in rats treated before the onset of 
diabetes with statistical s ignificance ( p<O.008 ) .  However, moderate dose 
induced a significant (p<O.0008) decrease in the number of i nsul in positive cel l  
in  nomlal rats (F ig. 4 8 ) .  
The high dose of itamin E also did not cause any significant c hanges in  
the  pattern of distribution of insu l in  i mmunoreactive cel l s  of nonna] and diabetic 
rats ( Fig.  5 1 ) . Moreover. the h igh dose of vitamin E induced a signi ficant 
increase in the number of insul in  positive cel l s  in rats treated before (p<O.002 7 )  
and after (p<0.0023 )  the onset o f  diabetes ( Fig.  48 ) .  
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Pe r c e n ta g e  distribut ion of In s u lin Immunoreac tive c e lls In the Is lets of normal  a n d  
diabet ic rats 
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F igure -18 :  H istogram showing the effect of d ifferent doses of vitam in  E on percentage d istribut ion 
of insu l i n  immunoreacti e cel ls  of nonnal and d iabetic rats. Different doses v i tamin  E induced 
signi ficant *p<0.002 ( nonn cont versus norm+ 0.2 mg of v itamin  E), * * p<0.0005 (nonn cont 
versus noml+ 0.-1 mg of v itami n  E) decrease in the insu l i n  pos i t ive cel ls of normal pancreas, and 
induced a ignificant * * * p<0.008 ( diab cont versus treated with 0.4 mg of v i tam in  E before OM)  
and  * * * *p<0.027 (d iab cont versus w i th  0 .8  mg of v itamin  E before D M ), * * * * * p<0.023 (d iab 
cont versus with 0 .8  mg of vitamin E after D M )  increase in the percentage of insul in 
imrnunoreacti e cel ls  in  d iabet ic rats when compared to contro l .  ( Data are mean ± SD, n= I 0) .  DM= 
d iabete mel l  itus. 
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F igure 49: Representative m icrographs showing insul in -posit ive cel ls  i n  the is let of Langerhans of 
normal and d iabetic rats. A = normal rat; B = untreated d iabetic rat; C = normal rats treated with 
0.2 mg of v itamin  E; D = rats treated with 0.2 mg of vitamin E before the onset of d iabetes and E = 
rats treated with 0.2 mg of itamin  E after the onset of d iabetes. Magn ification : X 400. 
7 1  
F igure 50:  Representat ive micrographs showing insu l in-posit ive ce l ls  in the islet of  
Langerhans of normal and d iabetic rats. A = normal rat; B = untreated d iabetic rat; C = 
nomlal rats treated with 0 .4 mg of vi tam in E ;  D = rats treated with 0 .4 mg of v itam in E 
before the onset of d iabetes and E = rats treated with 0.4 mg of vitam in  E after the onset of 
d iabetes. Magn ificat ion : X 400. 
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F igure 5 1 :  Representative micrographs showing insu l in-posit ive ce l ls  in the i s let of 
Langerhans of normal and diabetic rats. A = normal rat; B = untreated d iabetic rat� C rats 
treated .... i th 0 .8 mg of v i tamin  E before the onset of d iabetes and 0= rats treated with 0 .8  mg 
of v i tamin  E after the onset of d iabetes. Magn i fi cation: X 400. 
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3. 1 Effec t  of v i ta m i n  E on p lasma i ns u l i n  level  of n o r m a l  a n d  
d i a bet ic  rats 
Figure 52 hows th effect of low dose ( 0 .2 mg) of i tamin E on plasma 
insul in level in normal and diabet ic rats. No change was observed in plasma 
in u l in  level of normal rats compared with normal untreated rats. imi iarly, 
there wa no signi ficant d ifference in insu l in level of rat given 0.2 mg of 
vi tamin E before the onset of diabetes. The level of insul in  was reduced in 
diabetic rat treated after the onset of diabetes when compared with untreated 
diabetes rat . 
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T h e  e f f e c t  o f  0 2  mg o f  v ita m i n  E o n  p la s m a i n s u lin 
le v e l  of n o r m a l  a n d  d ia b e t iC r a ts 
N o r m  c o n t  N o r m  + V I t  E D l a b  c o n t  T b e f o r e  O M  T a f t e r  O M  
F igure 5 2 :  Histograms showing the effect o f  0 . 2  mg o f  v itam in  E o n  p lasma insu l i n  leve l o f  
nonnal and d iabetic rats. ( Data are mean ± D, n=6) D M =  diabetes me l l itus.  
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hown in figure 5 3 ,  the pia ma i nsul in level was highly increased in 
n011nal rats treated 'v\ ith moderate dose 0 .4 mg) of itamin E when compared to 
normal contro l .  However. the i ncrease in the plasma insul in level was not 
tati tical ly igni ficant. The moderate dose did not induce any sign i ficant 
increase in plasma in u l in  leve l .  
A lso, the high dose (0 .8  mg) of vitamin E caused a n  i ncrease in  the 
plasma insul in level in  nOl1nal rats. However, this increase was not stat ist ical l y  
d ifferent compared t o  control ( Fig.  5 4 ) .  I n  diabetic  rats, the high dose induced a 
significant decrease i n  the plasma insu l in  level i n  rats treated before the onset of 
diabetes. However. the high dose had no signi ficant effect on p lasma insul in  level 
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Figure 53:  H brogranr ho\\ 109 (he effect of 0 .-1- mg of \ i tamin E on pIa ma insul in level of 
nom1a1 and dtabett rats ( Data are mean ± D. n=6) DM= dlUbete mel l I tus. 
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Figure 54' HI togram howtng the effect of 0.8 mg of v i tamin E on plasma i n  ul in leve l  of 
noma! and d labettc rat . 0 mg of v i tarrun E induced a ign i ficant decrease in  the pIa ma 
i nsu l in  level 10 rat treated 1 0  day before the onset of OM *p<O.OS (diab cont versus treated 
before OM). ( Data are mean ± SO. n=6) DM= diabete me l l itu . 
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4. Effect of vitamin E on the pattern of distribution of 
glucagon im munoreactive cells of normal and diabetic 
rats 
Figure 56 shows the effect of low dos of vitamin E on the pattern of 
distribution of glucagon i mmunoreactive cel l s  of nOImal and diabetic rats .  I n  
normal pancreas. glucagon immunopositive ce l ls  were located in the peripheral 
part of the is let . On the other hand, in diabetic  pancreas these glucagon positive 
cel l were located in  both the peripheral and central regions of the is lets. The 
low dose of v itamin E did not induce any sign i ficant changes in the pattern of 
di  tribution of glucagon immunopositive cel l s  of the pancreatic i slets of nomlal 
and diabetic rats. Moreo er, low dose of v i tamin E induced an increase in the 
number of positive glucagon immunoreact ive ce1 ls  in the pancreatic is lets of 
normal rats but with no stat istical significance ( Fig.  5 5 ) . 
Moreover, moderate dose of vitamin E did not cause any significant 
morphological changes to gl ucagon immunopositive ce l ls  of the pancreatic i slets 
of normal and d iabetic rats ( Fig.  57 ) .  Moderate dose of vitamin  E caused a 
decrease i n  the n umber of positive glucagon immunoreactive cel l s  in the is lets of 
normal  rats and in  rats treated before the onset of diabetes without any stat istical 
significance. However, moderate dose i nduced an increase in the number of 
glucagon positive cel ls in  the is lets of rats treated 1 0  days after the onset of 
diabetes ( Fig. 5 5 ). 
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The high do e of i tamin E al 0 did not cause an significant changes in 
the pattern of di tribut ion of gl ucagon immun reacti e cel l s  of nonnal and 
diab t ic rat ( Fig. 5 8 ) .  Moreover. the high do e of i tamin E induced an increase 
in the number of glucagon positi  e cel l s  in the is lets of nonnal rats and a 
decrea e in the number of glucagon immunoposit i  e cel l in the islets of rats 
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F igure 5 5 :  H istogram showi ng the effect of d ifferent doses of vi tamin E on percentage distribution 
of glucagon immunoreactive cel l s  of nonnal and d iabet ic rats. ( Data are mean ± SO. n= 1 0) .  DM= 
d iabetes mel l i tus. V itam in  E induced no sign ificant change in  the insu l in  posit ive cells in the is lets 
of normal and d iabetic rats 
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Figure 56 :  Representative m icrographs showing gl ucagon-pos it ive ce l l s  in the i s let of  
Langerhans of normal and d iabet ic rats. A = normal rat; B = untreated diabetic rat; C = normal 
rats treated \>\ ith 0.2 mg of itamin  E; D = rats treated with 0.2 mg of vitamin  E before the onset 
of d iabetes and E = rats treated with 0.2 mg of v itam in E after the onset of d iabetes. 
Magn ificat ion :  X 400. 
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Figure 57 :  Representat ive micrographs showing glucagon-posit ive ce l l s  i n  the islet of  
Langerhans of normal and d iabetic rats. A = normal rat; B = untreated d iabetic rat; C = normal 
rats treated \\ i th 0.4 mg of itamin  E: 0 = rats treated with 0.4 mg of v itam in  E after the onset of 
d iabetes. Magn i ficat ion:  X 400. 
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F igure 5 8 :  Representati e micrographs showing glucagon-posit ive ce l ls  in the is let of Langerhans 
of normal and diabetic rats. A = normal rat; B = untreated diabetic rat; C = rats treated with 0.8 mg 
of v itamin  E before the onset of diabetes and 0 = rats treated with 0 .8  mg of v itamin  E after the 
onset of diabetes. Magn i ficat ion: X 400. 
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4. 1 E ffect  of v i ta m i n  E on  p lasma gl u cagon level of n o r m a l  a n d  
d i a bet ic  ra ts. 
Figure 59 ho\', the effect of low do (0.2 mg) of itamin  E on pIa rna 
glucagon level of normal and diabetic rat . In normal rat , low dose of i tamin 
had no ignifLcant effect compared with normal untreated rats. Low dose of 
vitanl in  E reduced the pIa rna glucagon Ie  el in rats treated before and after the 
n et of diabete \',ithout any statistical signi ficance when compared to 
untreated diabetic rat . 
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F igure 59: H istograms showi ng the effect of 0.2 mg of v itamin E on plasma glucagon level 
of norrnal and d iabetic rats. ( Data are mean ± SO, n=6) DM= d iabetes mel l itus. 
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hO\\1  in figure 60, the moderate do e (0 .4  mg) of vitamin E 
increa ed the pIa rna glucagon level in n01111al rats \ i thout any stat istical 
signi ficance.  On the other hand, the moderate dose sign i ficant ly ( p<0. 0073 ) 
r duced the pIa ma glucagon le\ el in rats treated before the onset of diabetes. 
Furthennore, the level of glucagon ""vas increased in nonnal rats given a 
h igh do (0 .8mg) of v i tamin E compared to untreated n0l111al rats ( Fig .  6 1 ) . On 
the other hand. the level of plasma glucagon level was significantly decreased 
( p<0.02 ) in rats treated before the onset of d iabetes whi le  the p lasma glucagon 
le\'el decreased in rats treated after the onset of diabetes without any stat istical 
significance. 
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F igure 60 :  H istogram howing the  effect of  0 .4 mg of itamin  E on plasma glucagon level 
of normal and diabet ic rat . 0 .4 mg of \ itam in  E i nduced a ign ificant decrease in  the plasma 
glu agon le\ e l  i n  rats treated after the on et of DM * p<0.05 (diab cont ver LIS treated after 
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Figure 6 1 :  H istograms showing the effect of 0 .8  mg of vi tamin E on plasma glucagon level 
of normal and d iabetic rats. 0.8 mg of v itam in  E induced a sign ificant decrease in the plasma 
sodium level in  treated before the onset of DM * p<0.05 (diab cont versus treated before 
D M ). ( Data are mean ± D, n=6) DM= d iabetes mel l itus. 
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5.  Effect of v i ta m i n  C on m eta bol ic  pa ra m eters of 
n o r m a l  a n d d i a betic ra ts 
5. 1 Body weight  
Figure 6 2  shows the effect of di fferent d o  e s  o f  itamin C o n  body 
\\ ight of normal and d iabetic rat . The oral administrat ion of low do e ( 1 0 
mg/kg body w ight) of  vitamin to rats treated 1 0  days after the on et of 
d iabete re ulted in weight gain compared to untreated d iabetic rats which lost 
\\"eight during the e. perimental period but this gain was sti l l  significantly 
mal ler compared to that of normal untreated and normal treated rats. Also, the 
weight gained by nonnal treated rats with low dose of vitamin C was st i l l  
maI ler compared t o  that o f  untreated nonnal rats. O n  the other hand. the 
admini tration of low do e of vi tamin  C to rats treated 1 0  days before the onset 
of d iabete re u l ted in high weight loss. 
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Figure 62 : H istograms showing the effect of 1 0  mglkg body weight of v itam in  C on 
weight gained or lost of normal  and diabet ic rats. ( Data are mean ± SO, n=6) DM= 
diabetes mel l itus. 
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Rat receiving a moderate do e (50  mg g b dy weight) of vi tamin 1 0  
day after the on et of diab te achie ed lower weight gain compared to normal 
contro l .  l Iow ever, oral admini  tration of moderate dose ( 50 mg/kg bod weight ) 
or  v i tamin fai led t increa e the \: eight of normal rat compared to control 
Fig.  6 . 
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F igure 63 :  H istograms show the effect of 50 mglkg body we ight of v itamin  C on weight 
gained or lost in  normal  and d iabet ic rats. ( Data are mean ± D, 11=6 )  DM= diabetes 
mel l itus. 
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The high do e ( 1  OOmg/kg bod v" eight) of vitamin given to diabetic 
rat al 0 re ul ted in vv eight 10  in both rat treated before and after the on et  of 
diabete . ormal rat , which received high do e of vitamin 
\\ eight in the ame rale a untreated normal rat ( Fig. 64 ) .  
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F igure 64 : H istograms sho\\ the effect of 1 00 ma kg body \ e ight of vitamin C on weight 
gained or lost in  normal  and diabetic rats. ( Data are mean ± SD, n=6)  DM= diabetes 
mel l i tu . 
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5.2 Blood g luco  e level 
Figur 5 ho� that the ral admini trat ion of I \'v do e ( 1 0 mg/kg body 
weight) of \ itamin reduced the level of blood glucose in rats treated before 
and after the on et of diabete . Moreo er, normal rat tr ated with low dose (1 0 
mg/kg bod) weight) of vitamin  had a signi ficant decrease in blood gl ucose 
le\ el  \\ hen compared to normal untreated rats. 
The effect of 10 rrglkg body w eight of v itamin C on blood glucose level 
of normal and diabetic rats 
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F igure 65 :  H istograms showing the effect of 1 0  mgfkg of itami n  C on blood glucose level 
of normal and d iabet ic rats. I n  \ ... eeks 3 and 4 there was a sign i ficant d i fference in  blood 
glucose le\ e l  in normal non d iabet ic rats *p<O.05 (nom1 cont ersus nonn vitam in  C) .  
A lso, there was a s ignificant d i fference i n  blood gluco e level in rats treated before the onset 
of DM rats in \'r eek 3 * * p<O.05 (d iab cont versus treated before D M )  and in rats reated after 
the on et of DM in weeks 3 and 4 * * *p<O.05 (diab cont versus treated after DM)  ( Data are 
mean ± D. n=6) DM= d iabetes mel l itus. 
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he blood gluco e level wa l ight ly unchanged in diabetic rats treated 
\\ ith m derate do e ( Omg/kg b dy w ight) of vitamin C aft r the on et of 
diab tc compared v" ith untreated diabet ic rats. On the other hand, the level of 
blood gluco \va igni ficantl ) reduced compared with untr ated nOlmal rats 
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The effect of 50 rrglkg body w eight of v ltamn C on blood glucose level 
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F igure 66 : H istograms shO\ ... ing the effect of 50 mglkg of v itam in C on blood glucose level 
of normal and d iabetic rats. In week I there was a significant d i fference in blood gluco e 
level in normal non d iabet ic rats *p<0.05 ( norm cont versus norm + vitam in  C ). A lso. 
there v. a  a ign i ficant d i fference in blood glucose level in rats treated after the onset of 
OM rats in \\ eek 3 * * p<0.05 (diab cont versus treated after O M )  ( Data are mean ± SO. 
n=6) DM= d iabetes mel l i tus 
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Figure 67 ho\\ that th ral admjni  trati n of high do e ( 1 00 mg/kg 
b d) v. eight ) of vi tamin fai led to reduce bl od gluco e level in rat treated 
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F igure 67:  H istograms showing the effect of 1 00 mg/kg of itamin  C on blood glucose 
level of normal and d iabetic rats. I n  week 1 , 2 and 4 there was a sign ificant d i fference in 
blood glucose level in normal non diabetic rats *p<0.05 (norm cont versus noml + 
\ Itamin  C) .  ( Data are mean ± D, n=6) DM= d iabetes mel l i tus. 
90 
5.3 Oral  g l u co e to lera n ce te t (OGTT) 
The OGTT of rat that received itamin C ( 1 0  mg/kg bod weight ) after 
the on et of diabete wa better than that of untreated diabet ic rats. Howe er, 
rat that received 10\ do e of vitamin C before and aft r the onset of diabete 
had a better OGTT at 0 min after the glucose load compared to untreated 
diabet ic rats ( Fig.  68 ) .  
I OGTT of normal and diabetic rats treated W ith1 0 rrg/kg body w eight of vltamn C 
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F igure 68: H istograms sho'" i ng the effect of 1 0  mglkg of v itam in  C on OGTT of normal 
and d iabet ic rats. At 60 min there was a signi ficant d ifference in  blood glucose Ie e l  in 
rats treated after the on et of DM *p<O.OS ( diab cont versus treated after D M )  and in  rats 
treated before the onset of DM * *p<O.OS (d iab cont versus treated before DM) .  ( Data are 
mean ± SD, n=6) DM= diabetes mel l itus. 
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The OGrr of rat that received vitamin C (50 mglkg body weight) 
before the onset of diabete was better than that of untreated diabetic rats (Fig. 
69) . Moreover, the OGrr of rats that received vitamin C before the onset of 
diabete showed a sign ificant reduction in the blood glucose level at 1 20 min 
after gluco e challenge compared to untreated diabetic rats. However, it 
appeared that the OGrr of rats that received vitamin C (50 mglkg body weight) 
before the onset of diabetes was better than that of rats that received vitamin C 
after the onset of diabetes. The OGrr values of normal rats treated with vitamin 
C showed a significant reduction in  the blood glucose level at 1 20 min 
compared to that of untreated diabetic rats. 
The OGrr of rats that received high dose ( 1 00 mglkg body weight) of 
vitamin C after the onset of diabetes was better than that of untreated diabetic 
rats Fig (70) . However, it appeared that the OGrr of rats that received vitamin 
C after the onset of diabetes was better at 60 and 1 20 min after glucose 
chal lenge compared to that of untreated diabetic rats. The OGrr values of 
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Figure 69. Histograms ho\'.. ing the effect of 50 mglkg of vitamin C on OGTI of normal and 
diabetic rat t 1 20 min there wa a sign ificant di fference in blood glu ose level in rat 
treated before the onset of OM rats *p<O 05 (diab cont versli treated be fore DM) and in 
normal non dtabetic rats * *p<0.05 ( norm cont ver us norm+ v i tamin C ). ( Data are mean ± 0, 
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Figure 70' Hl'tograms showing the effect of 1 00 mglkg of vitamin C on OGTI of normal 
and diabetic rats. At 60 and 1 20 min there was a ignificant di fference in blood glucose 
level In normal 000 diabetic rat *p<0.05 ( norm coot ver us norm+ vitamin C ) .  ( Data are 
mean ± 0, n=6) DM= diabete mel l i tus. 
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6. Effect of vitamin C on biochemical parameter of 
normal and diabetic rats 
6. 1 Liver enzymes 
6. 1 . 1  Plasma a l kaline phosphatase level 
Figure 7 1  show the effect of low dose ( 1 0  mglkg body weight) of vitamin 
C on the level of plasma alklaline phosphatase of normal and diabetic rats. The 
result show that the low dose of vi tamin C significantly (p<O.004) reduced the 
Ie el of pIa rna alkaline phosphata e in normal rats. On the other hand, the low 
dose of vitamin C caused a decrease i n  the plasma alkal ine phosphatase level of 
rats treated before the onset of diabetes. 
The moderate dose (50mglkg body weight) of vitamin C had no effect on 
the plasma alkaline phosphatase level of normal rats. Moreover, the moderate 
dose brought an i ncrease in the plasma alkaline phosphatase level of rats treated 
before and after the onset of diabetes but without any statistical sign ificance (Fig  
72). 
The oral administration of the high dose ( 1 00 mglkg body weight) of 
vitamin C had no effect on the plasma alkaline phosphatase level of the normal 
rats. On the other hand, in diabetic rats, the plasma a lkal ine phosphatase level 
increased compared to diabetic control .  
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The oral admini lration of the high do e of itamin C can elicit a 
ign ificant (p<0.005) increase in the pia rna alkaline pho phatase Ie el in  rat 
treated before the on t of diabete . While aft r admini tration of high do e, the 
pia rna alkaline pho phata e Ie el increa ed in rats treated after the on et of 
diabete compared to diabetic control Fig .  73) .  
6. 1 . 2  PIa rna alanine aminotransferase level 
Figure 74 how that the oral admini tration of low dose ( 1 0  mglkg body 
weight) of itarnin C had no effect on the pIa rna alanine aminotran ferase level 
of the normal rat . The low do e of i tamin C reduced the plasma alanine 
arni notran ferase level in  rats treated 1 0  day before the onset of diabetes 
without any tatistical i gnificance. In contra t, after the oral administration of a 
low do e of itamin C, the p lasma alan ine aminotransferase level i n  rats treated 
1 0  day after the on et of diabete i ncreased without any stati tical significance. 
On the other hand moderate dose (50 mglkg body weight) of vitamin C 
i ncreased the plasma alanine aminotransferase level i n  rats treated 1 0  days 
before and after the onset of the diabetes without any statistical significance 
(Fig. 75) .  The plasma alanine aminotransferase level of normal rats did not 
change after the oral admini  tration of moderate dose of vitamin C .  
After the oral administration of  high do  e ( 1 00 mglkg body weight) of 
vitamin C no sign i ficant change was observed in the alanine aminotransferase 
level in normal rats and in rats treated 1 0  day before the onset of diabetes. 
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However, th re wa a high increase in  the alanine aminotran fera e level in rats 
tr ated 1 0  day after the on et diabete without any tati tical ignificance (Fig. 
76) . 
6. 1 .3 PIa rna a partate aminotran ferase level 
Figure 77 how that the oral admini tration of low dose of vi tamin C 
had no effect on the Ie el of pIa rna asparatate arninotran ferase i n  normal rats. 
There wa a large but not ignificant reduction in the plasma asparatate 
arninotran fera e level in rat treated before and after the on et of diabete . 
After the oral administration of moderate dose (50mglkg body weight) 
of i tamin C the pIa rna a paratate aminotransfera e level in rats treated 1 0  days 
before the on et of diabete increased with no statistical significance (Fig.  78) .  
However, there was a i gnificant reduction in  the plasma asparatate 
aminotran fra e level of normal rats after treatment with moderate dose of 
i tamin C.  
On the other hand, the high dose ( 100 mglkg body weight) of vitamin C 
significantly i ncreased the level of plasma asparatate arninotransfrase in  normal 
rats. The high dose of vitamin C increased the plasma asparatate 
aminotran fera e level i n  rats treated before and after the onset of diabetes (Fig. 
79) . 
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6. 1 .4 Plasma lactic debyd rogena e level 
The effect of low do e ( 1 0 mglkg body weight) of vitamin C on plasma 
lactic dehydrogenase level in normal and diabetic rats is shown in figure 80. 
The result hows that low dose of vitamin C had no significant effect on the 
pIa rna lactic dehydrogena e level of normal rats and in rats treated before the 
on et of diabetes. Moreover, the plasma lactic dehydrogenase level of rats 
treated 1 0  days after the onset of diabetes increased without any statistical 
sign ificance after low dose treatement of vitami n  C .  
The oral administration of  moderate dose (50 mglkg body weight) of 
vitamin C sign i ficantly (p<0.OOOO5)  increased the plasma lactic dehydrogenase 
level of normal rats. However, the moderate dose of vitamin C decreased the 
plasma lactic dehydrogenase level in rats treated 1 0  days before and after the 
onset of diabetes without any statistical significance (Fig. 8 1 ) .  
The high dose ( 100 mglkg body weight) of  vitamin C significantly 
(p<O.OOO l )  reduced the plasma lactic dehydrogenase level in normal rats. On 
the other hand, the high dose of vitamin C elicited an increase in the plasma 
lactic dehydrogenase level after the onset of diabetes. Vitamin C had no 
significant effect on plasma lactic dehydrogenase level in  diabetic rats (Fig. 82). 
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6. 1 .5 Plasma gamma-glu tamyl transferase 
The oral admini tration of low dose ( 1 0 mglkg body weight) of vitamin 
C failed to induce sign ificant increase in plasma gamma-giutamyl tansferase 
Ie el in normal rats . However, there was a decrease in the plasma gamma­
glutarnyl tansferase level of rats treated 1 0  days after and before the onset of 
diabete compared to untreated diabetic rats (Fig. 83) .  
The treatment with moderate dose (50 mglkg body weight) of vitamin C 
ign ificantly decreased the plasma gamma-glutarnyl tansferase level of rats 
treated 1 0  days before (p< 0.0 1 8) and after (p<0.OOO8) the onset of diabetes and 
it had no effect on normal rats (Fig. 84) . 
The oral administration of the high dose ( l 00  mglkg body weight) of 
vitamin C was capable of reducing the plasma gamma-glutamyl tansferase level 
in rats treated before and after the onset of diabetes without any statistical 
significance. A lso, the high doses of vitamin C had no effect on the plasma 
gamma-glutamyl tansferase level of normal rats compared to normal control 
(Fig.  85) .  
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6.2 Effect of vitamin C on kidney parameters of normal and 
diabetic rats 
6.2. 1 Blood u rea nitrogen level 
Figure 86 show that low do e ( I Omg!kg body weight) of vitamin C had 
no effect on plasma urea nitrogen level in both normal and diabetic rats 
compared to control rats. The administration of moderate dose (50 mg!kg body 
weight) of vitamin C significantly increased the plasma urea nitrogen level in  
normal rats. On the other hand, moderate dose of vitamin C caused a decrease i n  
the level of  plasma urea nitrogen in  rats treated 1 0  days before the onset of 
diabetes without any statistical significance and in rats treated 1 0  days after the 
onset of diabetes with statistical significance (p<0.0 1 2) (Fig. 87). 
The level of plasma urea nitrogen i n  rats treated 10 days before the onset 
of diabetes significantly (p<O.O l l )  increased after oral administration of high 
dose ( l OOmg!kg body weight) of vitamin C (Fig.  88) while no change was 
observed in the blood urea n i trogen of rats treated 10 days after the onset of 
diabetes. Moreover, the high dose of vitamin C caused a significant increase i n  
the blood urea n itrogen level of  normal treated rats compared to normal control. 
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6.2.2 Pia rna creatinine level 
Figure 89 shows the effect of low dose ( 1 0  mglkg body weight) of 
itamin C on pIa rna creatinine level of normal and diabetic rats. The level of 
pia rna creatinine of non diabetic rats was not affected by the treatment with 
low do e of vitamin C. Moreover, the plasma creatinine level of rats treated 1 0  
days before and after the onset of diabetes decreased but without any statistical 
ignificance. 
The moderate dose of vitamin C had no effect on the plasma creatin ine 
Ie el of normal rats. However, moderate dose reduced the plasma creatinine 
level of rats treated 1 0  days before and after the onset of diabetes but with no 
statistical ign ificance (Fig.  90). 
After the oral administration of high dose ( 1 00 mglkg body weight) of 
vitamin C the p lasma creatin ine level of normal and in rats treated 1 0  days 
before the onset of diabetes did not change significantly. However, high dose 
induced a sign ificant (p<0.0 1 9) i ncrease i n  the plasma creatinine level in rats 
treated 1 0  days after the onset of diabetes when compared to diabetic control 
(Fig. 9 1 ) . 
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6.3 Effect of vita mi n C on electrolytes level in the normal and 
diabetic rats 
6.3. 1 Plasma calci u m  level 
The oral administration of low dose ( 1 0mglkg body weight) of vitamin 
C had no ignificant effect on the plasma calcium level of normal rats. On the 
other hand, the low dose caused a significant increase in rats treated 1 0  days 
before (p< 0.02) and after (p< 0.008) the onset of diabetes compared to diabetic 
controLs (Fig. 92) .  
The moderate dose (50 mglkg body weight) of vitamin C increased the 
plasma calcium level of normal rats but without any statistical significance. 
However, moderate administration of vitamin C caused significant increases in 
the plasma calcium level in  rats treated 1 0  days after the onset of the diabetes 
(Fig.  93) .  
After the oral administration of high ( 1 00  mglkg body weight) of 
vitamin C, a decrease in the plasma calcium level was observed in normal rats 
when compared to control .  However, this decrease did not reach statistical 
significance. No significant change was observed on the plasma calcium level in 
rats treated 1 0  days before and after the onset of the diabetes (Fig.  94) . 
1 0 1  
6.3.2 Pia rna pho phoru level 
The re u lts pre ented in figure 95 demonstrated the effect of low dose 
(50 mglkg body weight) of vitamin C on plasma phosphorus level in nonnal and 
diabete rat . The result hows that low dose of vitamin C caused no significant 
change in the pia rna pho phorus level of nonnal treated rats compared to 
nonnal controls. In diabetic rats, low dose of vitamin C caused a s light but not 
ignificant increa e in plasma phosphorus level when compared to diabetic 
control . 
The oral administration of moderate dose (50 mglkg body weight) of 
vitanlin C induced a significant (p<0.0 1 6) increase in  the level of plasma 
pho phorus level in  rats treated 1 0  days before the onset of the diabetes (Fig. 
96). The moderate dose had no effect on the plasma phosphorus level of treated 
nonnal rats. 
Figure 97 shows the effect of rugh dose ( 1 00 mglkg body weight) of 
vitamin C on the plasma phosphorus level of nonnal and diabetic rats. The 
result indicated that high dose of vitamin C had no significant effect on the 
plasma phosphorus level of nonnal and diabetic rats . 
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6.3.3 Pia rna odi u m  level 
The oral admini tration of low dose vitamin C ( 1 0 mglkg body weight) 
cau ed ign ificant (p<O.OOOO 1 )  increase in  plasma sodium level of nonnal rats. 
Al 0, in diabetic rats it induced ignificant increases in the level of plasma 
odium in rats treated 1 0  days before and after the onset of the diabetes 
compared to diabetic controls (Fig.  98) .  
The moderate do e (50 mglkg body weight) of vitamin C caused 
increase in plasma sodium level without any statistical significance in nonnal 
rats when compared to nonnal control .  In contrast, moderate dose i ncreased the 
pIa rna sodium level without any statistical significance in rats treated 1 0  days 
before the onset of diabetes. However, moderate dose of vitamin C induced 
i gnificant (p<0.033) increase in plasma sodium level of rats treated 1 0  days 
after the onset of the diabetes when compared to control (Fig.  99). 
The oral administration of high dose ( 1 00  mglkg body weight) of 
vitamin C i ncreased the plasma sodium level significantly in  nonnal rats and i n  
rats treated 10  days before and after the onset of  the diabetes (Fig .  100). 
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6.3.4 Pia rna pota i u m  level 
Figure 1 0 1  how that the oral treatment with low dose of vitamin C had 
no ignificant effect on the plasma potassium level in normal rats when 
compared to normal control.  The level of potassium was slightly increased in  
rats treated 1 0  days before and after the onset of  the diabetes when compared 
with untreated diabetic control .  
The moderate dose (50 mglkg body weight) of vitamin C given to 
normal and diabetic rats had no significant effect on the plasma potassium level 
(Fig. 1 02). 
The oral administration of high dose ( l oo mglkg body weight) of 
vitamin C given to normal and diabetic rats had no significant effect on the 
pIa rna potassium level (Fig.  1 03) .  
6.3.4 Plasma magnesiu m  level 
Figure 104 shows the effect of low dose ( l Omglkg body weight) of 
vitamin C on p lasma magnesium level in normal and diabetic rats. These resu lts 
show that normal rats treated with low dose of vitamin C had a significant 
(p<0.020) decrease in p lasma magnesium level when compared to normal 
control. In  contrast, there was no significant difference in  plasma magnesium 
level of rats treated before and after the onset of the diabetes when compared to 
diabetic control .  
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The moderate do e of vitamin C inerea ed the level of plasma 
magne ium but wi thout any tati tical ignificance and there was no effect on 
normal and diabetic rat either before or after the onset of diabetes when 
compared to control ignificantly (Fig. 1 05) .  
The effect of high dose of vitamin C on plasma magnesium level i s  
shown in  Fig 106. The result showed that high dose of  vitamin C signi ficantly 
(p<O.OO4) increased the p Ia rna magnesium level of normal rats when compared 
to normal control .  There was a significant (p<O.0 1 6) reduction i n  the plasma 
magne ium level in rats given high dose of vitamin C treated l O  days after the 
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figure 7 1 :  H i  tograms sho\\ i ng the effect of 1 0  mg/kg of itam in  C on plasma a lkal ine 
pho phata e level of normal and d iabetic rats. 1 0  mg kg of vitamin  C induced a s ign i ficant 
decrease in  the plasma alkal i ne pho phatase Ie e l  i n  normal non d iabetic rats *p< 0.05 
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Figure 72.  H istograms showi ng the effect of 50 mg/kg of vitamin  C on plasma alka l ine 
phosphatase leve l of normal and d iabetic rats. ( Data are mean ± SO, n=6). DM= 
diabetes mel l itus. 
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Figure 73 :  H i  tograms sho\\ ing the effect of 1 00 mg/kg of v itamin  C on plasma alkal ine 
pho phata e le\ e l  of normal and d iabetic rats. 1 00 mg/kg of v itam in  C induced a 
ign ificant increa e in the pia ma a lka l ine pho phatase level in rats treated before onset 
of the DM *p< 0.05 (d iab cont er u treated before D M ). ( Data are mean ± D, n=6). 
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F igure 74: H istograms showi ng the effect of 1 0  mg/kg of v itam in  C on plasma a lan ine 
aminotransferase level of normal and d iabetic rats. ( Data are mean ± SD, n=6). DM= 
d iabetes mel l itus. 
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The effect of 50 rrg/kg of vltamn C on plasma alanine amnotransferase level 
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F igure 75 :  H istograms sho'v\ ing the effect of 50 mg/kg of itam in  C on plasma alan ine 
aminotran fera e level of nonnal and d iabetic rats. ( Data are mean ± D, n=6). DM= 
diabetes me l l itus. 
The effect of 1 00 rrg/kg of v ltamn C on plasma alanine aminotransferase 
level In normal and diabetiC rats 
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F igure 76: H istograms howing the effect of 1 00 mglkg of v itamin  C on plasma alan i ne 
aminotransferase level of normal and diabetic rats. ( Data are mean ± S D, n=6) .  DM= 
diabetes mel l itus 
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The effect of 1 0  rrg/kg of v ltamn C on plasma aspartate amnotransferase level 
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F igure 77' H i  tograms howing the effect of I 0 m� kg of v itamin  C on pIa ma aspartate 
aminotran ferase le\ e l  of nomlal and diabet ic rat . DM= d iabetes mel l itus. 
The effect of 50 rrg/kg of v ltamn C on plasma aspartate amnotransferase level 
In normal and diabetic rats 
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F igure 78 :  H istograms showi ng the effect of 50 mglkg of v itam in C on plasma aspartate 
aminotransferase level of normal and d iabetic rats. 50 mglkg of v itam in C induced a 
significant increase i n  the plasma aspartate aminotransferase level in normal non diabetic 
rats *p< 0.05 (norm cont versus nonn +v itam in  C). ( Data are mean ± D, n=6) .  DM= 
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F igure 79 : H i  tograms hO\ ing the effect of 1 00 mg/kg of itam in  C on plasma aspartate 
aminotran fera e Ie el of normal and d iabetic rat . 1 00 mglkg of itam in C induced a 
ign i ticant increa e in the plasma aspartate aminotran ferase Ie el in nonnal non diabet ic 
rat *p<.. 0.05 (nom1 cont versus norm +v itamin  C). ( Data are mean ± D. n=6) .  DM= 

















The effect of 1 0  rrglkg of vltamn C on plasma lactiC dehydrogenase level 
In normal and diabetic rats 
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F igure 80: H istograms showi ng the effect of 1 0  mglkg of v itam in C on plasma lactic 
dehydrogenase level of normal and d iabetic rats. 50 mglkg of v i tamin  C had no significant 
effect on the plasma lact ic dehydrogenase level of the normal and diabetic rats. ( Data are 
mean ± D. n=6). DM= diabetes mel l itus. 
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The effect of SO rrg g of vltamn C on plasma lactic dehydrogenase level 
In normal and diabetic rats 
* 
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F igure 8 1  H I  togram ho\\ Ing the effect of 50 mg kg of v itamin  on pia ma lactic 
deh:- drogena e le  .. el of normal and d iabet ic rat . 50 mg kg of v itamin  induced a 
igl1l ficant In rea e in the pia rna lactic deh> drogena e level in normal non diabet ic 
rat- *p 0 0: (nonn cont ver u norm + itamin  ). ( Data are mean ± D, n 6) .  DM 
d iabete mel l itu . 
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The effect of 1 00 rrg/kg of v ltamn C on plasma laclic dehydrogenase level 
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F igure 82:  H istograms ho\\ ing the effect of 1 00 mg kg of itam in  C on plasma lactic 
deh> drogenase le\el of nonnal and diabet ic rats. 1 00 mg kg of v itam in induced a 
ign ificant decrea e i n  the p lasma lactic dehydrogena e Ie e l  of normal non diabetic rat *p  
0 .0- (nonn cont .. ersus noml .+.vitamin  C).  ( Data are mean ± D, n-6). DM= d iabete 
mel l i tus. 
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The effect of 1 0  rrg/kg of vltamn C on plasma garrma­
glutamyl transferase level In normal and diabetic rats 
Norm cont Norm +Vlt C Dab cont T before DIIII T after OM 
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o T before OM 
• T after DIIII 
Figure 83 :  H i  togram sho\\ ing the effect of 1 0  mg/kg of itam in  C on plasma 
gamma-glutam) I transfera e l eve l of normal and diabetic rats. 1 0  mg/kg of v itam in  C 
had no ign ificant effect on the p lasma gamma-glutamyl transferase level of normal 
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The effect of 50 rrg/kg of vitamin C on plasma garrma­
glutamyl transferase level In normal and diabetic rats 
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F igure 84: H istogram showing the effect of 50 mg/kg of v itam in C on p lasma 
gamma-glutamyl transferase leve l of normal and d iabetic rats. 50  mg/kg of v itam in  C 
i nduced a sign ificant decrease in the pia ma gamma-gl utamyl transferase Ie el in rats 
treated before and after the onset of DM *p<0.05 (diab cont versus treated before 
D M )  * * p<0.05 (d iab cont versus treated after DM) .  ( Data are mean ± S D, n=6) DM= 
diabetes 
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The effect of 1 00 rrg/kg of vltamn C on plasrra garrrna-giutamyl 
transferase level In norrral and diabetic rats 
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F igure 85 '  H i  tograms sho\\ ing the effect of 1 00 mglkg of v itam in  C on plasma gamma­
glutamy I tran ferase Ie  el of normal and diabetic rats. 1 00 mg kg of v itam in  C had no 
sign ificant e f ect on the plasma gamm-gl utamyl transferase leve l of the normal and 
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The effect of 1 0  rrg/kg of vltamn C on plasrra urea nitrogen level 
In norrral and diabetic rats 
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F igure 86' H istograms showi ng the effect of 1 0  mglkg of vitamin  C on plasma urea 
n itrogen level of normal and d iabetic rats. 1 0  mglkg of v itam in  C had no ign i ficant effect 
on the plasma urea n itrogen Ie e l  of the normal and d iabetic rats. ( Data are mean ± D, 
n=6) .  DM= diabetes mel l i tus .  
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The effect of 50 rrg/kg of vltamn C an plasrra urea nitrogen level 
In norrral and diabetic rats 
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F igure 87 '  H istograms show ing the effect of 50 mg/kg of itam in  C on plasma urea 
n itrogen le\ el of normal  and diabetic rats. 50 mo kg of itam in  C induced a signi ficant 
increa e in the plasma urea n itrogen Ie e l  of normal non d iabetic rats *p<0.05 ( norm 
cont \ ersu nom1-+- v itam in  C) .  A lso, there was a sign ificant decrease in plasma urea 
I1ltrogen in rat treated after the onset of DM * * p<0.05 (d iab cont ersus treated after 
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The effect of 1 00 rrg/kg of vltamn C an plasrra urea nitrogen level 
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F igure 88:  H istograms showing the effect of 1 00 mg/kg of v itam in  C on plasma urea 
n itrogen level of normal and d iabetic rats. 1 00 mg/kg of v i tam in  C had a sign ificant 
increase in the plasma urea n itrogen level of normal non diabetic rats *p<0.05 (norm 
coni versus norm+ vitamin C )  and in  rats treated before the onset of DM * * p<0.05 (diab 
cont versus before D M ». ( Data are mean ± D, n=6) DM= d iabetes mel l i tus. 
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F igure 89: H istogram showing the effect of 1 0  mglkg of v i tamin C on plasma 
creat in ine Ie  e l  of normal  and d iabet ic rats. 1 0  mg/kg of itam in  C had no significant 
effect on the pia ma creat in ine level of the normal and d iabet ic rats. ( Data are mean ± 
D. n=6). D M= d iabetes mel l itus. 
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F igure 90. H istograms show ing the effect of 50 mg/kg of vitamin C on plasma 
creat in ine Ie el of normal and d iabetic rats. 50 mglkg of v itam in  C had no significant 
effect on the plasma creati n i ne Ie e l  of the normal and diabetic rats. ( Data are mean ± 
D, n=6). DM= diabetes me l l itus. 
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The effect of 1 00 rrg/kg of vltamn C on plasma creatinine level 
In normal and diabetic rats 
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F igure 9 1 :  Histogram sho\\ ing the effect of 1 00 mg;kg of v itamin  C on plasma 
creat in ine level of nonnal and diabet ic rats .  1 00 mg/kg of i tamin  C induced a 
significant increase in the plasma creat in ine level in rats treated after the on et of OM 
*p<..O 05 (d iab cont versus after OM) . ( Data are mean ± D. n=6)  OM= diabetes 
mel l itus. 
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The effect of 1 0  rrg/kg of v itamin C on plasma calCium level 
in normal and diabetic rats 
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F igure 92 : H istograms showi ng the effect of 1 0  mg/kg of i tamin  C on plasma calcium 
level of nonnal and d iabet ic rats. 1 0  mg/kg of v itam in C induced a sign ificant decrease 
in the plasma calcium Ie el in rats treated before and after the onset of OM * p<'O.OS 
(d iab cont versus treated before OM) * *p<O.OS (d iab cont versus treated after O M ). 
(Data are mean ± SO. n=6 ) OM= d iabetes mel l itus. 
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The effect of 50 rrg/kg of vltamn C on plasrra calcium level 
In norrral and d iabetIC rats 
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Figure 93 : H I  togram ho\\ i ng th effect of 50 mg kg of v itamin on pia ma calcium 
le\el of normal and d iabetic rat 50 mg J...g of \ itam in had no igni ficant effect on the 
p lasma calcium le've l  of normal and d iabetic rat . ( Data are mean ± D, n 6). DM 
d iabete mel l itu 
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The effect of 1 00 rrg/kg of vrtamn C on plasrra calcium level 
In normal and diabetic rats 
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F igure 94 : H I  togram ho\\ ing the effect of 1 00 mg kg of 'v Itamin on pia ma calcium 
le\el of normal and d iabet ic rats. 1 00 mg kg of v itam in C had no ign ificant effect on 
the plasma calcium level of normal and d iabetic rats. (Data are mean ± D, n-6) .  DM 
d iabetes mel l itus. 
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The effect of 1 0  rrg/kg of v ltamn C on plasma phosphorus level 
In normal and diabetic rats 
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F igure 9: ·  Histograms sho\\ ing the effect of 1 0  mg/kg of v itamin on plasma 
pho phorus Ie e l  of normal and d iabetic rat . 1 0  mg kg of v itamin C had no ign ificant 
effect on the pia ma pho phorus Ie e l  of normal and diabet ic rat . ( Data are mean ± 0, 
n-6). DM= d iabete mel l i tu . 
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The effect of 50 rrg/kg of vitamn C on plasma phosphorus level 
In normal and dlabtlc rats 
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Figure 96: Histograms showing the effect of 50 mglkg of v itam in C on plasma 
phosphorus leve l of normal and d iabetic rats. 50 mg/kg of v i tamin C induced a 
sign ificant decrease in the plasma phosphorus level i n  rats treated before the onset of 
OM *p<O.05 (d iab cont ersus treated before OM).  ( Data are mean ± 0, n=6 ) DM= 
d iabetes mel l itus. 



















The effect of 1 00 rrg/kg of v rtamn C on plasma phosphorus level 
In normal and dlabellc rats 
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Figure 97: H i  togram sho\\ ing the effect of 1 00 mg/kg of itamin C on plasma 
pho phoru level of nomlal and d iabetic rats. 1 00 mg kg of v itamin had no signi ficant 
effect on the pia ma phosphoru Ie el of normal and d iabetic rat . ( Data are mean ± SO, 
n=6). 0 1- diabetes mel l itu . 
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The effect of 1 0  rrg/kg of v rtamn C on plasma sodium level 
In normal and dlabetc rats 
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Figure 98:  Histograms showing the effect of 1 0  mglkg of v itamin C on plasma sod ium 
level of normal and diabetic rats. 1 0  mg/kg of v itamin C induced a sign i ficant increase 
in the plasma sodium leve l of normal non d iabetic rats *p<0.05 ( norm cont versus 
norm� vitamin C) .  A lso. there was a signi ficant i ncrea e in the sod ium level in rats 
treated before * *p<0.05 (d iab cont versus before OM) and after * * *p<0.05 (d iab cont 
versus after OM)  the onset of OM.  ( Data are mean ± SO, n=6) OM= diabetes mel l itus. 
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The effect of 50 rrg/kg of vltamn C on plasma sodium level 
In normal and diabetIC rats 
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F igure 99' H ist gram _ ho\\ i ng the effect of 50 mg \...g of v itam in  on plasma odium 
le\ e l  of normal and diabet ic  rat . 50  mg I-g of v itam in  induced a ign ificant i ncrea e 
In the plasma sodium le\el in rat after the on et of DM *p<0.05 (d lab cont ver us after 
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F igure 1 00. H i  togram ho\\ ing the effect of 1 00 mg kg of v itam in  C on pia ma 
odium level of normal and d iabetic rats. 1 00 mgtkg of v itamin  C induced a significant 
i ncrea e in  the plasma odium level of normal non diabetic rat * p<0.05 ( norm cont 
versu norm v itam lll C). A lso, there was a ign ificant increase in the odium Ie e l  in 
rats treated before * * p  0 05 (diab cont versu before DM) and after * * * p<0.05 (d iab 
cont versus after DM ) the on et of DM.  ( Data are mean ± D. n=6)  DM- d iabete 
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The effect of 1 0  I'T9/kg of vltamn C on plasma potassium level 
I In normal and diabetic rats �, o Norm cont 
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F igure 1 0 1 :  H istograms shov,. ing the effect of 1 0  mg/kg of vitamin C on plasma 
pota lum le've l  of normal and d iabetic rat . 1 0  mgtkg of i tami n  C had no ign ificant 
effect on the pia rna pota sium level of normal and d iabet ic rats. ( Data are mean ± 0, 
n=6) .  DM= diabete mel l i tu . 
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The effect of 50 I'T9/kg of vltamn C on plasma potass ium level 
In normal and diabetic rats 
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Figure 1 02 :  H istograms showing the effect of 50 mg/kg of v itam in C on plasma 
potassium level of nomlal and diabetic rats. 50  mg/kg of itamin  C had no sign i ficant 
effect on the plasma potassium level of normal and d iabet ic rats. ( Data are mean ± SO, 
n=6). DM= diabetes mel l it us. 

















The effect of 1 0  erg/kg of vltamn C on plasma potass ium level 
In normal and d iabetic rats 
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F igure 1 0 1 :  H i  togram shm ing the effect or 1 0  mg/kg of itam in  C on plasma 
pora ium Ie e l  of normal and diabet ic rat . 1 0  mgfkg of v itamin  C had no ign i ficant 
effect on the pia ma pota sium level of normal and diabetic rats. ( Data are mean ± D, 















The effect of 50 erg/kg of vltamn C on plasma potass ium level 
In normal and diabetic rats 
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F igure 1 02 :  H istograms showing the effect of 50 mglkg of v itamin  C on plasma 
potassium level of normal and d iabetic rats. 50  mg kg of v itam in C had no sign ificant 
effect on the plasma potassium level of normal and diabetic rat . ( Data are mean ± D, 
n=6). DM= d iabetes mel l itus. 















The effect of 1 00 m;Jlkg of vltamn C on plasma potass ium level 
In normal and diabetic rats 
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F igure 1 03 :  H I  tograms shO\\ i ng the effect of 1 00 mglkg of v itamin  C on pIa ma 
pota sium level of normal and d iabetic rats. 1 00 mglkg of itam in  had no sign ificant 
effect on the pia ma pota s ium Ie el of nomlal and d iabetic  rats. ( Data are mean ± 0, 
n 6). DM- d iabete mell itus. 
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The effect of 1 0  m;J/kg of vltamn C on plasma magnesium level 
In normal and diabetic rats 
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Figure 1 04 :  H istograms showing the effect of 1 0  mglkg of v itami n  C on pia ma 
magnesium level of normal and diabet ic rats. 1 0  mglkg of v itam in C induced a 
significant decrease in the p lasma magnesium level i n  normal non d iabet ic rats (norm 
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The effect of 50 rrg/kg of v ltamn C on plasma magnesium level In 
normal and diabetic rats 
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Figure 1 05 :  H i  tograms howi ng the effect of 50 mglkg of itami n  C on plasma 
magne ium level of normal and d iabet ic rat . 50 mglkg of v itamin  C had no 
ign i ficant effect on the pia ma magnesium level of the normal and diabetic rats. 
(Data are mean ± D. n=6) .  DM= diabetes mel l itus.  
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The effect of 1 00 rrg/kg of vltamn C on plasma magnesium level 
In normal and diabetic rats 
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F igure 1 06 :  H istograms showing the effect of 1 00 mglkg of v itam in C on plasma 
magne ium level of normal and diabetic rats. 1 00 mglkg of vitam in  C induced a 
s ign i ficant increase in the plasma magnesium level of normal non diabetic rats * p<0.05 
( norm cont versus norm+ v itam in  C) and in  rats treated after the onset of OM * * p<0.05 
(d iab cont versus after O M ). ( Data are mean ± 0, n=6) DM= diabetes me l l i tus. 
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7. Effect of vitamin C on the pattern of distribution of 
insulin immunoreactive cells in normal and diabetic rats 
Figure 1 08 show the effect of low dose of vitamin C on the number of 
in u lin  immunoreactive cell in normal and diabetic rats. The re ult  shows that 
the oral admini tration of low do e of vitamin C did not induce any significant 
changes in the pattern of distribution of insulin positive cells in  normal and 
diabetic rats. Moreover, low dose of vitamin C i nduced a significant (p<0.OO03) 
increa ed in the number of positive insulin immunoreactive cells of the islets of 
rats treated before the onset of diabetes compared to diabetic control (Fig .  1 07) .  
A lso, moderate dose of  vitamin C did not cause any significant 
morphological changes to pancreatic islets of normal and diabetic rats (Fig.  1 09) .  
Moderate dose of vitamin C significantly increased the number of positive 
insul in cel ls i n  rats treated before (p<O.0 1 3) and after (p<O.OO l )  the onset of 
diabetes (Fig. 1 07) .  
The high dose of  vitamin C also d id  not cause any significant changes in  
the pattern of distribution of i nsulin immunoreactive cells in normal and diabetic 
rats (Fig.  1 1 0) . Moreover, the high dose of vitamin C i nduced a significant 
i ncrease i n  the number of insul in positive cel ls  i n  rats treated after (p<0.03 1 )  the 
onset of diabetes (Fig. 1 07) .  
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F igure 1 07 :  H istogram showing the effect of d ifferent do es of v itamin  C on percentage 
distribution of insu l i n  immunoreactive ce l l  of normal and d iabetic rats. Different doses of 
\ itam in  C induced sign ificant * p<0.0003 ( diab cont versus treated with 1 0  mglkg of v itam in C 
before OM) ,  * *p<O.O 1 3 (d iab cont versus treated with 50 mglkg of itamin C before OM ). 
* * *p<...O .OO l (d iab cont versus treated with 50 mg.Kg of itam in C before OM after OM)  and 
* * * * p<0.03 1 ( diab cont ersus treated with 1 00 mg/kg of itamin C OM after O M )  increase in 
the percentage of insu l in  immunoreactive cel ls  in i s lets of diabetic rats when compared to 
contro l .  ( Data are mean ± 0, n= \ O) .  DM= diabetes mel l i tus. 
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F igure 1 08 :  Representative m icrographs showing insul in -posit ive cel ls in the islet of Langerhans 
of normal and diabetic rats. A = normal rat: B = untreated d iabetic rat; C = normal rats treated 
with 1 0  mg 'kg of vitamin E; D = rats treated with 1 0  mglkg of v itam in  C before the onset of 
d iabetes and E = rats treated with 1 0  mg/kg of v itami n  C after the onset of d iabetes. 
Magni fication: X 400. 
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Figure 1 09: Representat i ve micrographs showing insul in-posit ive cel ls  in the is let of Langerhans 
of normal and d iabetic rats. A = nomlal rat; B = untreated d iabetic rat; C = normal rats treated 
w ith 50 m& kg of itami n  C and D = rats treated with 50 mglkg of itamin C before the onset of 
diabetes. Magn ificat ion: X 400. 
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F igure 1 1 0: Representative m icrographs showing insu l in-posit ive ce l ls  in the islet of Langerhans 
of normal and d iabet ic rats. A = normal rat; B = untreated d iabet ic rat; C = rats treated with 1 00 
mg 'kg of v i tam in  C after the onset of diabetes. Magn ificat ion:  X 400. 
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7. 1 Effect of vitamin C on plasma insulin level of normal and 
diabetic rats. 
Figure 1 1 1  shows the effect of low dose of 0 0  mg/kg body weight) of 
vitamin C on insulin level in nonnal and diabetic rats. The insulin plasma level 
was slightly increa ed in rat treated 1 0  days with low dose of vitamin C ( 1 0  
mglkg body weight) before and after the onset of the diabetes compared to 
diabetic controls compared to diabetic controls. The oral administration of the 
low dose of vitamin C decreased the plasma insu lin level of the normal treated 
rats compared to untreated nonnal controls.  
As shown in  figure 1 1 2, the plasma insulin level of nonnal rats treated 
wi th moderate dose (SOmglkg body weight) of vitamin C decreased when 
compared to nonnal control. Moderate dose did not induce any significant 
change in i nsuli n  level. 
Moreover, high dose ( l OOmglkg body weight) of vitamin C failed to 
i ncrease the plasma i nsulin level in rats treated with high dose of vitamin C 
before and after the onset of diabetes and the level was s lightly increased when 
compared diabetic control but without any statistical significance. A lso, the 
plasma i nsulin  level of nonnal rats decreased after treatment of the high dose of 
vitamin C when compared to untreated nonnal controls (Fig .  1 1 3) 
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The effect of 1 0  mg/Kg body w e ight of v itamin C on pla s ma Insu lin level  
of  normal and d iabetic rats 
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Figure I I I : H istogram show ing the effect of 1 0  mglkg body weight of itam in C on the 
plasma insu l in Ie el of nonnal and diabetic rat . ( Data are mean ± 0, n=6) DM= diabetes 
mel l it u  
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Figures 1 1 2 :  H istograms showing the effect of 50 mg/kg body weight of  v itam in C on the 
plasma insu l in level of normal and diabetic rats. ( Data are mean ± S O, n=6) DM= diabetes 
me l l itus. 
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Figure 1 1 3 :  H istograms showing the effect of 1 00 mg/kg body \\ e ight of vitamin C on the 
pIa ma in u l in  le\ el of normal and d iabetic rats. ( Data are mean ± D, n=6) DM= d iabetes 
mel l itu . 
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8. Effect of vitamin C on the pattern of distribution of 
glucagon immunoreactive cells in normal and diabetic 
rats. 
Figure 1 1 5 shows the effect of low dose of vitamin C on the pattern of 
distribution of glucagon immunoreactive cells in  nonnal and diabetic rats. The 
low dose of vitamin C did not induce any sign ificant changes in the pattern of 
di tribution of glucagon positive cel ls in normal and diabetic rats. The oral 
administration of the low dose of vitamin C i nduced a i ncrease i n  the number of 
glucagon immunoreactive cells in normal rats but with no statistical significance 
(Fig.  1 1 4) .  
Moreover, moderate dose of vitamin C did not cause any significant 
morphological changes to glucagon immunopositive cells of the pancreatic islets 
of nonnal and diabetic rats (Fig. 1 1 6) .  Moderate dose of vitamin C slightly 
i ncreased the number of glucagon positive cells in the islets of normal rats 
compared to untreated normal controls. However, there was a significant 
(p<O.0 1 9) decrease in the number of glucagon positive cells in  rats treated with 
moderate dose of vitamin C 1 0  days after the onset of diabetes compared to 
diabetic controls (Fig. 1 1 4) .  
The high dose of  vitamin C also did not cause any sign ificant changes i n  
the pattern of  distribution of  glucagon i mmunoreactive cells i n  nonna1 and 
diabetic rats (Fig. 1 1 7 ) .  Moreover, the high dose of vitamin C i nduced a 
decrease i n  the 
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number of glucagon po it i"e c I I  in the i let of normal rat and in rat treated 
after the n et of diabete without an tati t ical ignificance ( Fig. 1 1 4 ) .  
Percentage distribution of glucagon IrrrnunoreacllVe cells In the Is lets of normal 
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F igure 1 1 4 :  H istogram sho", ing the effect of d ifferent doses of itam in C on percentage 
distribution of glucagon immunoreacti e ce l ls  of nomlai and diabet ic rats. 1 0  mglkg of vitam in 
C induced a significant * p< 0.0 1 9  (diab cont versus treated after DM) decrease in the 
percentage distribution of glucagons immunoreactive cel ls  in the is lets of rats treated 1 0  days 
after the onset of diabetes. ( Data are mean ± SD, n= 1 0). DM= diabetes me l l itus. 
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Figure 1 1 5 :  Representat ive m icrographs showing glucagon-pos i t ive ce l ls  in the islet of 
Langerhans of normal  and diabetic rats. A = nonnal rat; B = untreated diabetic rat; C = normal 
rats treated \\ ith 1 0  mg/kg of vitam in E; D = rats treated with 1 0  mg/kg of vitamin C before the 
onset of diabetes and E = rats treated with 1 0  ma kg of v i tamin C after the onset of diabetes. 
Magn ification: X 400. 
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F igure 1 1 6: Representative m icrographs showing glucagon-posit ive cel ls  in the islet of 
Langerhans of normal and diabetic rats. A = normal  rat; B = untreated diabetic rat; C = normal 
rats treated with 50 mg"kg of v itamin E; D = rats treated with 50 mg/kg of v itamin C before the 
onset of diabetes and E = rats treated with 50 mglkg of vitamin C after the onset of diabetes. 
M agnification: X 400. 
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F igure 1 1 7 :  Representative m icrograph showing glucagon-posi t ive cel ls in the islet of 
Langerhans of nonnal and diabet ic rats. A = normal rat; B = untreated diabet ic rat; C = nonnal 
rats treated with 1 00 mg/kg of v itamin  E and D = rats treated with 1 00 mglkg of itam in C 
after the onset of diabetes. M agni fication: X 400. 
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8. 1 Effect of vita min C on plasma glucagon level of normal and 
diabetic rats. 
Figure 1 1 8 shows the effect of low dose of ( 1 0  mglkg body weight) of 
vitamin C on plasma glucagon level in normal and diabetic rats. The glucagon 
plasma level was slightly decreased in rats treated 1 0  days with low dose of 
vitamin C ( 1 0  mglkg body weight) before and after the onset of the diabetes 
without any statistical signi ficance. Moreover, the p lasma glucagons level 
decreased in normal rats after administration low dose of vitamin C. 
As shown in figure 1 1 9, the plasma glucagon level of normal rats treated 
with moderate dose (50mglkg body weight) of vitamin C significantly 
decreased when compared to normal controls. Moderate dose did not induce any 
significant change in plasma glucagon level in diabetic rats. 
High dose ( l OOmglkg body weight) of vitamin C decreased the p lasma 
glucagon level in rats treated 1 0  days after the onset of diabetes with a statistical 
sign ificance. Moreover, high dose of vitamin C decreased the plasma glucagon 
level i n  rats treated 1 0  days before the onset of diabetes when compared to 
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Figure J J 8 H istograms showing the effect of 1 0  mg/kg body we ight of itamin C on the 
pia rna glucagon level of normal and diabet ic rats. ( Data are mean ± SO, n=6 ) DM= 
diabetes mel l i tus 
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F igures 1 1 9:  Histograms show ing the effect of 50 mg/kg body weight of vitam in C on the 
plasma glucagon level of normal and d iabet ic rats. 50 mglkg of itamin C induced a 
sign ificant decrease in plasma gl ucagons level i n  normal rats *p<0.05 (norm cont ersus 
norm+ vitam in C) in normal rats. ( Data are mean ± SO, n=6) DM= diabetes mel l itus. 
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Figure LO: H i  tograms show the effect of 1 00 mglkg of body we ight of vitamin C on the 
pIa ma glucagon level of nomlal and diabetic rats. 1 00 mglkg of vitamin C induced a 
ign ificant decrea e in p lasma glucagon Ie e l  in rats treated 1 0  da s after the onset of 
OM *p<0.05 (d iab cont versus T after O M ). ( Data are mean ± 0, n=6) OM= diabetes 
mel l itu . 
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Effect of vitamin E on metabolic parameters of normal 
and diabetic rats 
1 .  Body weight 
The finding of this study have demonstrated that oral administration of 
different doses of vitamin E reduced body weight gain in  normal and diabetic 
rats. Vitamin E induced weight loss is associated with a decrease i n  the blood 
glucose level. The mechanism by which vitamin E reduced rats body weight is  
unknown.  On the other hand, vitamin E supplementation did not affect body 
weight gain of diabetic Wistar male rats (75).  Moreover, the administration of 
vitamin E has no effect on body weight gain in Goto Kakizaki (GK) (76).The 
supplementation with 60, 200 and 800 IV of vitamin E for 30 days did not affect 
the body weight of healthy persons (77) .  There was a negative relationship 
between body mass index and serum Tocopherols level in Costa Rican 
adolescents (78). Thi s  reduction in body weight after oral administration of 
vitamin E may be due to the presence of tocotrienol in  Tocopherols. There was a 
suppression of body weight gain of Fisher male rats after oral administration of 
3% of tocotrienol, which was purified from vitamin E (79) . 
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2- Plasma glucose level 
Significant i ncrease in  blood glucose level was observed in diabetic 
rats and this was maintained at high level throughout the experimental period . 
Interestingly, the blood glucose level of untreated diabetic rats was slightly 
lower compared to the untreated group .  However, this decrease in the blood 
glucose level did not reach statistical significance. This observation may be due 
to the relatively small  number of samples. The present study revealed that the 
oral administration of vitamin E reduced blood glucose level. Other studies have 
shown that vitamin E supplementation significantly improves glucose level i n  
Goto Kakizaki (OK) rats model and this improvement may result from 
minimizing free radical damage to pancreatic cells. A lso there was an 
improvement in  glucose metabolism and i nsulin action in obese Zucker rats and 
this may be due to the reduction i n  oxidative stress. Some investigators have 
reported that glucose stimulated hyperinsulinemia and lipid peroxidation i n  
obese Zucker rats cou ld be significantly reduced after vitamin E 
supplementation (80) . However, the diabetes state induced by STZ associated 
with increase in fasting blood glucose level and administration of vitamin E 
cou ld not normalize the hyperglycemia but i t  prevent lipid peroxidation induced 
by hyperglycemia i n  eyes and aorta of diabetic rats (76) . The supplementation 
(800 IUI l day) of vitamin E significantly reduced fasting glucose level in 
NIDDM patients (8 1 ) .  
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3. Glucose tolerance test (OGTT) 
The pre ent tudy al 0 showed that oral admini tration of vitamin E 
can improve gluco e tolerance. The moderate and high do e of this vitamin were 
effecti e in improving gluco e tolerance in rats treated 1 0  days before the onset 
of diabete mellitus compared to rats treated 1 0  days after the onset of diabetes 
mellitu e pecially at 30. 60, 1 20, and 1 80 min after glucose chal lenge. The 
baseline blood glucose levels were slightly lower compared to severe diabetes. 
This may be due to the vitamin E treatment and even a possible recovery of 
pancreatic �-cells. 
Vitamin E thus has a beneficial effect in the improvement of glucose 
tolerance. The blood glucose levels were decreased significantly at 30 min and 
1 20 min in tocopherol supplemented Goto Kakizaki (GK) rats. The reduction of 
oxidative stress by tocopherol decreased glucose level due to accumulation of 
tocopherol in pancreatic islets and improvement of insulin secretion (76). 
4. Plasma i nsulin level 
The present study demonstrated that insulin resistance may be 
accompanied by intracellu lar production of free radicals. Ceriel lo (8 1 )  noticed 
that insulin increases the production of hydrogen peroxide which has been 
shown to mimic the action of insulin and form this vicious circle between 
hyperinsulinemia and free radical could be operating. Insulin resistance might 
cause elevated plasma free radical concentrations which may contribute to the 
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deterioration of insulin action . He found that vitamin E improves insulin action 
in healthy, elderly and nonin ulin dependent diabetes (82) .  
3. Effect of vitamin E on biochemical parameters of 
normal and diabetic rats 
3. 1 Effect of vita min E on l iver enzymes 
Liver enzymes including ALT, AST, ALP and GGT reflect different 
functions of the liver such as excretion of anions, hepatocellular integration, 
formation and subsequent free flow of bile and protein synthesis .  The 
aminotransferase ALT and AST are important indicators of hepatocellu lar 
damage. They a lso p lay an important role in gluconeogenesis  (83) .  
AST is found in  several organs l ike liver, brain ,  kidney, lungs and 
pancreas and it is present in cytosolic and mitochondrial enzymes. In the present 
study the plasma level of AST increased after the onset of diabetes mellitus. 
Only treatment with low dose of vitamin E sign ificantly reduced the AST level 
in rats treated 1 0  days after the onset of diabetes. The reason for the i nabi l i ty of 
other doses to signi ficantly i ncrease or decrease the level of AST in normal and 
diabetic rats is not clear. 
ALT is more specific to liver and it is present i n  cytosolic enzyme. It is 
found in  large quantity i n  l iver. The plasma level of AL T i ncreased after the 
onset of diabetes mel litus. In contrasts, the oral administration of low dose of 
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vitamin E ignificantly decrea ed ALT in the pIa rna in  rats treated 1 0  days 
before and after the onset of diabete . 
The hepatocellu lar injury is  the trigger for the release of these enzymes 
into the circu lation . The increase in the plasma level of these liver enzymes 
how that STZ had a toxic effect on the liver. Treatment with low dose of 
vitamin E reduced this toxic effect on the liver of diabetic rats. Also, this result 
indicated that low dose of vitamin E is  more effective than moderate and high 
does on plasma AST and ALT and this may be due to what was reported 
previou ly, that the use of high single doses of micronutrient antioxidant 
supplements such as vitamin E poses potential risks because it cou ld pertub the 
antioxidant peroxidant balance. It has been recommended that high doses of 
micronutrient antioxidan ts vitamins should be administered in combination 
rather than in single supplements (84) .  
The plasma ALP level also increased after the onset of diabetes. The 
ALP originates mainly form two sources, the liver and bone and it may be 
present i n  many other tissues such as the intestine, kidney, placenta and blood . 
Hepatic ALP is  present i n  the canalicular and luminal domain of bi le duct 
epithel ium and i ts level rise as a result of increased synthesis and before being 
release into circulation .  The level of ALP may not rise until  two days after 
biliary obstruction (85) .  The oral administration of vitamin E failed to decrease 
the ALP level in rats treated 1 0  days before and after the onset of diabetes. The 
plasma level of ALP increased significant after administration of low dose of 
vitamin E in normal non diabetic rats. 
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The data obtained from this study show that low vitamin E had a 
sigruficant effect on LDH level in  untreated normal rats. On the other hand, the 
LDH Ie el in rats treated 1 0  days after the onset of DM is slightly simi lar to the 
level in normal rats. The high oral administration of vitamin E significantly 
increased LDH level .  
GGT i found in  hepatocytes and biliary epithelial cells. I ts level i s  
raised i n  pancreatic disease, renal fai lure and diabetes (85) .  There was a 
significant i ncrease i n  the GGT level in  diabetic rats. After the oral 
administration of vitamin E there was no significant change in GGT level in rats 
treated either before and after of the onset of diabetes. This means that treatment 
with vitamin E did not have any beneficial effect on decreasing GGT level i n  
diabetic rats. 
3-2 Effect of vitami n  E on kidney parameters of normal and 
diabetic rats 
In the present study, only administration of low dose of vitamin E 
significantly i ncreased blood creatin ine level while al l  other two doses of 
vitamin E had no effect on creatinine the i n  the normal rats and this suggest that 
low dose of vitamin E may have adverse effect on kidney function. Diabetes 
elevated the plasma creatinine level in rats and vitamin E treatment fai led to 
reduce i ts level .  Other study i ndicated that the disturbance of renal function 
which appeared in high level of plasma creatin ine and they found that a decrease 
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in creatinine level of diabetic rats correlated significantly with vitamin E 
treatment and this effect may be due to the influence of vitamin E on the 
di turbance of redox balance. The high dose of vitamin E significantly i ncreased 
blood urea ni trogen level ( B UN) of treated 1 0  days after the onset of diabetes. It 
does not appear that the higher the vitamin E dose the higher the level of BUN. 
4. Effect of vitamin E on the pattern distribution of 
insulin immunoreactive cells in the pancreas of normal 
and diabetic rats 
There were significant changes i n  the pattern of distribution of insulin 
positive cel ls in  the pancreas of diabetic rats when compared to normal 
control .  Insulin positive cells were located on the central and peripheral parts 
of the islets i n  normal pancreas. This  observation on the pattern distribution of 
i nsulin producing cells is simi lar to other reports (87) .  Moreover, the oral 
administration of different doses of vitamin E did not change the pattern of 
distribution of insuli n  immunoreactive cells in the islets of normal and diabetic 
rats . The number of insulin positive cells was significantly h igher in normal 
pancreas compared to STZ-induced diabetic rats. The STZ does not destroy al l  
of the fS-cells i n  the diabetic pancreatic islets and this resu lt corroborates with 
previous report (88).  The moderate and high doses of vitamin E have 
beneficial effect by increasing the number of insulin positive cells in diabetic 
rats. The mechanism by which vitamin E causes the increase in the number of 
i nsulin positive cells is unknown.  However, this i ncrease in the number of 
insulin positive cells may be due the abi lity of vitamin E to reduce the toxic 
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effect of STZ on {S-cell and it may help in the regeneration of pancreatic {S-
cel l  which are damaged by STZ. The low and moderate doses of vitamin E 
induced a significant decrease in  the number of insulin posi tive cells in normal 
rats. The abi lity of vitamin E to induce a decrea e in the number of pancreatic 
p-cell is unknown. This may indicate that vitamin E is useful in tissue 
subjected to oxidative stress such as STZ-induced diabetes. 
5. Effect of vitamin E on the pattern of distribution of 
glucagon immunoreactive cells in the pancreas of 
normal and d iabetic rats 
There were significant changes in the pattern of distribution of 
glucagon positive cells in the pancreas of diabetic rats when compared to 
normal control. In normal pancreas, glucagon positive cells were located 
main ly on the peripheral parts of the islets and this is simi lar to other report 
(89). After the onset of diabetes, the number and pattern of distribution of 
glucagon positive cells changed significantly when compared to normal 
control.  Glucagon positive cel ls were located in both peripheral and central 
regions of the islets of diabetic rats. Moreover, the oral administration of 
different doses of vitamin E did not induce any statistical significance on the 
pattern of distribution and number of glucagon immunoreactive cells in the 
islets of normal and diabetic rats. The reason for the increase in the number of 
glucagon positive cells is unknown but this could be due to the absence of the 
inhibitory effect of i nsulin on glucagon . 
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Effect of vitamin C on metabolic parameters of normal 
and diabetic rats 
1 - Body weight 
The present study showed that the administration of vitamin C has 
completely inverse correlation with body weight gain  in rats treated 1 0  days 
before the onset of diabete . Low dose of vitamin C can e levate body weight 
gain in rats treated 1 0  days after the onset of diabetes. Moderate dose also 
increase body weight gain in  a rate smaller than that of low dose. However, high 
dose decreased body weight gain i n  treated 1 0  days after onset of DM. This 
observation suggested that only the low dose of vi tamin C has a beneficial effect 
on diabetes and the moderate and high doses had an adverse effect on body 
weight gain especial ly after the onset of diabetes. 
A lso, the administration of vitamin C on rats before the onset of 
diabetes did not reduce the effect of diabetes on body weight. Further studies 
are required to establish the mechanism of action of vitamin C on body weight. 
The mechanism by which high dose of vitamin C reduces body weight is  not 
clear. 
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2. Blood glucose level 
The pre ent study showed that vitamin C can improve plasma glucose 
Ie el. The admini tration of low do e of vitamin C wa more effective than 
moderate and high do e . It i gnificantly reduced the plasma glucose level in  
rats treated 1 0  days before and after the onset of diabetes. Also, vitamin C 
upplementation signi ficantly elevated glucose level i n  non diabetic rats. 
The data from this tudy showed that low dose of vitamin C 
ign ificantly improved the glucose tolerance in  rats treated 1 0  days before and 
after the onset of diabetes especially at 60 min .  On the other hand, 
administration of high do e of vitamin C significantly reduced glucose level at 
60 and 1 20 min only in rats treated 1 0  days after the onset of diabetes. The 
beneficial effect of ascorbic acid noted in the present study can be attributed to 
the antioxidant effects of vitamin C. vitamin C is a scavenger of oxygen free 
radicals which are toxic by-products of many metabolic process and in  STZ­
induced diabetes. 
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Effect of vitamin C on biochemical parameters of 
normal and diabetic rats 
1 .  Liver enzyme 
A mentioned before, liver enzymes are used as markers of 
hepatotoxicity especial ly ALT, which is a more specific indicator for liver 
damage. From the demonstrated data, the plasma level of alan ine 
aminotran fera e i ncrea ed after diabetes and vitamin C administration had no 
beneficial effect in  reducing ALT level also it can ' t  reduce the level of plasma 
AST. 
Serum alkaline phosphata e level also increased in  diabetes mel litus. 
The low dose of vitamin C significantly reduced the ALP level. However, the 
administration of high dose of vitamin C had a negative effect on ALP level 
because the level of ALP is  increased . There was no significant effect on plasma 
level of lactic dehydrogenase in diabetic group after treatment with vitamin C 
but low dose significantly i ncrease LDH level and high dose can also 
ignificantly reduce its level in normal non diabetic rats . 
The plasma level of GGT was significantly increased in  diabetic rats. 
Low dose of vitamin C did not reduce GGT plasma level in rats treated 1 0  days 
before and after the onset of diabetes . There was no significant effect of vitamin 
C on normal non diabetic rats. This may be due to the dosage of vitamin C 
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applied. A much lower or higher dose of vitamin C may be required for an 
effective reduction in the pIa rna GGT level of diabetic rats. 
2. Effect of vitamin C on kidney parameters of normal and 
diabetic rats. 
In the present study, al l  the three doses of vitamin C had no effect on 
creatinine level in the normal rats. The administration of high dose of vitamin C 
significantly increased blood creatinine level in rats treated 1 0  days after the 
onset of diabetes and this may be because that high dose of vitamin C had 
adverse effect on kidney function . The high dose of vitamin C significantly 
increased blood urea nitrogen level in both treated 1 0  days before and after 
onset of diabetes. 
Effect of vitamin C on the pattern of distribution of 
insulin immunoreactive cells in the pancreas of normal 
and diabetic rats 
The oral administration of different doses of vitamin C did not induce 
any changes in  the pattern of distribution of insulin immunoreactive cells in 
islets of normal and diabetic rats. However, the oral administration of vitamin 
C has beneficial effect by the increasing the number of positive insulin cel ls i n  
diabetic rats. The mechanism by which vitamin C causes an increase i n  the 
number of insulin positive cells is unknown.  This increase in the number of 
insulin positive cel ls may be due the abi li ty of vitamin C to prevent the death 
of �-cells or permitting the recovery of the destroyed �-cel l  by STZ. The STZ-
1 52 
induced a ca cade of event during which cytokine wil l  be able to destroy 
pancreatic �-cel l  i slets (88) and the effects of these cytokines may be 
neutralized by vi tamin C, and thus increase the number of insulin posi tive 
cell . 
Effect of vitamin C on the pattern of distribution of 
glucagon immunoreactive cells in the pancreas of 
normal and diabetic rats 
The oral administration of the low dose of vitamin C is more effective 
in reducing the number of glucagon positive cells in the islets of rats treated 1 0  
day after the onset of diabetes. The other two doses of vitamin C failed to 
i nduce any statistical significance on the pattern of distribution and number of 
glucagon immunoreactive cel ls in the islets of normal and diabetic rats . As 
mention earlier the reason for the i ncrease i n  the number of glucagon positive 
cells i s  unknown but this could be due to the absence of the inhibitory effect of 




I t  can be concluded from this study that the administration of  vitamins 
E and C to normal and STZ-induced diabetic rats significantly decreased body 
weight gain in a dose-correlated manner. The oral administration of vitamin E 
and C also, reduced blood glucose level and improved glucose tolerance. Both 
vitamin E and C significantly affected the biochemical parameters of both 
normal and diabetic rats. The investigation on li ver enzymes, kidney parameters 
and electrolytes showed that the levels of these parameters are altered during 
STZ-induced diabetes. The administration of vitamin E and C affect the level of 
these biochemical parameters. The i nsulin immunoreactive cells were 
significantly decreased in STZ-induced diabetic rats and the administration of 
vitamin E and C significantly increased insulin posi tive cells. However, 
glucagon positive cells i ncreased i n  STZ-induced diabetic rats and the 
administration of vitamin E and C fai led to decreased glucagon positive cells. 
The result of obtained from this study have provided insight into the 
hypoglycemic effect of vitamin E and C and they may be a useful therapies in 
the management of diabetes mellitus. 
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3eneficial effect of vitamin E on the metabol ic 
)arameters of diabetic rats 
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, bst ract 
e role of v itamin E I n  the pathogenesis of diabetes mel l i tus is unknown. The purpose of  this study was to examine the effect 
oral admin istration of itamin  E on some of the metabo l ic parameters of experimental diabetic rats. Diabetes was induced 
intraperitoneal injection of streptozotocin  (60 mg/kg body weight at 1 2  weeks of age). Vitamin E (0.2, 0.4, 0.8 mg/kg body �.ght) was administered oral ly for a period of 3 weeks to normal and diabetic Wistar rats. In some experiments, Vitamin E 
s given e ither before or after the induction of diabetes mell i tus. Blood glucose level and weight were recorded for each rat in  
erent groups on a wed.ly basis. Oral glucose tolerance test (OGTT) wa perfomled on fasted nomlal .  d iabetic and vi tamin E 
at�d ralS al the end of the experi ment. Vitamin E significa�t ly v: < 0.0 I )  re?uced bl�od gl ucose levels in experimental d iabetes 
r l l Itus at a l l  doses as compared to untreated rats
: 
Vitamin E I nduced weIght loss III normal as well as in diabetic rats. The 
neficlal effect of \, Itamln E on the hyperglycaemla of d IabetIC ral S  \� a� dose-dependent. Moreover. v i tamin E also improved 
GTT III dlalxtlc rJh compared to untreated dIabetics. In conclUS IOn.  \ I la l l l l ll E may play a role in g lucose metabol ism and 
s be a useful adju\ ant therapy in type I diabetes. ( Mol Cell  B iochem 26 1 :  35-42. 2004) 
�' words: vitamin  E, diabetes mel l itus, anti-oxidants, g lucose, glucose tolerance lest, weight 
l t roduct ion 
re I S  l iu le doubt that \\ e are in the midst of a worldwide 
demic of diabetes. There are an estimated 1 43 mi l l ion peo-
worldwide with the d Isease. almost five t imes more than 
i mates of 1 0  years ago. This number wi l l  probably double 
2030 [ I ] . Although diabetes is more prevalent in  devel­
cd countries, i t  is l ikely that the developing world w i l l  bear 
brunt of the epidemic in lhe future. In diabetics, the risks 
eart disease and stroke are escalating. Moreover, diabetes 
he leading cause of end-stage renal disease, bl indness, and 
�-traumatic 1 1mb amputation. It is rather d i fficul t  to calcu­
e the human and economic costs of d iabetes worldwide. 
ever, the total medical costs mcurred annual ly  in the 
' ted S tates alone are close to $ lOO bi l l ion [2 ] .  
iabetes mel l i tus i s  a metabolic d isorder caused by an ab­
te or relative lack of i nsu l in .  As a result ,  the metabol ism of 
uels including carbohydrates, fats, and proteins is altered 
This results in elevated fasting and post-prandial serum 
glucose (hyperglycaemia) that leads to compl icat ions if left 
untreated. 
Hyperglycaemia induces i ncreases in gl ucose autoxidation 
and prote in glycation, and the subsequent ox idative degrada­
tion of glycated proteins leads to enhanced production of 
reactive oxygen species ( ROS) (4 ) .  ROS are thought to play 
a major role in a variety of physiologic and pathophysiolog­
ical processes in which increased ox idat ive stress may play 
an important role in d isease mechanisms; however, increased 
oxidative stress may be a result  of the pathologic process 
[ 5 ) .  In d iabetes, persistent hyperglycaemia may cause high 
production of free radicals generated in  d i rect autoxidation 
processes of  glucose [6], the non-enzymatic and progressive 
glycation of proteins with the consequent increased forma­
tion of glucose-derived advanced g lycosylation end products 
[7 ] ,  activation of NAD(P)H oxidases [8 ] ,  ni tric ox ide yn­
thase [9] ,  and a spec ific enzyme act iv ity, xanthine oxidase, 
which produces oxidant species and subsequent ox idative 
stress [ 1 0] .  There is also evidence that hyperglycaemia 
ess for offpnnls: Ernest Adeghate, Department of A natomy, Faculty of Medicine and Health Sciences. United Arab EmIrates University. PO Box I � 66, 
in, Unlled Arab Emirates (E-mail: eadeghale@uaeu.ac.ae) 
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Diabetes mellitus. N = 10 rats. 
at of untreated nomlal control. There was a signi ficant 
t loss tn rats that received v itamin E before the onset 
�betes compared to that in untreated diabetic raLS. 
ie administration of a medium dose of 0.4 mg of v itamin 
rats after the onset of diabetes resulted in weight loss 
l b). This weight loss was more pronounced compared to 
f untreated diabetic rats. The weight loss observed in rats 
d with 0.4 mg vi tamin E before the onset of diabetes was 
cantly higher than that of untreated diabetics. Normal 
at received v itamin E failed to gain weight in the same 
n as untreated control rats. 
oral administration of 0 .8  mg of v itamin E to diabetic 
esulted in weight loss (Fig. L c). The weight loss ob­
in  rats treated with 0 .8  mg vitamin E after the onset 
of diabetes was comparable to that untreated diabetics. How­
ever, the treatment of rats with vitamin E before the on' I of 
diabetes infl icted severe weight loss compared to unl1� led 
diabetic rats. Normal rats that received vitamin E, did not 
gain as much weight as untreated control rats. 
Effect of vitamin E 011 blood glucose level 
Figure 2 shows the fasting blood glucose (FBG) level of nor­
mal and diabetic rats after treatment with vitamin E. Oral 
administration of 0.2 mg/kg body weight of vi tamin Y 
that were already diabetic caused a significant (p ( )  
reduction in FBG level compared to untreated diabel 
In  contrast, there was no signi ficant difference in the b BG 
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disrupt natural antioxidant defence mechanisms [ 1 1 .  1 2 ]. 
Such metabolic perturbatIons elicit a lterations in ussues that 
undergo insulin-independent g lucose uptake, thereby pro\'ok­
ing early tissue damage i n  target organs of d iabetic compl i­
cations such as ocular lens, ret ina, peripheral nerve and renal 
glomerulus [ 1 3- 1 5 ] .  
There are two common mechanisms that lead t o  increased 
oxidative stress in diabetes: one of them is increased free rad­
ical productIOn during elevated autoxidation of glucose and 
the other is the hyperglycaemia-induced reduction i n  the lev­
els of protec l lve endogenous antiOXidants such as itamins 
A, E, C, glutathione, etc., and decrease in the act ivi t ies of an­
tIOxidant enzymes such as glutathione peroxidase. Reduction 
of the antioxidant capacity generates more H10:� and other 
reactive intermediates such as hydroxyl radicals. Therefore, 
l ipids but also proteins, carbohydrates and nucleic acids are 
affected by alteration of the oxidant and antioxidant systems. 
Increased free radical production and reduced activi ty of an­
tiOXIdant defence systems in diabetes and hence t issue dan1-
age are faci l i tated [ 1 6,  1 7] .  Lower endogenous antioxidants 
and elevated l ipid perox idation levels are risk factors for the 
development of diabetic compl ications such as atherosclero­
sis [ 1 8 , 1 9] .  
Studie 10 animal models revealed that some of t he 
diabetes-related functional and morphological abnomlalit ies 
could be prevented by antio.\ ldant. ( 20 ] .  However, in gen­
eral,  these findings are inconclusi e because several reports 
Ind icated the absence of Improvement ( 2 1 ]  and even wors· 
ening [ n ]  of diabetic nephropathy with antiox idant treat ­
ment. The latter could result from insu fficient understanding 
of the mechanisms underlying renal OX idative damage and, 
In  part icu lar, very contradictory infomlation on the effects 
of d iabetes on major components of free rad ical production 
and anti ·oxidati e defence. which hampers the selection of 
speci fic targets for antioxidant therapy as well as proper an­
l Io:l. idants and ant iox idant combinations [ 23 ] .  
Vitamin E i s  a l ipid-soluble, chain-breaking antioxidant, 
wh ich protects especial ly biological membranes from l ipid 
peroxidation [24 ] .  I t  was recently reported that v i tamin E 
prevents elevated l ipid perox idation in rats [25 ] .  Other vi­
tamins such as v i tamin C are also involved in antiox idative 
defence [26] .  
The purpose of this study was to characterize some STZ-
10duced metabol ic act ivi t ies as wel l  as to examine the antiox­
Idant effect of v itamin E on diabetic rats. 
M aterials and met hods 
Animals and operation procedures 
Seven- to eight-week-old male Wistar rats ( 200-300 g) were 
used in this study. All rats were housed in temperature- and 
humidiry-controlled r m ,  and all \\ ed free ac-
\\ ater and tandard rat chow ad hbilllm. Dlabete \\ In. 
duced b) a s in�le intraperit neal injecu n of TZ ( Igm 
SL Lou is, 10, USA) at a do e of 6 mg/kg bod) \\ el�ht 
[21] .  STZ was d lssolved immediatel) be fore u.e in 0.0: m V 
sodium citrate (pH 4.5) [- ] .  B lood \\' drawn from the tad 
vein, and blood glueo e \\ as me ured \\ eekl� u ' 1Og a g �. 
cometer (One Touch I I  Glucometer. Life can, 1 t 1pita . � 
USA). Rats were considered dtabetl If theIr bl od gluco.'c 
Ie els e 'ceeded 250 mgJdl [29] .  Rat bod) \\ elght \\ ere 1 0  
recorded on a \\ eekl} bast . 
Rats were aSSigned to three groups a c rding to the do 
of vitamin E they received ( low, 0.2, m derale, 0.4; and high 
O. mg/kg body weight).  Each group \\ as then dl\'ided Into 
fi\'e subgroup : (a) untreated nOli-diabetiC (conlro\).  \\ here 
rats have not been treated \\ i th ellher STZ or \ ltamm E, (b) 
untreated diabetic. STZ-induced d iabetic rats that were not 
treated with vitamin E; (c) treated diabetic r ,  where rats \\ ere 
treated wilh vitamin E for 1 0  da s prior to the TZ·inductlon 
of diabetes: (d)  treated diabet ic I I ,  where rats were treated 
with vitamin E 1 0  days after the onset of diabete ; (e) treated 
non-diabetic. 1 0  th is  ubgroup, rat were treated with v i tamin 
E only. 
Oral glllcose' lel/CrallCe II ' H  (ocrTi 
At the end of tht? \LUdy. rats \\'en� \unJt?ctt?d to ora l g l uco\t' 
tolerance te:,.t ( OG IT ) .  1l1e rats were fa:.ted tor 1 � h and 
g iven glucose at a dose of 2 g/kg b dy weight with gastric 
intubation. Blood samples were col lected from tat !  vem at 0, 
30, 60, 1 20 and 1 80 111 1 0 .  
Statistical allalnis 
Data are expressed as mean ± S . D. Student 's t test was used to 
analyse the igni ficance of d i fferences between mean values, 
and different groups were analysed by analysis of variance 
(ANOYA). A P value of less than 0.05 was considered statls, 
t ically signi fiean! .  
Resu lts  
Effect of I'itamin E Oil body weight 
Rats that received 0.2 mg/kg body weight of v i tamin E 1 0  
days after the onset o f  diabetes gained weight compared 
to untreated diabetic rats. However, the weight gain in til lS 
group was s t i l l  significantly smaller compared to normal ralS 
(Fig. L a). Moreover, the weight galOed by normal rats treated 
with 0.2 mg of vitamin E was significantly smaller compared 
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H lstogTams sho ..... ing the effect of dIfferent do;,e, (�.  0 2: b: 0.4: c: 0.8 mglkg body welghl)  of '· 113mln E on body weight of normal and dl3bellc rats. 
labetes mellitus. N = 10 rats. 
�t of untreated normal control. There was a significant 
pt loss in rats that received vitamin E before the onset 
fbetes compared 10 that in untreated d iabetic rats. 
f adm inistration of a medium dose of 0.4 mg of v itamin 
ats after the onset of diabetes resulted in weight loss 
1 b). This weight loss was more pronounced compared to 
f u ntreated d iabetic rats. The weight loss observed in rats 
d with 0.4 mg vitamin E before the onset of diabetes was 
cantly higher than that of untreated diabetics. Normal 
at received v itamin E fai led to gain weight in  the same 
n as untreated control rats. 
oral administration of 0.8 mg of v i tamin E to diabetic 
suited in weight loss (Fig. l c) .  The weight loss ob­
in rats treated with 0.8 mg vitamin E after the onset 
of diabetes was comparable to that untreated d iabetics. How­
ever, the treatment of rats with vitamin E before the on ' of 
diabetes infl icted severe weight loss compared to unti L led 
d iabetic rats. Normal rats that received vi tamin E, did not 
gain as much weight as untreated control rats. 
Effect of vitamin E on blood glucose Level 
Figure 2 shows the fasting blood glucose (FBG) level of nor­
mal and diabetic rats af1er treatment with vitamin E. Oral 
administration of 0.2 mg/kg body weight of v i tamin 
that were already diabetic caused a significant (p 0 ) 
reduction in FBG level compared to untreated diabcl 
In contrast, there was no significant difference in the H3G 
36 
disrupt natural antioxidant defence mechanisms [ 1 1 ,  1 2 ] .  
Such metabolic perturbations e l icit  alterations in tissues that 
undergo insul in-independent glucose uptake, thereby pro ok­
ing early tissue damage in target organs of diabetic compli­
cations such as ocular lens, retina, peripheral nerve and renal 
glomerul us [ 1 3- 1 5 ] .  
There are two common mechanisms that lead t o  increased 
oxidative stress in dIabetes: one of them IS i ncreased free rad­
ical production during e levated auto idat ion of glucose and 
the other is the hyperglycaemia-induced reduction in the Ie -
els of protective endogenous antIOxidants such as v itamins 
A, E, C, glutathione, etc., and decrease in the acti i ties of an­
tioxidant enzymes such as glutathione peroxidase. Reduction 
of the antioxidant capacity generates more H201 and other 
reactive intennediates such as hydroxyl radIcals. Therefore, 
l ipids but also proteins, carbohydrates and nucleic acids are 
affected by alteration of the oxidant and antioxidant systems. 
lncreased free radical production and reduced activity of an­
t IOxidant defence systems in diabetes and hence tissue dam­
age are facil i tated [ 1 6, 1 7 ) .  Lower endogenous antiox idants 
and elevated l ipid perox idation levels are risk factors for the 
development of diabetic compl ications such as alhero c1ero­
sis [ 1 8, 1 9] .  
StudIes 1 0  animal models revealed that some of the 
diabetes-related functional and morphological abnomlal i t ies 
could be prevented by antio \ ldant. [ 20] .  However, in  gen­
eral, these findtngs are inconclusive because several reports 
Indlc<Hed the absence of improvement [ :2 1 ]  and even wors­
enl l1g [ 22 J  of diabetic nephropathy with antioxidant treat­
ment. The latter could result  from insufficient understanding 
of the mechanisms underlying renal OXidative damage and, 
10 particular, very contradictory infomlation on the effects 
of d iabetes on major components of free rad ical production 
and anti -ox idative defence. which hampers the selection of 
spt:ci fic targets for antiox idant therapy as well as proper an-
1 I0x idants and ant ioxidant combinations (23 ) .  
Vitamin E is a l ipid-soluble, chatn-breaking antioxidant, 
which protects especial ly biological membranes from l ipid 
peroxidation [24 ] .  I t was recently reported that v i tamin E 
prevents elevated l ipid perox idation in rats [25J .  Other vi­
tamins such as vitamin C are also involved in ant ioxidative 
defence (26) .  
The purpose of this study was to characterize some STZ­
tnduced metabolic act ivit ies as wel l  as to examine the antiox­
idant effect of vi tamin E on diabetic rats. 
Materials and methods 
A n illla Is and operation procedllres 
Seven- to e ight-week-old male Wistar rats (200-300 g) were 
used in this study. Al l  rats were housed in temperature- and 
humidity-conlrolled rooms, and al l  \\ ed free a to t 
v. ater and standard rat cho\\ ad Ithilllm. Dlabete" \\ 
duced by a single intraperitoneal LnJe tion of TZ l<:-m 
SL Lou is, 10, USA) at a dose of 60 m� g bod) \\ elght 
[ _7]. STZ was dl  olved lmmedlatel. be fore we in O.O: molJl 
sodIUm citrate (pH 4.5)  [ - ) . B lood was drawn from the tJJI 
vein. and blo d glucose v. measured \\ eekl) USLng g u­
cometer (One Touch I I  G lucometer, L i fe can, f i lp l tas. 
USA). Rats were con Ide red d lab t ic If their blo d glu O:e 
Ie e ls e ceeded 2. 0 mg/dl (29) .  Rat bod) \\ eight \\ ere at 0 
recorded on a weekI) baSIS. 
Rat were aSSigned to three group according to the do e 
of \ i tamin E they received ( 10\\ . 0.2; moderate, 0.4; and high 
O. mg/kg body weight). Each group \\ a tllen dl\ Ided lnt 
five subgroups: (a)  untreated non-dlabellc (control ) , \\ here 
rats have not been treated \\ Ilh ellher STZ or \ itanlln E; (b) 
untreated diabetic, STZ-l Oduced d iabetic rats that were not 
treated with vitamin E; (c) treated diabetic 1, where rat were 
treated with v itamin E for 1 0  days prior t the STZ-induction 
of diabetes; (d) treated diabetic I I , where rats were treated 
with v itamin E 1 0  days after the on et of d labete ; (e) treated 
non-diabet ic. in this subgroup. rats were treated wtth vttamin 
E only. 
Oral glllco.\(' lolow/cc' 1" .1'1 rOCTT} 
At the end of Ihe  qudy. rats were ,uhjcctcd to oral gluC<hc 
tolerance tc�t ( OGIT).  The rats were fa).ted for 1 8  h and 
given glucose at a dose of 2 g/kg body weight with gastnc 
intubat ion. B lood amples were collected from tat !  ve in dt 0, 
30, 60. 1 20 and 1 80 min.  
SlaIlSlical liIlO/'·S;S 
Data are expressed as mean ± S. D. Student 's 1 te t wa used to 
analyse the signi licance of d i fferences between mean values, 
and di fferent groups were analysed by analysis of vanance 
(ANOYA). A {J value of less than 0.05 was considered stat ts· 
t ically signil icant . 
Res u l ts 
Effect oj I'ila nz ill E all body weighl 
Rats that received 0.2 mg/kg body weight of  vitamin E 1 0 
days after the onset of d iabetes gained weight compared 
to untreated diabetic rats. However, the weight gam in tillS 
group was st i l l  sign i ficant ly smaller compared to nonnal rats 
(Fig. l a) .  Moreover, the weight gained by nonnal rats treated 
with 0.2 mg of v itamin E was signi ficant ly smaller compared 
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H,stograms shov. lng the effect of different do,e, (a.  0.2: b: 0.4: c: 0.8 mg/kg body weight) of v itamin E on body weight of normal and diabetiC [:lIS. 
iabeles mellllus. II' = 10 rats. 
t of untreated normal control. There was a significant 
t loss lfl rats that received vitamin E before the onset 
betes compared to that in untreated diabetic rats. 
e administratIOn of a medium dose of 0.4 mg of vitamin 
rats after the onset of diabetes resulted in weight loss 
I b). This weight loss was more pronounced compared to 
f untreated diabetic rats. The weight loss observed in rats 
with 0.4 mg vitamin E before the onset of diabetes was 
'cantly higher than that of untreated diabetics. Normal 
at received vi tamin E fai led to gain weight in the same 
n as untreated control rats. 
oral administration of 0.8 mg of vi tamin  E to diabetic 
'sul ted in weight loss (Fig. I c). The weight loss ob­
in rats treated with 0.8 mg vitamin E after the onset 
of diabetes was comparable to that untreated diabetics. How­
ever, the treatment of rats with v itamin E before the on I of 
diabetes infl icted severe weight loss compared to untrl led 
diabetic rats. Normal rats that received v itamin E, did not 
gain as much weight as untreated control rats. 
Effect of viramin E 011 blood glucose level 
Figure 2 shows the fasting blood glucose (FBG) level of nor­
mal and diabetic rats after treatment with vitamin E. Oral 
administration of 0.2 mg/kg body weight of v itamin 
that were already diabetic caused a significant (p U ) 
reduction in FBG level compared to untreated diab<:t 
In  contrast, there was no significant d ifference in the rBG 
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dIsrupt natural antioxidant defence mechanisms ( 1 1 ,  1 2J .  
Such metabolic perturbations e licit alterations in tissues that 
undergo insulin-independent glucose uptake, thereby provok­
ing early tissue damage in target organs of d iabetic compli­
cations such as ocular lens, retina, peripheral nerve and renal 
glomerulus [ 1 3- 1 5 J .  
There are two common mechanisms that lead t o  i ncreased 
oxidative stress in dIabetes: one of them is increased free rad­
ical production during e levated autoxidation of glucose and 
the other is the hyperglycaemia-induced reduction in the lev­
e ls of protective endogenous antioxIdants such as v itamins 
A, E, C, g lutathione, etc. ,  and decrease in  the activities of an­
tiOXIdant enzymes such as glutathione peroxidase. Reduction 
of the antioxidant capacity generates more H202 and other 
reactive intermediates such as hydroxyl radicals. Therefore, 
l ipids but also proteins, carbohydrates and nucleic acids are 
affected by alteration of the oxidant and antio idant systems. 
I ncreased free radical production and reduced activity of an­
tioxidant defence systems in diabetes and hence tissue dam­
age are fac i l itated [ 1 6, 1 7J .  Lower endogenous antiox idants 
and elevated l ipid peroxidation levels are risk factors for the 
development of diabetic complications such as atherosclero­
sis [ 1 8. 1 9) .  
Studies i n  animal models revealed that orne of the 
di abetes-related functional and morphological abnonnalit ies 
could be prevented by ant lo\ ldants [20 J .  However. in gen­
eral , these findings are inconclUSive because everal repons 
Ind icated the absence of improvement [ 2 1  J and even wors­
enl llg [ 22 J  of diabetic nephropathy \\ ith antiox idant treat­
ment. The lalter could result from insufficient understanding 
of the mechanisms underlying renal OX Idat ive damage and, 
I II part icular, ve!)/ contradictory infomlation on the e ffects 
of diabetes on major components of free radical production 
and anti -oxidative defence. which hampers the selection o f  
speci fic targets for antioxidant therapy a w e l l  a s  proper an­
t lo>.. idants and antioxidant combinations [ 2 3 J .  
Vitamin E i s  a l ipid-soluble, chain-breaking antiox idant, 
which protects especial ly biological membranes from l ipid 
peroxidatlon [24 ) .  I t  wa recently reported that v itanl in E 
prevent elevated l ipid perox idation in rats [25 J .  Other vi­
tamins such as vitamin C are also involved in antioxidative 
defence (26) .  
The purpose of th is  study was to characterize some STZ­
I Ilduced metabolic activit ies as well as to exam ine the antiox­
idant effect of vitamin E on diabetic rats. 
Materials and met hods 
Anifllals alld operation procedures 
Seven- to eight-week-old male Wistar rats (200-300 g) were 
used in this study. A l l  rats were housed in temperature- and 
humidiry-controlled room , and all \\ ed free aCt:e. - to t 
\\ ater and stand3.fd rat chow ad Itballl1l. Dlabete- \\ as In­
duced by a ingle intraperitoneal inje non of 17 Igm 
SI.  Louis. 10. USA) at a do e of 60 m:3 'g bod) \\ elg 
[27] .  STZ \\ as di o lved immedlatei) before u e In 0.0: mo� 
sodIUm citrate (pH 4.5) [2 J .  B lood \\ a dra\\ n from the tail 
\ ein, and blood a l uco e \\ as measured \\ eddy u:ing a glu. 
cometer (One Touch I I  G lucometer, L i fe can, hlptta., A 
SA).  Rats \\ ere considered d IabetIC if their blood gluco 'e 
levels exceeded 250 mg/dl [ 29 ] .  Rat bod} \\ eIght \\ ere al 0 
recorded on a week.ly baSIS. 
Rat were a S igned to t hree group accordmg to the do e 
of i tamin E the) received ( 10\\ , 0.2; moderate, 0.4; and hIgh, 
O. mg/kg body weight ) .  Each oroup \\'a' then dl\'ided into 
five subgroups: (a)  untreated non-d iabetIC (control) ,  \\ ht;re 
rats have not been treated \\ I th either S17 r \ Itamin E: (b) 
untreated diabetic, STZ-induced dIabetic rat that were not 
treated with v itamin E; (c) treated d Iabetic I ,  where rats were 
treated with vi tam in E for l O  days prior to the S17-inductlOn 
of diabetes; (d) treated diabetic I I ,  where rats were treated 
with itamin E 1 0  days after the onset of diabetes: (e ) treated 
non-diabetic. 10 this  ubgroup, rats \\ ere treated \\' Ilh vitamin 
E only. 
Oral gillco \c  tolcrt/nce tcSI (oefT) 
At the end of t he ,tudy. rats \\ ere suhJt'ctcd to oral g luc:o,e 
toleran e te�t ( OGTT). The rat were fa:,ted for I X  h and 
given gl ucose at a do e of 2 g/kg body weight with gastnc 
intubat ion. B lood samples were col lected frolll tat l vem at 0, 
30, 60. 1 20 and 1 0 min.  
Slal/slicGI analYSIS 
Data are expressed a mean ± S . D .  Student 's t test wa used 10 
anal yse the significance of di fferences between mean val ues, 
and d i fferent groups were analysed by analysis of variance 
( ANOVA ) .  A P value of less than 0.05 was considered stal ls­
ticall y signi ficant . 
Resu l ts  
EffecI of vitam ill E 011 body weight 
Rats that received 0.2 mg/kg b dy weight of vitamin E 10 
days after the onset of diabetes gained weight compared 
to untreated d iabetic rats. However, the weight gain in tillS 
group was st i l l  significantly smaller compared to normal rats 
(Fig. I a). Moreover, the weight gained by nonnal rats treated 
with 0.2 mg of vitamin E was signi ficant ly  smal ler compared 
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Diabetes mell itus. N = 10 rats. 
at of untreated normal control. There was a significant 
�ht loss in rats that received vitamin E before the on et r 
iabetes compared to that in untreated dlabeuc rats. 
he admlOlstration of a medium dose of 0.4 mg of vitamin 
rats after the onset of diabetes resulted in weight loss 
1 b). This weight loss was more pronounced compared to 
f untreated diabetiC rats. The weight loss observed in rats 
ed with 0.4 mg vitamin E before the onset of diabetes was 
ficantly higher than that of untreated diabetics. Normal 
lat received v itamin E failed to gain weight in the same 
on as untreated control rats. 
e oral administration of 0.8 mg of vitanlin E to d iabetic 
resulted in  weight loss (Fig. l c) .  The weight loss ob­
d in rats treated with 0.8 mg vitamin E after the onset 
of d iabetes was comparable to that untreated diabetics How­
ever, the treatment of rats with v itamin E before the or of 
diabetes infl icted severe weight 10 compared to untr \:d 
diabetic rats. ormal rats that received vitamin E, dId not 
gain as much weight as untreated control rats. 
Effect of vitamin E 011 blood glucose lel'el 
Figure 2 shows the fasting blood glucose ( FBG) level of nor­
mal and diabetic rats after treatment with v i tamin E. Oral 
administration of 0.2 mg/kg body weight of v i tamin 
that were already diabetic caused a significant (p 
reduction in FBG level compared to untreated diatx. 
In contrast, there was no signi ficant difference III the I 1:30 
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disrupt natural antioxidant defence mechanisms [ 1 1 ,  1 2] .  
Such metabolic perturbations el icit alterations in  tissues that 
undergo insulin-independent g lucose uptake. thereby provok­
ing early tissue damage in target organs of diabetic compli­
cations such as ocu lar lens, retina, peripheral nerve and renal 
glomerulus [ 1 3- 1 5] .  
There are tl), 0 common mechanisms that lead t o  increased 
oxidative stress in diabetes: one of them is increased free rad­
ical production during elevated auto idatlOn of g lucose and 
the other is the hyperglycaemia-induced reduction in the lev­
els of protective endogenous antioxidants such as v i tamins 
A. E, C, glu tathione, etc., and decrease in the activities of an­
tIOxidant enzymes such as g lutathione peroxidase. Reduction 
of the antioxidant capacity generates more H202 and other 
reactive intermediates such a hydroxyl radicals. Therefore. 
l ipids but also proteins, carbohydrates and nucleic acids are 
affected by al teration of the oxidant and antioxidant systems. 
i ncreased free radical production and reduced activity of an­
tioxidant defence systems in diabetes and hence t issue dam­
age are facil itated [ 1 6, 1 7] .  Lower endogenous antiox idants 
and elevated l ipid perox idation levels are risk factors for the 
development of diabetic complications such as atherosclero­
sis [ J  8,  19 ] .  
Studies In animal models revealed that some o f  the 
d iabetes-related functional and morphological abnomlali t ies 
could be prevented by ant io:>. ldants [ 20 ) .  However. in gen­
eral,  these findings are incond usl e because everal repor1 . 
Ind icated the abo ence of I mprovement [ 2 1  J and even wors­
enl llg l 2 2 ]  of diabetic nephropathy with antiox idant treat­
menl. The I alter could resul t  from insufficient understanding 
of the mechanisms underlying renal oxidative damage and. 
In par1 icular, very contradictory infomlation on the e ffects 
of d iabetes on major components of free radical production 
and anti-oxidative defence, which hampers t he selection of 
spec i fic targets for antiox idant therapy as wel l  as proper an­
t ioxidants and antioxidant combinat ions [ 2 3 ) .  
VItamin E i s  a l ipid-soluble. chain-breaking anlioxidant, 
which protects especially biological membranes from l ipid 
peroxidation [24 ] .  I t  was recently repor1ed that vi tamin E 
prevents e levated l ipid perox idation in raLS (25 ) .  Other vi­
tamins such as v i tamin C are also invol ved in  antioxidative 
defence [26J .  
The purpose of thiS  study was to characterize some STZ­
induced metabolic act iv i t ies as wel l as to exam i ne the antiox­
idant effect of vi lamin E on diabetic rats. 
Materials and methods 
Animals and operation procedures 
Seven- to eight-week-old male Wistar raLS (200-300 g) were 
used in th i  study. Al l  rats were housed in temperature- and 
humidity-controlled rooms. and allo" e free a e - to t P 
\\ ater and standard rat c ho\\ ad l,biwnI. Dlabele' \\ a' In­
duced by a single i ntraperitoneal tnJecllon of TZ ( tgma, 
Sl.  Lou is. 10, USA) at a do e of 60 m� -g bod) \\ ei_m 
[27] .  STZ \\ as disso h ed immedlatel before u, e in 0.0':- mo 1 
sodium citrate (pH 4.5) [2 ] .  B lood \\ df3wn fr m the t:til 
vein, and blood gluco e I), a measured \\ eell) u ing a glu­
cometer (One Touch rr G l ucometer. LIfe can. { i [plta . �. 
USA).  Rats were con idered d iabetic If their bl od glu '0. e 
level exceeded 250 mg/dl [29 ] .  Rat bod} " eight' \\ ere L'o 
recorded on a weekly basi . 
RaLS were aSSigned to three group a cording to the dose 
of itamin E they received ( 10\\ , 0.2:  moderate. 0.4: and high. 
O. mg/kg body weight).  Each group was then dIvided into 
fi e subgroups: (a) untreated non-dlabellc (c ntro!). where 
rats have not been treated " ith either STZ or Vitamin E: (b) 
untreated diabetic. STZ-i nduced diabetic raL that \\ ere not 
treated with vitamin E; (c) treated d iabetic l ,  where raLS were 
treated with v itamin E for L O  days pnor to the STZ-inductlOn 
of diabetes; (d) t reated diabe t ic H .  where rats were treated 
with v itamin E 1 0  days after the on el  of d iabetes. (e) treated 
non-diabetic. In this subgroup.  rats were I reated \\ Ith vitamin 
E only, 
Oral gltlco.\(' 101crOIlC(, lesl (OCTr) 
At the end of I he �t udy. rats were \uojcClcd 1 0  oral g l uco\e 
tolerance tc�t ( OGlT ) ,  The rab were fa�led for I X  h and 
given g lucose at a dose of 2 g/kg body weight with gastnc 
intubatton. B l ood samples were collected from taI l  vein at O. 
30. 60. 1 20 and 1 80 min,  
Slal/slieal allalysis 
Dala are expressed as mean ± S . D. St udent 's I test was used to 
analyse the signi ficance of d i ffe rences between mean val ues. 
and di fferent groups were analysed by analysis of vanance 
( ANOVA).  A {J value f less than 0.05 was considered statis­
t ically signi ficant. 
Res u l ts 
EffecI of \'ilal1lill E 011 body weight 
Rats that received 0.2 mg/kg body we ight of vitam in E 1 0  
days after the onset o f  d iabetes gained weight compared 
to untreated diabe t ic raLS. However, the weight gain in tim 
group was stil l  sign i ficant ly smaller compared to normal rats 
(Fig. l a). Moreover, t he weight gained by nomlal raLS treated 
with 0.2 mg of v itamin E was signi f icant Ly smaller compared 
39 
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c( of nIall/ill E 011 OGrr 
OGTI of rats that received vitamin E (0.28 mg/kg body 
ht) after the onset of diabetes was better than that of un­
ted diabetic rats ( Fig. 5).  However, rats that were given 
in E before the onset of diabetes had a comparable 
value 1 20 min after the glucose load as compared 
treated diabetic rats. A l though the OGTI values of nor­
rats treated with vitamin E was better than that of the 
eated normal rats, it was nonetheless comparable. 
e OGTI of normal and vitamin E (0.4 mg/kg body 
ht) treated rats is shown in Fig. 6. Rats treated with 
vitamin E be fore and after the onset of d iabetes had a better 
OGTI value compared to untreated diabetic rats. However, I t  
appeared that the OGTI of rats that received vitamin E I fore 
the onset of diabetes was better than that of rats treatL v. IIh 
vi tamin E after the onset of d iabetes. The OGTI valul' of 
normal rats treated with vitamin E was comparable to those 
of untreated normal rats. 
The OGTI of normal and diabetic rats treated with 0.8 
mg/kg body weight of vitamin E is depicted in Fig 7 1 1 �  
treated with vitamin E before and after the onset of l, 
had a better OGTI than the OGTI of untreated diabcl l  r t 
However, the OGTI of rats than received vitamin E belO1 the 
3 
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level of rats given 0.2 mg/kg body weight before the onset of 
dtabetes when compared to untreated diabetic rats. Normal 
rats treated with vitamin E had a small bUI not signi ficant 
decrease in FBG level compared to untreated nomlal rats. 
The FSG level was slightly reduced in diabetic rats treated 
with a h igher dose of vitam i n  E (0.4 mg/kg body weight )  
either before or after the onset of diabetes compared t o  un­
treated d iabetics. However, the reduction i n  FBG level was 
not statistically significant (Fig. 3) .  The FSG level of nor­
mal rats treated with v itam in E was comparable with that of 
untreated normal rats. 
The oral admin istration of 0.8 mg/Kg body weight of 
vitam i n  E to rats after the onset of diabetes signi ficantly 
(p < 0.05) reduced the FBG level when compared to un­
treated diabetic rats. The reduction in the level of FBG 
was consistent throughout the experimental peflod. S1I11I­
larly, there was a sign i ficant (p < 0.05) reduction in the 
FSG level when rats were given higher doses of vitamtn 
E (0.8 mg/kg body weight) before the onset of diabetes. 
Vitamin E (0.8 mg/kg body weight) also decreased the 
FSG level of normal rats compared to untreated normal rats 
( Fig. 4).  
s in Goto Kakizaki  (GK) ralS fed with v itamin E (20 and 
g/kg) at 30 and 1 20 mlO after glucose load 109 [33] .  An 
entoneal tolerance test revealed a significant increment 
ulin secret ion at 30 min and a significant decrement of 
glucose levels at 30 and 1 20 min after glucose chal­
in  the GK ralS fed with high a-tocopherol d iet [33] . 
levels of glycosylated haemoglobin A l e, an indicator 
caemic control, were also reduced [33] .  The resul t  of 
tudy and those of pre ious studies show that vi tamin E 
es blood gluco e levels in d iabetic ani mal . The mech­
by which i tamlO E reduces blood glucose levels i far 
clear. However. itamin E as an antiox idant may help 
clearance of free radicals responsible for the compl i ­
ns of diabetes mell itus. In  addit ion. i t  may also promote 
sorption or uptake of glucose from the intestine and 
respectively. Vitamin E may also participate in the in­
Ie? ca�boli
.
sm �f glucose, a �oss �ble �xplanation for the 
etlon 10 we ight 10  rats fed With v ltamlO E.  
at are the effects of v i tamin E at the t issue level? H igh 
of vitamin E caused interst i t ial inflammat ion and ade-
tous hyperplasia of the lung ( 3 1 ) . Moreover. high do es 
mg/k.g) of I tamin E have been a sociated with haem­
gic dlathest in both males and females and increased 
l Iary e!)lthropoiesi 1I1 the pleen of one male [ 3 1 ) . How­
it has been reponed that \ I t .lInin E supplementat ion s ig­
lntl) IOcrca.scd glutath ion� S -trallsferase (GST) le\ 'eb I n  tal plasma of rabbit. as compared with the controls [ 34 ] .  
l in E i s  thus a �lHnulan t  o f  �ndogenous antiox idant ell­
s such as GST. An 1I1crea e in the t issue level of GST 
h tum help organisms destroy the ROS. reactive n itrogen 
s and other free rad icals that are relea ed into the cyLO­
and interst i t ia of diabetic rat cel ls  as a result of hyper­
emia. Hyperglycaemia is a known i nductor of react ive 
�n and ni trogen spec ies [ 35 ]  in d iabet ics. In add it ion to 
�neficial effect of vitamin E on blood glucose level and 
rr in d iabetic rats. it has been shown that v i tamin E can 
�cantly reduce LOtal plasma cholesterol, triglyceride and 
ensity l ipoprotein  levels in diabetic rats [ 1 9) .  In conclu­
vi tanl in  E decreases body weight and has a beneficial 
on the metabolic parameters of STZ-induced d iabetiC 
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onset of diabetes was belter than that of rats that received v i ­
tamin E after the onset of  diabetes. The OOTT of nomlal rats 
treated with v itamin E was comparable to that of untreated 
normal rats. 
Discussion 
Effect oj vitamill E 011 body weight 
The result  of this study shows that v i tamin E can reduce body 
weight in both normal and diabetic rats. The mechanism by 
which v i tamin E reduces weight is unknown. Reports per­
formed in rabbits showed that dietary vi tamin E supplemen­
tation does not affect their growth or the lipid concentration 
in the plasma [30, 3 1 ] . A reduction in the weight of these ani­
mals was not reported. A possible reason for this d iscrepancy 
is that d ifferent doses were used in the experiments. Studies 
perfonned by Abdo (!t 01. [ 3 1 ]  used high do es ( 1 25-200 
mg/kg) of v itamin  E. Many of the animals died especially 
when the higher doses were used. In a more recent slUdy. 
Shamla et al. [ 32] sh wed that v itamin E did not have any 
effect on the weight of diabetic rats after treatment with oral 
650 mg/kg body weight of a-tocopherol .  
The relatively smaller doses of v i tamin E employed In thiS 
study decreased body weight in both nomlal and diabetic rats. 
It is not known how vitamin E contributes to weight loss 1 0  
this group of animals. The weight loss may, however, play a 
role in the lowering of blood g lucose i n  diabetic rats treated 
with v i lanlin  E. 
Effect of vitamill E on blood glucose and GGTT 
The resul t  of this study showed that v itamin  E can reduce 
blood glucose levels and improve the values of OOTT. Sim­
i lar stud ies reported significant decrease in blood glucose 
int J D,abe(es &. 1clabolosm (2003) I I 1 4-29 
A b  tracts 
4 th I nternat ional  Sympos ium on D i abetes Mel l i tus and i ts Compl ications:  
From Molecular  B iology to C l i n ical Med i c i ne 
Preston, UK 
,\a+/ a2+ excha nge current ( INa/C.) a n d  sarcop lasmic 
"eticu l u m  ( R) aH release in  catecholam ine-ind uced 
:ardiac hypert rophy 
�Izbeta Chorvatova, George Hart and Munir Hussain 
)epartment of Medicine, Universit) C l in ical Departments, 
Jniversity of L iverpool ,  Livcrpool ,  L69 3GA. 
Ve invest igated the effects of cardiac hypertrophy, 
roduced by catecholamine admin istration, on IN&lCa and SR 
�a2+ release in isolated rat left ventricular myocytes. Steady I
tate lNa'c, density. measured using descending (+80 to -
1 0  mV) \ ol tage ramps in the \\ hole cel l  configuration, was 
creased in h) pertrophicd myoc)'tcs ( P<0.05 ) .  a2' release 
om the R \\'as also increased, \\ hereas rest ing (Ca2' J, and 
e rate of decl ine of (Ca2' ]. to control levels were 
nchanged R Ca2 • content, estimated by usi ng 1 0.0 
mol/L caffeine \\'as a lso s igni ti cant l�  increased in 
) pertrophied 01) oe� tes, but on l )  \\ hen 01 ) OC) tes \\ ere held 
nd st imulated from their normal rest ing potent ial (-80 01 V )  
ut not from -40 01\ ' .  I lo\\ e\ er .  the rate o f  dec l ine o f  
freine-induced Ca2 - transients or 1 'I� c. was not 
gni fieantl) di fferent between control and h) pertrophied 
) OC) tes. Ca2' -dependence of IN. C.. examined by 
mparing the slope of the descending phase of the 
ysteresis plots of I" .. ca vs. [Ca2 ' ] " was also s imi lar in the 
\'0 groups of cel l s. The observation that increased S R  
nction occurred only \\ hen myOC)1eS were st imulated 
om -80 mV suggests that Na' inOu.\ ma) play a role in 
Itering Ca2• homeostasis in hypertrophied cardiac muscle, 
ssibly through increased reverse Na ' /Ca2+ exchange, 
tffect of s t rep tozotocin on insu l in  and glucagon 
ecretion from t h e  isolated rat pancreas. 
mest Adeghate and Abdulsamad Poner) 
epartment of A natomy, Facul ty of Medicine and Health 
ciences, United Arab Emirates Un iversity, P.O. Box 
666, AI  Ain, United Arab Emirates. 
lreptozotocin  (STZ) is one of the most common ly used 
ents in studies on experimental  diabetes. It was the aim of 
is stud) to examine the effect of STZ on insu l in  and 
ucagon secretion from the isolated rat pancreas. 
ancreatic tissue fragments were incubated with different 
ncentrations of STZ for 1 h and the supernatant 
dioimmunoassayed for insu l in  and i l ucagon. Stimu lation 
the isolated pancreas with STZ ( 1 0' _ 1 0-4 M) resulted in  
dose-dependent i ncrease in  i nsu l i n  secretion. I nsu l in  
reted into supernatant (mean ± standard deviation) was 
. 3 1 ± 2.05, 3 7 . 2 8  ± 7 .99 and 4 1 .94 ± 1 1 .42 � I U  L'I when 
1 4  
pancreatic tissue fragments were incubated with 1 0,8 M ,  1 0  
M and 1 0-4 M o f  T Z  respectively. The level o f  i nsul in 
secretion obtained with STZ stimulation at I O� and 1 0-4 M 
were sign i ficantly ( P  < 0.02) higher than that of basal 
( 1 9.83± 5 . 1 0  � I U  L'( ). STZ el icited a dose-dependent 
increase in gl ucagons secretion from the pancreas. 
Glucagon secretion expressed as mean ± standard deviation 
was 1 84 .75  ± 44 .44, 205.83 ± 44 .30 and 248.0 I ± 98.20 pg 
mol , I , after stimulation with 1 0,8 M, 1 O� M and 1 0-4 M of 
STZ, respectively.  Glucagon secretion at 1 0-4 M of STZ 
was almost a two-fold of that obtained in the basal ( 1 56.27 
± 9.52 pg mol . ( ) .  [n  summary, STZ can el icit sign ificant 
dosc-dependent increases in  insul in and glucagons secretion 
from the isolated pancreas. STZ can thus be regarded as a 
secretagogue of pancreatic hormones. 
An update  on t h e  aet iology and epidem iology of d iabetes 
me l l i tus  
Ernest Adeghate ' ,  Peter Schattner1 and Earl Dunn) 
' Department or  Anatomy, Facult) of  Medic ine and l Iealth 
Sciences, United Arab Emirates University, AI Ain, Un ited 
Arab Emirates and 2 Department of Commun ity Medicine 
and General Practice, Monash University, Australia, and 
JDepartment of Fami ly  Medicine. Faculty of Medicine and 
Health Sciences, Uni ted Arab Emirates University, A I  Ain,  
United Arab Emirates. 
Diabetes mel l itus is one of the most common endocrinc 
disorders affecting al most 6 percent of the world's 
popU lation. The number o f  diabetic patients wi l l  reach 300 
mi l l ion in 2025 ( I nternat ional D iabetes Federation, 200 1 ) . 
More than 97 % of these patients wi II have type I I diabetes. 
The projected increase in the number of diabetic patients 
wi l l  strain the capabi l i t ies o f  health care providers the world 
over. Thus it is of paramount i mportance to revisit the 
causes and epidemiology of diabetes mel l i tus. Diabetes 
mel l itus is caused by both environmenta l  and genC'tic 
factors. The environmental factors that may lead to the 
development of diabetes mel l itus inc lude phy s ical 
inactivity, drugs and toxic agents, obesity, viral infection 
and location. Whi le  Type [ diabetes is not a genetical ly pre­
destined d isease, an increased susceptibi l i ty can be 
inherited. Genetic susceptibi l i ty p lays a crucial role in the 
aetiology and man i festation of Type [[ diabetes \� , 
concordance in monozygotic twins approach ing 1 00')-0. 
Genetic factors may have to be modified by environmental 
factors for diabetes mel l itus to become overt. An individual 
with a susceptible gene may become diabetic i f  
environmental  factors modi fy the expression o f  these genes . 
Since there is an increase i n  the trend at which di�,h�te 
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male rabbits. Antm Reprod Sci 76. 99- 1 1 1 . 2003 
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body wt) and cardiac function and protcin  phosphatase 
activities examined a fter I ,  2, 3, 4 and 8 wceks. One group 
of 4-week diabetic animals received subcutaneous injection 
of insu l in  (3U1day) for a further pcriod of 4 weeks. Cardiac 
dysfunction was apparent early on (after 2 wecks of 
induction of diabetes) and deteriorated with time. A 
signi ficant increase in protein phosphatase activity appeared 
very early (after one week) and persisted unti l 8 weeks. 
I ncreased protein phosphatase act iv i ty was consistent with a 
corresponding increase in thc protein  contents of protein 
hosphatase I and protein phosphatase 2A. Treatment \\ ith 
'nsul in partl )  reversed the abnomlal it ies observed in 
aiabctic animals. The results o f  this stud) suggest that 
i ncreased protein phosphatase act iv i ties and therefore 
enhanced protein dephosphoryation may play a role in 
diabetes induced cardiac dysfunction. 
Fructose transport and metabol ism in adipose t issue of 
Zuch.er rat : d imin ished G LUTS act ivity d u ring o besity 
and in  ul in res i tance 
Gar) J .  Litherland, Eric Hajduch, Gwyn W. Gould " & 
Hannder Hundal 
0 1 \  ision of Molecular Physiology, School of L i fe Sciences. 
1 IIWTB Complex, The University of Dundee, Dundee 
0 1  SEH U . K .  and - D i \  is ion of B iochemistry and 
!olccular l3 iolog) . Uni\  crsit) of Glasgo\\', Glasgo\\ , U .K.  
ructose I S  a major dietary sugar which is elevated in the 
erum of diabetic humans, and is associated with metabol ic 
)ndromes important in the pathogenesis of diabetic 
ompl ications. The faci l itative fructose transporter, GLUTS, 
Is expressed in insu l in  sensiti ve tissues of humans and 
rodents, where it mediates the uptake of substantial 
�uantities of dietary' fructose. a l though l i ttle is known about 
Its regulation. Here, we present evidence that GLUTS 
Fxpression and activity are compromised severely during 
pbesit) and insul i n  resistance in  Zucker (fafa) rat 
rdipocytes. Adipoc)'tes from young (falja) , highly insulin­
responsive Zud.er rats present considerably more surface 
GLUTS than those from their l ean counterparts ( l .8-fold per 
ricrogram membrane protein), and exhibit higher fructose 
ensport (4-fold) and metabolism (3 -fold) rates, largely 
�irected to\\ ard l actate production.  As rats age and become 
more obese and insul in-resistant, adipocyte G LUTS density 
r 1 2-fold) and fructose transport ( I  O-fold) and uti l i sation 
rates (3-fold) fal l  markedly. The G LUTS loss is more 
t1ramatic in adipocytes from obese animals, which develop a 
more marked insul in resistance than l ean counterparts. The 
decline of GLUTS density in adipocytes from older, obese 
animals does not appear to be a general ised effect, being 
neither shared by the Na+fK+ ATPase, a plasma membrane 
marker, nor observed in k idney. Our findings suggest that 
GLUTS expression and thus fructose ut i l isation rates in 
adipocytes are dependent upon cel l u l ar insu l in  sensitivity, 
Inferring a sign ificant role for G LUTS in the elevated 
t:irculating fructose observed during diabetes, and the l ikely 
pathological consequences. 
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The effect of Type 1 d iabetes mel l i tus on tbe  
morpho logy, cytosolic ca lc ium ([Ca2+1 , )  signals and fa tt) 
acid l ip id p rofiles in t h e  isolated rat parot id gland. 
S .  MahaY'a), 1.  Singh(a), E. Adeghate(b), M.Z. LindlcY'a) and 
C.E. Rolph(a). 
(a)Department of B iological Sciences, University of Central 
Lancashire, Preston and (b)Deparlment of Human Anatomy 
F.M.H.S,  United A rab Emirates University, P.O. Box 
1 7666, A I -Ain, UAE. 
Diabetes mel l itus (OM) is associated with numerous 
conditions including hypo-secretion of d igestive enzymes. 
This study investigates the morphology, rCa'· j, signals  anti 
fally acid l ipid profiles i n  isolated parotid glands of diabetic 
and age-matched control rats in  order to understand the 
cel lu lar mechan ism of hypo-secretion. The techniques 
employed included l ight m icroscopy, nuorimetric and gas 
chromatography analysis (GC), respectively. OM was 
induced in adult male Wistar rats by a single ( I P ) injection 
of streptozotocin (STZ) (60 mg kg! body weight). Control 
animals were injected with a s imi lar \olume of ci trate 
buffer. The animals were tested for OM 4 days after STZ 
injection and 2 months later when the\ \\ c�e humanelv 
k i l led for the experi ment. The morphologi
·
cal results sho\\ ed 
diabetic parotid glands to bc extensivel) i n fi l trated \\ ith 
l i pid droplets of various magni tudes. whereas glands from 
control animals. displa) normal structure \\ Ith the absence 
of l i pid droplets. OM produced no sign i ficant change I n  
either basal o r  Ach-e\ okcd init ia l  pe a k  rCa1 - "  signals \ \  hen 
compared to age-matched control cel l s. In  contrast, D I\ 1  
induced a signi fi cant (P<O.O I )  reduction in the plateau 
phase of the [Ca2' ] , signal compared to control cel ls. Levels 
of fatty acids ( 1 6:0, 1 6 :  I and 1 8 : I )  in diabetic parotid 
glands were signi ficantl), ( P<O.O I )  reduced comparcd to 
control glands. Thc resul ts indicate OM can elicit changes 
in the morphology, [Ca2'] ,  s ignals and in fally acid l i pid 
profi les of the isolated rat parotid gland, compared to glands 
from healthy age-matched control rats. 
The e ffect of Vita m i n  E on metabo l ic parameters of 
E x per imenta l  Diabetes Mel l i tus  
I A I  Shamsi MS, 2 Amin A and 3 Adeghate E 
Department of Graduate Studies, Department of Biology, 
Faculty of Science and Department of A natomy, Faculty of 
Medicine, United Arab Emirates University, AI Ain,  UAE. 
The role of v i tamin E on Diabetes Mel l i tus is unknown [ he 
purpose of this study was to examine the effect of "r,d 
administration of v i tamin E on some of the metah d lc 
effects of experi mental diabetic rats. Diabetes was i nduLl 
by intraperitoneal injection of STZ (60 mglkg body weight 
at 1 2  weeks of age). V itamin E (0.2, 0.4, 0.8 mgfKg body 
weight) was administered ora l ly  for a period of thrcl 
to normal and diabetic Wistar rats. In some expcr t l  I 
Vitamin E was given either before or after the induct l l 
diabetes mel l i tus. Oral glucose tolerance test (OGTl ) were 
performed on fasted normal ,  diabetic and v i tamin E-treated 
rats at the end of the experimental period. B lood sugar level 
and weight were a lso recorded on a weekly basis fn- I' h 
rat in d i fferent groups. V itam i n  E s igni ficantly (p < 0.0 1 )  
reduced blood sugar Ie el  and i mproved weight gai n  i n  
experimental diabetes mell itus a t  a l l  doses when compared 
to untreated rats. Thi s  beneficial e ffect of vitamin E on the 
hyperglycaemia of diabetic rats was dose-dependent. 
Moreover, vitami n  E also i mproved OGTT in diabetic rats 
compared to untreated d iabetic rats. In conclusion, Vitamin 
E ma) play a role i n  insu l in  metabol ism and thus be a useful 
adjuvant therapy i n  type 1 diabetes mel l i tus. 
The time cou r e of changes in a m i n e  concentrations i n  
t h c  rat t a i l  artery fol lowing ind uct ion of d iabetes with 
s t rep tozotocin.  
John Morrison, S Dhanasekaran and Rajan Sheen, 
Dcpartments of Physiology and Pharmacology, UAE 
Uni\ crsit)'. AI  A i n, UAE 
I n t roduction:  We have examined the changes in 
concentrat ions of noradrcnal ine, dopamine and seroton in in 
the proximal, middle and d istal segments of  the rat tai l  
arter) fol lo\\ i n g  the induction of  d iabetes b y  injection of  
TZ (60 mgslkg ip  at  10  wccks of  age);  the  present abstract 
is concerned with the t ime course of the changes from 1 7. 5  
\\ ee)..s o f  age to 52  wee)..s o f  age. Tissues \'vere taken under 
pcntobarbitone anaesthesia. weighed and treated with 1 0% 
sodium metabisulphite. Amines were extracted and 
anJ" �t"J u�inl!. I I P LC. Resu l t s :  The conLrol blood gl ucose 
cOn�enlrJliOn; \\ ere I n the range 57 to 68 mgs/dl and the 
diabetic le\'els were 227 to 380 mgsld\. In the control 
animab there " as a s ign i ficant increase in noradrenal ine, 
dopamine and seroton i n  concentrations with age i n  the 
proximal portion of the tail arter)', whereas this  was not 
seen in the middle (except in the case of serotonin) and 
distal segmenLS. Between 20 and 30 weeks of age, 
noradrenal i ne \ as the most abundant amine, fol lowed by 
serOlonin. dopamine and adrena l i ne.  STZ d iabl!tes resulted 
in major i ncreases in the concentrations of noradrenal i ne. 
dopamine and serotonin ( 4- 1 1 fol d )  that general ly occurred 
ahout 1 6  \\ ee)..s  1i.')l lo\\' ing the injection of STZ. The 
maximum i ncreases in amine concentrations occurred in the 
distal segments of the tai l  artery. 
Conclusion: STZ-diabetes is associated with an increase in 
the concentrations of noradrenali ne, dopam ine and 
serotonin in all segments of the tail artery of the rat. These 
peak bet\\ecn 1 0  and 20 wceks fol lowing the i nitial 
treatment. 
Biochem ical effects of Citrullus colocyntllis in non­
d iabetic and diabet ic rats. 
I AI-Ghaithi F, I EI-Rid i  M, 2Adeghate E, I A meri MH 
I Department of B iology, Faculty of Science, 2Department of 
Anatomy, Faculty o f  Medicine and H ealth Science, United 
Arab Emirates University, Al A i n, UAE.  
Diabetes mell itus is  one of  the most  common endocri ne 
diseases in the world that affects a lmost 6% of the world 
population ( I ) . In UAE many tradi tional plants are used as 
anti-diabetic remedies, such as the Citru/lus colocynthis 
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(Handal) .  The a i m  of  this  study was exami ne the effect of 
the oral admi nistration of aqueous extract of Citru/lus 
colocynthis seeds on biochem ical and metabolic parameters 
of normal and streptozotocin (STZ)-i nduced diabetes rats. 
Diabetes mel l i tus (OM) was induced by a s ingle 
i ntraperitoneal (60 mg Kg body wt . 1 ) injection of 
streptozotocin. Normal and diabetic rats were fed with the 
plant extract dai ly by oral i ntubations for two weeks. B lood 
sample col lected at the beginning and at the end of the 
experiment for measurement of biochemical parameters. 
The plasma level of A L  T increased signi ficantly after the 
onset of experimental diabetes. In contrast, the plasma level 
of AL T decreased sign i fi cantly after the adm inistration of 
the plant extract. A l l  of  these results rai sed and confirm a 
number of i nteresting issues. F i rstly, that STZ has a 
hepatotoxic  effect by i ncreas i ng the plasma level of A L  T 
and secondly, the aqueous extract of the C. colocynthis can 
ameliorate the toxic e ffect of STZ in the l i ver. Moreover. 
this study suggests that C. colocynth is is not toxic at least 
when given in the h igher doses in th is  study. In diabetic rats 
there was a signi ficant i ncrease in plasma GGT level .  This 
elevation is an indicator of hepatotoxicity caused by STZ. 
There were no signi ficant changes in  the level of GGT even 
after treating diabetic rats with low and moderate doses of 
the aqueous extract of the plant. There was no significant 
change in  the blood level of  creat in ine, calcium. sodium. 
phosphorus. I t  is not known why there were no changes in 
these biochemical paramcters a fter treatment \\ ith the pl ant 
e:--lracl . It  is possible that the concentration of the extract 
may be t oo  weak to have a signi ficant effect or the t issue or 
organ damage may be too severe to sho\\ an) delectable 
improvement. In conclusion, the results of this study 
revealed that oral administration of the aqueous extract of 
the Citru/lus colocynthis can ameliorate the toxic effect of 
STZ. 
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fncreased I n cidence o f  
Smokers :  9 year Fol low 
Prospective Diabetes Study 
Diabetic Neuropathy o n  
U p  Resu l t  of Sheffield 
S M Raj bhandari ( I ), LA Scott ( 2 )  N D Harris (2)  J D 
Ward (2)  & S Tesfaye ( 2 )  
Lancashire Teaching Hospital ,  Chorley & South Ri bble, 
PR7 I PP, (2) D iabetes Research Uni t, Royal Hal lamslme 
Hospital ,  Sheffield S 1 0 2JF, U K .  
I n t roduct io n :  A number of macrovascular risk factors have 
been associated with the development of diabLlIc, 
neuropathy (DN),  however the relation of smoking to DN 
has not been clearly establ ished in a prospective study. 
A ims: The aim of  Sheffield Prospective Diabetes stu 
to identi fy the early abnormal i t ies of c l in ical ,  biochclI l ".d, 
neurophysiological and haemorrheological functions 1 01 he 
development of complications of type 1 diabetes. Materials 
and Methods:  66 newly diagnosed diabetes subjects ( me�n 
age 3 I ± 9 (SD) duration (3  years ± 2) were identi fied and 
fol lowed up for 9 years. They had deta i led smoking h i stnry 
1>=1J"ll 'H)11l �l)1A�l lu� 
�l �t.l)�l l�t.L 
� � �tl.J\J �L�lHol\ ;.li.,l\ � ; ��\ �\ JL;"4 �W 
��\ �JA: �\.J"J\ W\�\ � 4;"J�\ 
� " 
�1iJl � "t.A. .. ),>- �)£ 
e�1 4.�1 �IJ\.o� 1 �b:- - � #1 4lS' - et;-I � � 4f y..JY� 
�#\ � �. 'I�W\ 4JJ � Jy"" '\ �, -,'hi J �, ASi· y\ 
ro �\ �  (i)1 
2 005 - 2004 

UAEU L ibrary 
11 1 1 1 1 1 11 1 11 1 11 1 1 11 1 11 1 1 1 11 1 1 11 11 1111 11 1 
1000413613 
